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1 
Abstract 
Directed differentiation of human Embryonic Stem cells (hESC) and induced Pluripotent Stem 
Cells (hiPS) is used to produce in vitro models to understand the mechanisms involved in neural 
development and to study the cellular and molecular processes affected in neurodegenerative 
diseases. Furthermore, these cells represent a potential source of in vitro generated mature 
neurons that can be used in cell replacement therapies. 
 
The laboratory where I performed my PhD thesis is interested in studying Huntington Disease 
(HD), a rare inherited disorder caused by an expanded stretch of CAG trinucleotide repeats in 
the huntingtin (HTT) gene, which results in neuronal dysfunction and death. In HD, the medium 
spiny neurons (MSNs) of the striatum represent the population most severely affected. The 
study of the different stages of striatal development in vitro from human pluripotent stem cells 
(hPSC) could be instrumental for both the identification of the molecular processes that are 
affected in HD and the generation of MSNs for cell replacement therapies. For this reason, the 
main goal of my doctoral degree was to create in vitro models that recapitulate human striatal 
development in vivo and ultimately generate authentic MSNs. 
 
In the first part of my thesis, I confirmed previous data from the lab showing that H9 hPSC can 
efficiently differentiate towards the striatal lineage (Delli Carri et al., 2013). Moreover, I 
extended this finding by showing that this protocol can be successfully applied to other three 
hPSC lines. Additionally, to better characterize the progenitor and neuronal subpopulations 
generated at different stages of the in vitro differentiation, I developed an automated microscope 
image quantification pipeline that enabled a high degree of accuracy in a diverse range of 
molecular marker measurements. With this new method, I was able to monitor cell identity 
transitions observed during in vitro differentiation and quantify the resulting neuronal 
subpopulations.  
 
Previous in vivo analysis of cell transitions in the human developing striatum allowed to identify 
two transcription factors (TFs), Gsx2 and Ebf1, involved in neuronal identity progression. 
Based on this, in the second part of my PhD work, I developed a strategy to improve MSNs 
generation efficiency from hESC. Following in vitro differentiation, I monitored the effects of 
the exogenous TFs expression by analysing the expression of various cell identity molecular 
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markers by immunofluorescence. By using this strategy, I was able to improve the 
differentiation of hPSCs into MSNs in vitro from 7% to 38%. 
In the future, we are planning to take advantage of the tools and knowledge gathered in the 
course of my PhD to develop a differentiation protocol in line with the GMP procedures 
necessary for the cell replacement approach. 
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State of the Art 
1. Huntington’s disease 
1.1. The CAG repeats in the etiology of HD 
Huntington’s disease (HD) is a rare neurodegenerative disease that leads to movement, 
behaviour and cognitive defects, and ultimately to death, as there is no effective treatment 
available at the moment.  The disease is inherited in a dominant autosomic fashion and is due to 
the expansion of a CAG repeat, which encodes for a polyglutamine (polyQ) tract, in the first 
exon of the huntingtin (HTT) gene.  
The disease has a CAG-related and age-dependent penetrance, in particular the lengths of the 
CAG tract of 36 or more repeats are associated with nearly full penetrance by age 65 years. In 
some cases, symptoms start before the age of 20 years (Juvenile Huntington's disease; JHD). 
Therefore, longer CAG repeats predict earlier onset, accounting for up to 50–70% of variance in 
age of onset, with the remainder likely to be due to modifying genes and the environment (Ross 
& Tabrizi, 2011). The prevalence in the Caucasian population is estimated at 1/10,000-1/20,000.  
Clinical features of HD include progressive motor dysfunction, cognitive decline, and 
psychiatric disturbance, probably caused by both neuronal dysfunction and neuronal cell death. 
In particular, mutant huntingtin contains an abnormally long polyQ sequence that corresponds 
to the CAG genetic expansion; the protein exhibits toxic properties that cause dysfunction and 
death of neurons. Medium spiny neurons of the striatum are particularly vulnerable to mutant 
huntingtin induced harm, but HD is increasingly recognized as a disease of the whole brain 
(Bates et al., 2015). In fact, studies carried out by in vivo neuroimaging of brains of HD patients 
have detected early changes in the volume and shape of the basal ganglia, cerebral cortex, and 
other regions, and these were evident several years prior to symptomatic onset (Rosas et al., 
2005). Within the brain, in fact, there is massive striatal neuronal cell death, with up to 95% loss 
of GABAergic medium spiny projection neurons, which project to the globus pallidus and the 
substantia nigra, whereas large interneurons are selectively spared (Ross & Tabrizi, 2011). The 
damages affecting progressively the whole brain reflect clinical disorders caused by HD. 
 
1.2. HD in the striatum 
 
The striatum, the most affected brain structure in HD, is also one of the core components of the 
basal ganglia circuitry. The term basal ganglia refers to nuclei embedded deep in the brain 
hemispheres (striatum or caudate-putamen and globus pallidus), whereas related nuclei consist 
of structures located in the diencephalon (subthalamic nucleus), mesencephalon (substantia 
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nigra), and pons (pedunculopontine nucleus) (Nery et al., 2002) (Figure 1). 
 
 
Figure 1: Nuclei in the basal ganglia. 
 
The basal ganglia, therefore, is a heterogeneous structure that receives afferents from several 
cortical and subcortical structures and projects to other basal ganglia nuclei. In particular, the 
basal ganglia and related nuclei can be broadly categorized as (1) input nuclei, (2) output nuclei, 
and (3) intrinsic nuclei. Input nuclei are those structures that receive incoming information from 
different sources, mainly cortical, thalamic, and nigral in origin. The caudate nucleus (CN), the 
putamen (Put), and the accumbens nucleus (Acb) are all considered input nuclei. The output 
nuclei are those structures that send basal ganglia information to the thalamus and consist of the 
internal segment of the globus pallidus (GPi) and the substantia nigra pars reticulata (SNr). 
Finally, intrinsic nuclei such as the external segment of the globus pallidus (GPe), the 
subthalamic nucleus (STN) and the substantia nigra pars compacta (SNc) are located between 
the input and output nuclei in the relay of information. Cortical and thalamic efferent 
information enters the striatum (CN, Put, and Acb) to be processed further within the basal 
ganglia system (Lanciego et al., 2012) (Figure 2). 
 
                                                                                                                                                      State of the Art 
 
 
 
7 
 
Figure 2: Identification of the areas in the striatum (Lanciego et al., 2012). 
 
The striatum, in fact, receives inputs from different areas of the cerebral cortex, including 
association cortical areas as well as the sensori-motor cortex, and has connections via the globus 
pallidus and substantia nigra to the thalamus and thence to premotor and prefrontal cortical 
areas. Recordings of the activity of neurons in different parts of the striatum show that they have 
the following properties: (i) neurons in much of the putamen, which receives inputs from the 
sensori-motor cortex, have activity related to movements; (ii) neurons in the caudate nucleus, 
which receives from the association cortex, have activity related for example to environmental 
stimuli which signal preparation for or initiation of behavioural responses; (iii) neurons in the 
tail of the caudate nucleus, which receives strongly from the inferior temporal visual cortex, 
respond when a patterned visual stimulus changes; (iv) some neurons in the posterior ventral 
putamen, which receives from the inferior temporal visual cortex and the prefrontal cortex, 
respond in a visual short term memory task; (v) some neurons in the ventral striatum, which 
receives from limbic structures such as the amygdala and hippocampus, respond to stimuli 
associated with reinforcement or to novel stimuli (Ehrlich, 2012). The disruption of these 
striatal pathways in HD leads to the development of motor dysfunction including hyperkinetic, 
hypokinetic, and dyskinetic movements. 
Therefore, to understand the disease and its progression is important to study the striatum, the 
most affected in this pathology. 
The striatum encompasses two different types of neurons: projection neurons and interneurons 
(90% and 10%, respectively). Projection or striatofugal neurons are also called medium-sized 
spiny neurons (MSNs) because these multipolar neurons have small to medium cellular somata 
(20 µm in diameter), and their dendritic processes are covered by postsynaptic specializations 
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called dendritic spines. All striatal MSNs are inhibitory neurons that use γ-amino butyric acid 
(GABA) as the neurotransmitter. The medium spiny neurons are innervated by excitatory 
neurons from the cerebral cortex, by thalamic neurons, and by dopaminergic neurons from the 
SNc, and cholinergic and GABAergic interneurons of the striatum (Figure 3). 
 
MSNs 90%  
(GABAergic  projection) 
 
Interneurons 10%  
(Aspiny interneurons) 
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Figure 3: Schematic of type of cells that are present in the striatum (modified from Kreitzer, 2009). 
 
According to their projection targets, the MSNs can be divided further into those innervating the 
GPe nucleus and those projecting to the output nuclei GPi and SNr. Striatal MSNs innervating 
the GPe nucleus express the dopamine receptor subtype 2 (D2R), which inhibits intracellular 
adenyl-cyclase trough G protein signalling, and projects via the indirect pathway (striato-GPe-
STN-GPi/SNr). Striatal MSNs that project directly to GPi and SNr contain dopamine receptor 
subtype 1 receptors (D1R), which activate adenylcyclase signalling (D1-containing neurons), 
take part in the direct striatopallidal pathway. Direct and indirect MSNs can be further identified 
by the expression of a few neuropeptides. Indeed, indirect MSNs express enkephalin, whereas 
substance P and dynorphin are expressed in direct MSNs.  
In addition to these spiny projection neurons, the striatum also contains several different classes 
of local-circuit neurons (interneurons), all of which show smooth dendrites. Interneurons in the 
striatum are often classified into four groups depending on their neurochemical profiles and 
morphological characteristics (Kawaguchi et al., 1995) (Figure 4).  
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Figure 4: Cell types in the striatum. MSNs Drd1, involved in the direct pathway, are indicated in red, whereas 
MSNs Drd2, involved in the indirect pathway, are indicated in blue. The four types of interneurons are represented 
in four different colours: in green the interneurons GABAergic somatostatin positive, in violet the calretinin and 
GABAergic positive, in yellow the parvalbumin and GABAergic positive, and in blue the cholinergic. 
 
In HD, both enkephalin and substance P MSNs neurons are lost, but indirect MSNs have been 
shown to be the most vulnerable in the disease process (Deng et al., 2004; Reiner et al., 1988), 
and degenerate prior to direct MSNs (Deng et al., 2004; Gerfen et al., 1990).  
The possible pathogenic mechanisms of HD that affect preferentially MSNs include abnormal 
aggregation (inclusions) and clearance of polyQ-HTT, bioenergetic deficits, neurotrophin 
deficiency, transcriptional dysregulation, disorders of axonal transport, and excitotoxicity. The 
first point is the transcriptional dysregulation induced in MSNs by full length mutant HTT 
(mHTT) or a fragment thereof (polyQ-HTT) are to some extent exclusive to the MSN, even if 
the same transcripts are expressed outside the striatum (Sugars & Rubinsztein, 2003); in vivo, 
viral mediated expression of polyQ-HTT exclusively in the striatum results in reversible 
formation of inclusions, transcriptional dysregulation, and MSN death, while sparing 
interneurons (Ruiz & Déglon, 2012).  
The cortex is the source of 80 to 90% of the BDNF in the striatum, to where it is anterogradely 
transported (Altar et al., 1997; Canals, 2004; Fusco et al., 2003). Several works have 
demonstrated the important role for BDNF in the maturation of the MSN, and there is also a 
requirement for BDNF in the maintenance of adult striatum. In HD, the amount of BDNF 
reaching the striatum is further reduced secondary to axonal transport deficits (Cattaneo et al., 
2001; Crook & Housman, 2011; Gauthier et al., 2004). 
Finally, the status of autophagy and the role of ubiquitin-proteasome system and the clearance 
of aggregated polyQ-HTT are of great interest, and could clarify the toxic effect of mHTT on 
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MSNs (Ehrlich, 2012). 
Albeit less pronounced than in the striatum, differential vulnerability and loss of selected 
neuronal populations is also readily observed in the cerebral cortex of HD patients. Specifically, 
large pyramidal projection neurons in cortical layers V, VI and to a lesser extent, layer III, are 
preferentially lost (Cudkowicz & Kowall, 1990; Hedreen et al., 1991). Long axons emanating 
from cortical projection neurons in layers V and VI innervate the striatum. In primates, these 
axons are thin and unbranched with a single target. As in the striatum, there is remarkable 
preservation of small cortical interneurons (i.e., layer IV granule cells) in HD (Cudkowicz & 
Kowall, 1990; Han et al., 2010) (Table 1).  
 
MSN +++ projection neurons, Cortex (Glu), GPi, SNr D1, GABA Substance P/ DARPP32
(direct pathway) long axon SNc (DA), NMDA, Dynorphin GAD
Thalamus (Glu) AMPA
MSN +++++ projection neurons, Cortex (Glu), GPe D2, GABA Enkephalin DARPP32
(indirect pathway) long axon SNc (DA), NMDA, GAD
Thalamus (Glu) AMPA
Interneurons + extensive dentritic MSNs, other MSNs, other D2, Ach. Neuropetide Y, iNOS
network, axon projects interneurons interneurons NMDA, parvalbumin somatostatin
locally AMPA
Pyramidal neurons +++ projection neurons, Thalamus, Striatum, Glu, Glu MAP2 CaMK
(layers V/VI) long axon brainstem nuclei brainstem, Ach,
thalamus DA, NE,
5HT
Interneurons + extensive dentritic Thalamus Pyramidal Glu, GABA Neuropetide Y, GAD
network, axon projects neurons GABA somatostatin
locally
NT receprtors NT Peptides Other molecular markers
Cerebral Cortex
Striatum
Anatomical location Cell type Relative vulnerability Morphology Afferents Target
 
Table 1: Summary of striatal and cortical neurons affected in HD and their characteristics (modified from 
Han et al., 2010). 
 
1.3. Using hPS to generate MSNs in vitro 
Currently, there is no known cure for HD. However, the specificity of cell loss seen at least in 
early stages of the disease principally involving loss of the MSN projection neurons has made 
cell transplantation a viable therapeutic prospect (Reddington et al., 2014). Transplants using 
primary human fetal striatal tissue have demonstrated “proof-of-principle” that cell replacement 
is feasible, that the grafts are safe and do not accelerate disease progression (Bachoud-Levi et 
al., 2000; Bachoud-Lévi et al., 2006; Barker et al., 2013). These studies have been conducted on 
a very small number of HD subjects and have revealed a significant, although incomplete and 
temporally limited to a few years after transplantation, functional recovery in at least some 
patients (Bachoud-Levi et al., 2000; Bachoud-Lévi et al., 2006; Barker et al., 2013). However, 
due to the ethical issues associated with the use of human fetal cells obtained from elective 
termination of pregnancies, the logistical issues arising from the amount of fetal tissue required 
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per patient, and the difficulties in achieving an appropriate level of standardization and quality 
control for tissues derived from such a recurrent clinical source, better renewable sources of 
cells for transplantation are under active exploration.  
Human pluripotent stem cells (hPSCs) are the leading contender under consideration, by virtue 
of their capacity for indefinite expansion as well as their potential for differentiation to 
essentially any mature fate. The principle sources being human embryonic stem cells (hESCs) 
and/or induced pluripotent stem cells (hiPSCs), followed by directed differentiation in vitro 
towards a specific neural phenotype prior to transplantation as required for each disease target.  
Over the last 6 years there has been some considerable success in producing MSN-like neurons 
from diverse hPSC sources, including from hESCs that have been directed to a neuronal 
phenotype, and then ventralised using sonic hedgehog (Arber et al., 2015; Aubry et al., 2008; 
Delli Carri et al., 2013; Ma et al., 2012; Nicoleau et al., 2013). These studies are very important 
as they may improve our understanding of the mechanisms underlying HD and to study the 
specific deficits of MSNs and, in the future, to obtain MSNs for the cell replacement approach. 
However, although there is some evidence that the transplanted cells corrected motor deficits in 
a rodent model of striatal neurodegeneration, in no case to date have the cells demonstrated a 
full repertoire of functional improvements (Arber et al., 2015; Aubry et al., 2008; Delli Carri et 
al., 2013; Ma et al., 2012; Nicoleau et al., 2013). Thus, this data suggest that the obtained cells 
are not pure MSN populations and that an improved protocol for in vitro differentiation is 
necessary. 
 
To obtain authentic human MSNs from hPSCs it is important to accurately guide their 
differentiation and to do so, it is vital to take in account the lessons gained from the study of 
embryonic development, in particular to reconstruct the passages that in vivo lead to striatum 
formation.  
 
 
 
 
 
 
 
 
2. Embryonic development of the brain 
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2.1. Neurulation 
Neurulation is the developmental process upon which the neural tube is formed. This complex 
developmental phenomenon starts around the third week post fertilization in humans and 
involves numerous cell processes that result in the formation of the central nervous system and 
the spinal cord.  
At the end of the 2nd week (post fertilization), the embryo consists of a bilaminar disc with 
epiblast cells located at the top, and hypoblast cells located at the bottom layer (Figure 5). Soon, 
a groove, the primitive streak, appears in the caudal third of the disc, along the midline, 
signalling the initiation of gastrulation: the formation of a trilaminar disc containing three germ 
layers, ectoderm, mesoderm, and endoderm (Figure 5). 
Primitive streak 
Endoderm 
Epiblast 
Hypoblast 
Ectoderm 
Mesoderm 
Definitive 
endoderm 
Bilaminar 
Disc 
Trilaminar 
Disc 
 
Figure 5: Schematization of the disc with two and three germ layers, ectoderm, mesoderm, and endoderm 
(modified from Sanes & Harris, 2006). Cross-sectional view of embryo to show movements of epiblast 
(ectoderm)(blue) through primitive streak to form the prospective endoderm (yellow), and mesoderm (red). 
 
At the cranial end of the streak lies the primitive node, Hensen’s node, an important center for 
the organization of the embryonic axes. During gastrulation, epiblast cells migrate towards and 
through the streak and the node, detach, and form two new layers ventral to the remaining 
epiblast. Cells remaining in the epiblast that do not migrate through the streak or node constitute 
the ectoderm. Cells that migrate cranially through the node will form the prechordal plate and 
the notochord. These structures initiate the process of neurulation by inducing formation of the 
neural plate from the overlying ectodermal cells. The remaining ectodermal cells surrounding 
the neural plate will form the epidermis. Induction of the neural plate originates from the 
inhibition of epidermis formation by signals emanating from the primitive node. Thus, the 
default state of the original ectodermal germ layer is neural, not epidermal (Figure 6).  
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Figure 6: The image represents the primary neurulation process where the neural plate folds to originate the 
nascent neural tube (modified from Feinberg & Mallatt, 2013). 
 
The neural plate is subsequently converted into the neural tube by a two-stage process, the 
primary and the secondary neurulation. The primary neurulation gives rise to the neural tube 
that will develop later into the brain and most of the spinal cord; the secondary neurulation leads 
to the formation of the neural tube in the caudal sacral and coccygeal regions (Copp et al., 2003; 
Greene et al., 2009; Schoenwolf & Nichols, 1984; François Guillemot, 2005). In both, the 
primary and secondary neurulation processes, closure of the tube does not occur synchronously 
along the anterior-posterior axis, but generally progresses from anterior to posterior axis.  
 
2.2. Neural tube regionalization 
At the end of the process of neurulation, the neural tube will differentiate to create patterns of 
cell types in three axes, antero-posterior, dorso-ventral and medio-lateral, thus forming the brain 
in the anterior part, and the spinal cord in the posterior end of the neural tube. 
Based on gene expression patterns as well as morphological information, a segmental-
topological model called “prosomeric model” has been used to interpret neural plate and tube 
regionalization (Puelles & Rubenstein, 1993; Rubenstein et al., 1994). This model hypothesizes 
that the embryonic forebrain is a neuromeric structure subdivided into a grid-like pattern of 
histogenic domains by longitudinal (columnar) and transverse (segmental) boundaries (Puelles 
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& Rubenstein, 1993; Bulfone et al., 1993; Rubenstein et al., 1994; Shimamura et al., 1995). The 
longitudinal boundaries segregate columns of cells with similar properties that are specified by 
dorso-ventral (DV) patterning mechanisms, while the transverse boundaries are specified by 
antero-posterior (AP) patterning. DV and AP patterning originate from the interplay between 
different morphogens gradients and transcription factor expression patterns in the neural tube. 
At the end of these processes, the Central Nervous System (CNS) is highly regionalized along 
these main axes.  
 
2.3. Neural tube patterning 
Along the AP axis, signals divide the neural tube into four major divisions: forebrain, midbrain, 
hindbrain, and spinal cord, and these differences can be detected soon after the formation of the 
neural plate. The FGF, WNT, and RA signalling pathways have been implicated in the 
caudalization of neural tissue. Boundaries of Hox gene expression are observed along the AP 
axis and have been suggested to be involved in establishing different identities in the hindbrain 
and spinal cord (Altmann & Brivanlou, 2001). 
Along the DV axis, cell fate determination involves the action of two opposing signalling 
pathways: SHH ventrally from the notochord and BMP dorsally from the boundary of neural 
and non-neural ectoderm and later from the roof plate. In addition, WNT signalling has been 
shown to act in DV patterning too (Altmann & Brivanlou, 2001) (Figure 7). 
 
Figure 7:  Signalling involved into dorso-ventral pattering (modified from Rowitch & Kriegstein, 2010). 
 
Before the expression of other morphogens, the initial AP pattern is induced by the combined 
action of Lim1, Otx2 and Cerberus signals, produced by the dorsal mesoderm, that initiate 
neural development and induces the neuroectoderm, which has an anterior neural fate (forebrain 
and midbrain) (Doniach, 1993). Candidate transcription factors for neuroectodermal induction 
are Lim1 and Otx2, while a candidate morphogen is Cerberus, a WNT inhibitor. The two 
homeodomain transcription factors, Lim1 and Otx2, are expressed in the tissues underlying the 
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anterior neural plate and seem to be essential for the development of anterior CNS structures. 
Loss-of-function mutants result in mouse embryos lacking forebrain and midbrain structures, 
suggesting that Lim1 and Otx2 have a role in early AP patterning.  
Basic FGF and RA, regulating Hox gene expression, create a gradient of signals that are able to 
posteriorize the neural plate, inducing hindbrain and spinal cord development (Lamb & Harland, 
1995; Cox & Hemmati-Brivanlou, 1995; Hemmati-Brivanlou & Melton, 1997) . 
Fgf8 encodes a signalling molecule that regulates forebrain morphogenesis (Rubenstein et al., 
1998) and that is expressed in the rostrodorsal and rostroventral midlines (and surrounding 
tissues), respectively (Ohkubo et al., 2002; Fukuchi-Shimogori, 2001). Additionally, recent 
work has shown that FGF signalling has a role also in ventralization of the telencephalon and 
the eye (Lupo et al., 2006). 
The first signalling molecule to be implicated, as a regulator of Hox expression, was a derivative 
of vitamin A, RA. Experiments performed on ES cells have demonstrated that with low 
concentrations of RA only those Hox genes normally expressed in the anterior embryo are 
expressed, while at progressively higher concentrations of RA, more posteriorly expressed Hox 
genes are expressed in the cells (Simeone et al., 1995). In mammals, this latter gene family 
comprises closely related genes for homeodomain transcription factors, organized in 4 
homologous clusters (Pearson et al., 2005). Hox genes are principally involved in specifying 
segmental identity, but before any molecular marker of morphological segmentation exists. The 
pattern of expression of the different Hox genes determines the morphological identity of the 
cranial nerves and other pharyngeal arch derivatives that arise from specific rhombomeres 
(Lumsden & Krumlauf, 1996). 
 
Another morphogen important in AP patterning and implicated also in DV pattering are the 
WNTs, which belong to the wingless protein family and are a class of ligands that are crucial in 
embryogenesis. WNTs can signal through three different pathways, one of which is the 
canonical pathway, which is implicated in DV pattering. In this case, β-catenin is indirectly 
activated by a WNT ligand binding to the cell surface receptor, Frizzled. 
Early in vertebrate development, WNT signalling controls AP axis formation (Takahashi & Liu, 
2006). In particular, essential to this process is the establishment of a rostral–caudal WNT 
gradient, as the effects of WNTs are highly dose-dependent. Low levels of anterior WNT 
activity and high posterior levels are required for proper patterning of neural structures along the 
AP axis (Takahashi & Liu, 2006). 
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Bone-morphogenic proteins (BMPs) are members of a very large family of proteins, known as 
the TGF- β family of factors, which are mainly involved in DV patterning. BMPs are expressed 
in the prospective neuroectoderm before neural induction, and then in the dorsal neural tube and 
adjacent non-neural ectoderm, whereas secreted BMP antagonists are expressed in the 
notochord and the paraxial mesoderm surrounding the ventrolateral neural tube. Diffusion of 
BMPs and their antagonists is thought to create a dorsal (high) to ventral (low) gradient of BMP 
activity, which specifies distinct progenitor domains in the dorsal spinal cord. The results of 
several studies strongly support this model, showing that increasing or decreasing BMP 
signalling in the dorsal neural tube expands or reduces specification of dorsal cell types. 
BMP signals have a role in patterning the dorsal telencephalon, and inhibition of BMP 
signalling, for example effect of SHH signal, might be necessary for ventral telencephalic 
specification (Furuta & Hogan, 1998) (Figure 8).  
 
Figure 8: Schematic representation of BMP signal, which promote dorsalizing fate, in opposition to 
ventralizing effect of SHH signal (from Developmental Biology, 11th edition). 
Different concentrations of BMPs differentially regulate the growth of different prosencephalic 
regions, suggesting that a normal function of these molecules may be necessary to regulate 
regional growth and patterning of the brain (Crossley et al., 2001).  
There are many similarities between the WNT and BMP signalling pathways. In fact, there are 
several natural inhibitors of these pathways; for the BMP pathway, FOLLISTATIN, NOGGIN, 
and CHORDIN can interfere with the activation of the pathway by blocking BMP from binding 
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to the receptor, and for the WNT pathway, CERBERUS, and Dickkopf-related protein 1 (DKK 
1) prevent activation, most likely by blocking the WNT. 
In particular, NOGGIN binds several BMPs with very high (picomolar) affinities, with a 
marked preference for BMP2 and BMP4 over BMP7. By binding tightly to BMPs, NOGGIN 
prevents BMPs from binding their receptors (Zimmerman et al., 1996) (Figure 9).  
 
Figure 9: The current model of neural induction in embryos (Development of the Nervous System, 2012). 
NOGGIN interferes with the activation of the BMP receptor by the BMPs in the ectoderm and thereby blocks the 
anti-neuralizing effects of BMP4. In other words, NOGGIN “induces” this region of the embryo to develop as 
neural tissue, ultimately generating the brain, spinal cord, and most of the peripheral nervous system. 
 
Although NOGGIN does not play an essential role in the induction of neural tissue, it is 
required for subsequent development of the neural tube. In noggin mutants, the neural tube fails 
to close in cranial and lumbar regions: there is a dramatic reduction in the amount of posterior 
neural tissue, and a precluded ventral development in the posterior neural tube. Mice lacking 
dkk1 alone are similar to the double noggin/chordin knockout mice: they lack head and brain 
structures anterior to the hindbrain (Schoenwolf & Smith, 1990). 
 
Sonic hedgehog (SHH), which has an opposite effect to BMPs signalling, is a member of the 
HH family of secreted proteins and is expressed in the floor plate and the underlying notochord. 
Overexpression and functional inhibition studies have shown that SHH is necessary and 
sufficient to induce the floor plate and the ventral progenitor domains all along the neural tube 
(Briscoe & Ericson, 2001; Jessell, 2000; Ruiz I Altaba et al, 2003). Extensive experimental data, 
based on both gain- and loss-of-function approaches performed in all the main vertebrate model 
systems (fish, frog, chick and mouse), have shown that SHH signals are crucial in the 
specification of ventral cell fates throughout the CNS (Briscoe & Ericson, 2001; Chiang et al., 
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1996; Wilson & Maden, 2005). Shh is expressed, also, along the entire AP extent of the 
prechordal plate and the notochord. Whereas SHH induces the expression of some genes (e.g. 
Shh, HNF3, Nkx2.2) in all regions of the medial neural plate/ventral neural tube, other genes are 
induced specifically within particular regions along the AP axis. For instance, SHH induces the 
expression of Nkx2.1 in the prosencephalic neural plate, whereas in more posterior locations it 
induces Nkx6.1 expression (Hogan et al., 1995) (Figure 10). 
 
Figure 10: Schematic representation of SHH and TGF-β gradient in the CNS (Development of the Nervous 
System, 2012) 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
3. Development of the striatum 
Following neural patterning, the most anterior portion of the neural tube shows drastic changes 
before the posterior portion of the tube is formed. Indeed, in this region the tube balloons into 
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three primary vesicles: the forebrain (prosencephalon), midbrain (mesencephalon) and hindbrain 
(rhombencephalon). While the rhombencephalon is subdivided into the metencephalon and 
myelencephalon, the forebrain is subdivided into the prosencephalon, from which are derived 
the telencephalon and diencephalon (Figure 11). 
 
Figure 11: Schematic representation of forebrain (prosencephalon), midbrain (mesencephalon) and 
hindbrain (rhombencephalon) (modified from Pearson Education, 2011). 
 
In particular, the prosencephalon is subdivided into the anterior secondary prosencephalon 
(telencephalon and hypothalamus) and the more caudal diencephalon (Pombero & Martinez, 
2009) (Figure 12).  
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Figure 12: Subdivization of the prosencephalon into the anterior secondary prosencephalon (telencephalon 
and hypothalamus) and the more caudal diencephalon (Vieira et al., 2010). 
 
The telencephalic primordium is located in the anterolateral neural plate and anterior neural 
ridge (ANR), and it is the latter structure that is important in regulating the growth of the 
anterolateral neural plate. For its specification, there is a discrete group of adjacent cells that act 
as an organizer to induce the formation of the telencephalon. Cells at the rostrolateral end of the 
neural plate are fated to become the telencephalon (Cobos et al., 2001; Inoue et al., 2000). These 
cells turn on expression of Foxg1, a transcription factor that belongs to the forkhead family of 
genes. RNA in situ hybridization analysis and lineage tracing using Foxg1Cre mice have shown 
that Foxg1 expression in the anterior neuroepithelium specifically marks telencephalic precursor 
cells and delineates most of the embryonic telencephalon (Hébert & McConnell, 2000; 
Shimamura et al., 1995, 1997; Tao & Lai, 1992).  
Once the anterior neural plate acquires a telencephalic fate and expresses Foxg1, it becomes 
further subdivided into domains distinguishable by the expression of other molecular markers. 
These include genes encoding transcription factors that are expressed in specific telencephalic 
subdomains, such as Nkx2.1, Gsx2, Pax6, and Emx2, as well as extracellular factors that are 
expressed in signalling centres at the edges of these subdomains, such as SHH, FGFs, WNTs, 
and BMPs (Hébert & McConnell, 2000; Shimamura et al., 1995, 1997; Tao & Lai, 1992). The 
expression and function of these TFs will be described in the following sections. 
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3.1. Molecular definition of the telencephalic region  
The specification of the DV patterning of telencephalic region requires the correct establishment 
of SHH signalling, and Glioma-associated oncogene homolog 3 (GLI3) activity. The latter is a 
member of the Gli family of zinc finger TFs, and its expression is regulated in a SHH-dependent 
manner. Specifically, it is believed that the activity of Gli3 is negatively regulated by SHH. At 
the dorsal region of the telencephalon, where the concentration of SHH is limited, the Gli3 
protein is converted from an activator into a repressor form and promotes dorsal patterning 
(Evans, Kelly, Precious, & Rosser, 2012). SHH signalling also supports the expansion of 
progenitors of the ventral telencephalon by inducing and maintaining the expression of Nkx2.1 
until at least E14 in the mouse and later into neurogenesis (Evans et al., 2012). Although BMP 
inhibition is required for neuronal development, BMPs are needed to dorsalize the 
telencephalon and restrict ventral telencephalic development. BMPs over-expression has shown 
inhibition of Foxg1, Nkx2.1, and Dlx2 genes, TFs typical of the ventral telencephalon. 
Likewise, WNTs are crucial for the generation of the dorsal telencephalon (Houart et al., 2002) 
and specific concentrations are needed to further refine regional patterning and to induce the 
expression of Pax6, a dorsal telencephalon marker (Kim, Anderson, Rubenstein, Lowenstein, & 
Pleasure, 2001). 
Taken together, these conserved mechanisms provide the core of telencephalon patterning 
(Lupo et al., 2006) (Figure 13). 
 
 
Figure 13: Signalling involved in telencephalon patterning (Lupo et al., 2006). 
 
The primary division within the telencephalon is the pallial-subpallial boundary (PSB), a cell-
lineage restricted boundary that divides the telencephalon into the ventral (subpallial) and dorsal 
(pallial) telencephalon (L Puelles & Rubenstein, 1993; Rink & Wullimann, 2002) (Figure 14). 
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Figure 14: Dorsal-ventral subdivision of the telencephalon (modified from Toresson et al., 2000). 
 
The pallium includes the developing cerebral cortex, while the subpallium the ganglionic 
eminences which are constituted by the medial (MGE) and lateral (LGE) elevations, whereas at 
caudal levels there is a single eminence, known as the caudal ganglionic eminence (CGE) 
(Figure 15). 
 
Figure 15: Partition of the telencephalon into cerebral cortex, lateral ganglionic eminence and medial 
ganglionic eminence (modified from Lupo et al., 2006). 
 
 
3.2. Dorsal telencephalon  
The pallium contains the cortical structures and the pallial nuclei (Nural & Mastick, 2004). 
Several transcription factors are important for dorsal telencephalic patterning, Pax6 and Emx2 
are two examples of TFs whose expression is essential for cortex development (Figure 16). 
Pax6 in mouse is first detected at embryonic day 8 (E8) in the developing forebrain in a broad 
domain, encompassing the prospective optic vesicles, telencephalon and diencephalon. During 
the period of neurogenesis in the telencephalon (E10.5–18.5), Pax6 is expressed in the 
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mitotically active ventricular zone of the dorsal telencephalon, and in the stream of cells linking 
the ventral pallium through the adjacent striatum and parastrial area. Pax6 is also expressed at 
low levels in the ventricular zone of the LGE, future striatum, located just ventral to the pallio-
subpallial boundary but is absent in the MGE, future pallidum (Manuel & Price, 2005). Pax6 
loss-of-function leads to an expansion of the expression of MGE marker genes Shh, Nkx2.1 and 
Lhx6 into the territory of the LGE. This mispatterning alters the regional identity of the LGE, 
resulting in an enlargement of the MGE territory at mid gestation followed by 
underdevelopment of the striatum later on (Manuel & Price, 2005) (Figure 16). 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 16: Pallium and subpallium border in WT and Pax6−/− embryos (Manuel & Price, 2005). 
 
The bHLH transcription factors Ngn1, Ngn2 and Ascl1 are implicated in the specification of 
dorso-ventral fates in the telencephalon. Ngn1 and Ngn2 are required to establish pallial 
properties and to repress subpallial properties including the expression of the ventral specific 
genes like Ascl1. Since there is evidence of a direct regulation of Ngn2 by Pax6 in the dorsal 
telencephalon, it is likely that Pax6 regulates pallial development in part by activating the 
expression of Ngn1 and Ngn2, which in turn represses ventral identity (Manuel & Price, 2005). 
The homeobox gene Emx2 is expressed in the ventricular zone of the dorsal telencephalon in a 
gradient opposite to that of Pax6, rostro-laterallow to caudo-medialhigh (Muzio et al., 2002). 
As in Pax6−/− mutants, the dorsal telencephalon of Emx2−/− embryos is severely affected. 
Nevertheless, in the absence of either EMX2 or PAX6, the cerebral cortex forms and is 
morphologically and molecularly distinguishable from adjacent structures such as basal ganglia 
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and fimbria. In double homozygous Pax6−/−/Emx2−/− mutants the cortex does not form, and 
ventral progenitor domains expand across the entire dorsal telencephalon (Molyneaux et al., 
2007) (Table 2). 
Thus, PAX6 and EMX2 define rostral and caudal cortical areas, and in combination are both 
essential for the formation of the telencephalon. 
 
 
 
 
 
 
 
 
 
 
 
Table 2: Neural phenotypes of mutant mice carrying null alleles of genes enriched in the dorsal 
telencephalon (Takahashi and Liu, 2006). 
 
 
3.3. Ventral telencephalon (Subpallium) 
The subpallium is marked by the expression of Gsx1 and Gsx2 and develops into the basal 
ganglia, which is responsible for coordination and planning of movement and quickly further 
subdivides into the dorsal pallidum and the ventral olfactory bulbs (Puelles et al., 2000; Sueiro 
et al., 2004). 
Gsx1 and Gsx2 are homeobox genes that are expressed in subpallial progenitor neuroepithelium 
regions (Valerius et al., 1995). Their expression patterns largely overlap, which suggests 
functional redundancy. However, Gsx2 expression extends beyond the dorsal limit of Gsx1 in 
the LGE, implying that Gsx2 has unique functions in the dorsal LGE. In addition, Gsx1 mutants 
do not show an obvious telencephalic phenotype (Li et al., 1996), while Gsx2 mutants have a 
hypoplastic LGE (Szucsik et al., 1997).  
Different studies have provided evidence that PAX6 and GSX2 have complementary functions 
in patterning the progenitors that flank the PSB by regulating opposing genetic programs (Yun 
et al., 2001). In fact, deletion of the murine Gsx2 gene causes an expansion of the dorsal Pax6 
expression into the ventral LGE territory, whereas Gsx2 misexpression represses the dorsal 
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marker Pax6 and upregulates the ventral markers, Dlx and Ascl1. These data indicate that Gsx2 
regulates dorsal/ventral marker expression and LGE specification (Kyuson et al., 2003).  
Several other transcription factors have also been linked to different phases of neuronal 
development within the ventral telencephalon, some of them are shown in Table 3 below. 
 
 
 
 
 
 
 
 
 
 
 
 
Table 3: Neural phenotypes of mutant mice carrying null alleles of genes enriched in the ventral 
telencephalon (Takahashi & Liu, 2006). 
 
Within the subpallium, the MGE, LGE, and CGE produce distinct groups of neurons and 
interneurons that populate the entire dorsal and ventral telencephalon. Similar to the patterning 
of the dorsal telencephalon, morphogenetic molecules and transcription factors are engaged in 
patterning and specification of LGE, MGE, and CGE (Takahashi & Liu, 2006) (Figure 17). 
 
Figure 17: Morphogenetic molecules engaged in patterning and specification of the ventral telencephalon 
(modified from Greenberg et al., 2015). 
 
3.3.1. MGE 
The MGE is a very heterogeneous structure, giving rise to progenitors of interneurons from the 
cerebral cortex and the hippocampus, and progenitors of the globus pallidus (Marin et al., 2000; 
Wichterle et al., 2001).  
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Otx2 expression in the E9.5–E12.5 subpallium is restricted to the ventricular zone (VZ) and sub-
ventricular zone (SVZ), where in the MGE it is required to generate normal numbers of SVZ 
progenitors and mantle zone (MZ) neurons (Casarosa et al., 1999; Yun et al., 2001). 
Furthermore, Otx2 promotes oligodendrogenesis through positive regulation of Olig1 and Olig2 
(Hoch et al., 2015; Petryniak et al., 2007; Yuen et al., 2014). Within the MGE, Otx2 is required 
for the production of specific MGE derivatives (Hoch et al., 2015). In fact, Otx2 may be 
involved in regulating and responding to FGFs. This signalling is essential for the generation of 
ventral cell types in the telencephalon. In fact, disruption of the gene that encodes FGF receptor 
1 (Fgfr1) leads to a loss of expression of LIM homeobox protein 6 (LHX6) and LHX7, two 
LIM-domain transcription factors that are expressed in the MGE and are necessary for the 
differentiation of MGE-derived interneurons. In these mutants, Nkx2.1, which is normally 
expressed in the MGE and is necessary for its development is no longer expressed (Hébert & 
Fishell, 2008). Nkx2.1 encodes a homeodomain transcription factor that is expressed in the VZ, 
SVZ and in a subset of neurons in the MZ of the MGE (Sussel et al., 1999). Several lines of 
evidence demonstrated that Nkx2.1 function is essential for the specification of ventral identities 
and required for the specification of major subgroups of cortical interneurons of the MGE. In 
fact, Nkx2.1-/- mouse mutants, show molecular features of the LGE inside the MGE domain and 
generates striatal rather than pallidal neurons (Elias et al., 2009; Sussel et al., 1999). However, 
the human fetal brain development study had shown the expression of NKX2.1 also in the 
developing striatum. At 7–8 w in human embryos, in fact, ~74% of the total striatal cells was 
NKX2.1+ and most NKX2.1+ cells co-expressed ISLET1 and CTIP2 (80.7 ± 6% and 95.9 ± 
0.9%, respectively). At 20w NKX2.1 and ISLET1 were restricted to a few scattered cells (6.3 ± 
2.7%). These observations suggested that the co-expression of NKX2.1 identifies the majority 
of striatal precursors, which later switch off the expression of NKX2.1 and ISLET1, and only 
CTIP2 expression is maintained (Onorati et al., 2014). 
  
3.3.2. LGE 
Within the LGE, the ventral part contains progenitors of GABAergic projection neurons in the 
striatum and the nucleus accumbens, while the dorsal part contains interneuronal progenitors 
that will migrate to the olfactory bulb (Rubenstein et al., 1998; Stenman et al., 2003; Wichterle 
et al., 2001). Working downstream the dorsal-ventral patterning are domain-specifically 
expressed transcription factors (TFs), whose expression is critical for the proper establishment 
of the LGE (Fjodorova et al., 2015) (Figure 18).  
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Despite expression in both the LGE and MGE, Gsx2 encodes for a protein involved in 
delineating dorsal-ventral cell fate, and it seems to be intimately involved in LGE development 
(Szucsik et al., 1997). This gene is present in large amounts in the developing ventricular 
eminences of the mouse brain, and mice with a targeted mutation of Gsx2 show aberrant LGE 
development, as outlined by a reduction in size and the lack of Dlx2, Ascl1 and Ebf1 expression 
(Corbin et al., 2000; Szucsik et al., 1997; Toresson & Campbell, 2001). Using conditional gain-
of-function and loss-of-function approaches in mice, different studies have demonstrated the 
temporally distinct roles for Gsx2 in the specification of ventral LGE (vLGE) and dorsal LGE 
(dLGE). In particular, at early stages of telencephalic development, Gsx2 is necessary and 
sufficient to correctly specify the vLGE and its major derivatives: the striatal projection 
neurons. However, at later stages, high levels of Gsx2 specify LGE progenitors towards a dLGE 
fate including olfactory bulb interneurons (Waclaw et al., 2009). 
Gsx2 together with Gsx1 is essential for specifying LGE precursors. In Gsx1-/-; Gsx2-/- mouse 
mutants, LGE precursors are dorsalized and fail to express Ascl1, which acts as an effector of 
GSX2 function (Toresson & Campbell, 2001; Waclaw et al., 2009a). Gsx2 is upstream of Ascl1 
(Mash1), a bHLH transcription factor, which is expressed in the SVZ and a subset of VZ cells in 
the ganglionic eminences (Guillemot et al., 1993; Lo et al., 1991). Ascl1 null mice show a 
severe loss of neuronal precursors, especially in the SVZ of the MGE, additionally, the VZ 
shows premature differentiation and results in discrete neuronal populations of the basal ganglia 
being absent. Thus, it appears that Ascl1 is important in maintaining distinct the two cell 
populations that make up the VZ and SVZ, and also for specification of neuronal precursor cells 
in the MGE (Casarosa et al., 1999). 
Another group of transcription factors important for ventral telencephalic development are the 
Dlx genes. Dlx act downstream of both Gsx2 and Ascl1 (Casarosa et al., 1999; Toresson et al., 
2000; Waclaw et al., 2009; Yun et al., 2001). There are four Dlx genes expressed in the 
developing forebrain: Dlx1, Dlx2, Dlx5, and Dlx6 (Panganiban & Rubenstein, 2002). Dlx1/2 and 
Dlx5/6 form big gene clusters that are regulated coordinately by intragenic and extragenic 
enhancers following a specific temporal sequence (Eisenstat et al., 1999; Ghanem et al., 2003).  
Dlx1/2 are co-expressed within subsets of Gsx2 and Ascl1 progenitor cells; loss of Dlx1/2 
function results in maintenance of Gsx2 and Ascl1 expression but failure to express Dlx5/6 
(Anderson et al., 1997; Long et al., 2007; Long et al., 2009; Yun et al., 2002). More recent 
studies suggest that Dlx2 expression may in fact, precede that of Dlx1. Whilst Dlx5/6 are 
expressed in the same forebrain regions as Dlx1/2, their transcripts are found in more 
differentiated cells (Long et al., 2009).  
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Striatal differentiation is also associated with the expression of Ebf1 (Garel et al., 1999). Ebf1 is 
a member of the Ebf gene family and encodes for a transcription factor that is expressed in both 
the LGE and MGE between E11 and E17.5 in mice (Garel et al., 1999). In Ebf1 deficient mice, 
cells at the SVZ/mantle transition zone in the embryonic LGE show an inability to downregulate 
SVZ specific genes such as Dlx5, and they are unable to activate mantle-specific genes such as 
Cadherin 8 and CRABP1. Thus, Ebf1 acts in the regulation of the SVZ–mantle transition and it 
may be specifically involved in striatal differentiation since tangentially migrating interneurons 
are not affected in homozygous Ebf1 knockout embryos. 
 
 
Figure 18: Summary of markers specific for subpallium development (Fjodorova et al., 2015). 
 
 
3.3.3. CGE 
The CGE gives rise to a diversity of GABAergic interneurons that populate different CNS 
regions, including supragranular layers of the cortex, consist of layers I to III, the nucleus 
accumbens, the bed nucleus of the stria terminalis, the hippocampus, the amygdala, the caudal 
striatum, and the globus pallidus (Bartolini & Ciceri & Marín, 2013; Kepecs & Fishell, 2014; 
Nery et al., 2002).  
Analysis of CGE specification is less well developed, although Gsx2 and Dlx1/2 are required 
(Long et al., 2009). Given the strong expression of COUP-TFI and COUP-TFII (Kanatani et al., 
2008; Long et al., 2009), it is likely that these genes contribute to CGE early development.  
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3.4. Medium-sized Striatal Projection Neurons 
The principal neuronal subtype of the basal ganglia is the GABAergic medium-sized striatal 
projection neuron (MSN), which derives exclusively from the ventral LGE (Campbell et al., 
1995; Deacon et al., 1994; Stenman et al., 2003) and from a portion of the CGE that likely 
represents a caudal extension of the ventral LGE (Nery et al., 2002).  
These neurons convey the output of the striatum by projecting to the output nuclei of the basal 
ganglia through a ‘direct’ pathway that connects to the SNr/GPi and an ‘indirect’ pathway 
which projects to the GPe (Gerfen, 2000), as shown in Figure 19.  
 
Figure 19: Schematic representation of direct and indirect pathways (Han et al., 2010). 
 
Gsx2 expression is important for the maintenance of the pool of LGE progenitors (Corbin et al., 
2000; Toresson et al., 2000; Yun et al., 2001) and for their specification toward MSN fates. This 
specification takes place at early stages of telencephalic neurogenesis, prior to E10.5 in mice 
(Corbin et al., 2000; Toresson et al., 2000; Waclaw et al., 2009; Yun et al., 2002), and from 7 w 
in the VZ, as demonstrated from the analysis of human fetal brain development (Onorati et al., 
2014). The role of Gsx2 in the correct formation of MSNs was demonstrated in Gsx2 mutant 
mice, where the numbers of early born MSNs were severely reduced (Toresson & Campbell, 
2001; van der Kooy & Fishell, 1987). 
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Following the specification of MSNs in the developing striatum, the Dlx genes (Dlx1, 2, 5, and 
6) are expressed in the SVZ and also detected between 7 w until 11 w of human brain 
development (Onorati et al., 2014). As described in several mutants, loss of function of these 
genes causes striatal differentiation defects (Corbin et al., 2000; Toresson et al., 2000; Yun et 
al., 2001). In particular, Dlx1/2 mutant mice show a strikingly reduced expression of MSN 
markers in the striatum, including dopamine receptors DR1/DR2 (Long et al., 2009).  
 
For the subsequent migration of the striatal precursors from the SVZ to the MZ Ebf1 expression 
is required. This TF is essential for the survival and differentiation of precursors toward MSNs 
fate, and also for the formation of the matrix and patch regions in the developing striatum (Garel 
et al., 1999). After migrating radially into the developing striatum, in fact, MSNs segregate into 
two principal compartments: the patches (also known as striosomes) and the matrix that 
surrounds them (Gerfen et al., 1990). The first MSN to migrate into the developing striatum 
aggregate into the patches, whereas later generated neurons form the matrix (Krushel et al., 
1989, 1995; Song & Harlan, 1994; van der Kooy & Fishell, 1987). Striatal patches develop 
concomitantly with the arrival of dopaminergic afferents from the substantia nigra (Herkenham 
et al., 1984). In addition, Ebf1 has been implicated in the development of the direct pathway 
MSNs. In the Ebf1 mutants, in fact, the most affected region is the MSNs in the striatal matrix 
compartment, which projects through the direct pathway (Lobo et al., 2008). The expression of 
EBF1 was detected also in the human fetal brain development in the MZ at 8 w in combination 
with IKAROS (Onorati et al., 2014).  
This zinc finger transcription factor, in fact, is expressed in the MZ of the LGE (Agoston et al., 
2007; Martín-Ibáñez et al., 2010) and requires DLX1/2 for its expression (Long et al., 2009; 
Martín-Ibáñez et al., 2010). Ikaros regulates differentiation of striatal projection neurons in the 
developing striatum (Arlotta et al., 2008; Garcia-Dominguez, 2003; Lobo et al., 2008; Martín-
Ibáñez et al., 2010).	
 
To become post-mitotic and to mature, striatal precursors in the MZ need to express the COUP-
TF1-interacting protein 2 (CTIP2) (Arlotta et al., 2008). Loss-of-function studies have shown 
that Ctip2 is required for MSN differentiation as well as for the normal formation of the patch 
compartment (Arlotta et al., 2008). There is evidence that these defects result from a failure of 
aggregation between patch compartment MSNs, in fact, Ctip2 controls the expression of cell 
surface molecules that are involved in sorting MSNs into the patch and matrix compartments 
(Arlotta et al., 2008). In human fetal development, the expression of CTIP2 was detected at 8 w, 
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11 w and 20 w in the MZ, but also in the cortical plate, where this TF has shown co-expression 
with DARPP32, but this neural population CTIP2+/DARRP32+ of cortical plate did not display 
GABAergic identity, that is peculiar of MSNs resident in the striatum (Onorati et al., 2014).  
 
4. How to obtain authentic MSNs in vitro from human pluripotent stem cells (hPSC) 
Based on the information gathered in the study of embryonic development summarized above, 
various differentiation protocols have attempted to recreate striatal developmental features in 
vitro in order to differentiate human pluripotent stem cells into striatal MSNs with characteristic 
expression of gamma-aminobutyric acid (GABA), along with other known regional markers 
(Table 4).  
Protocol Cell source Results Transplant
1. Aubry et al. 
(PNAS, 2008)
hESCs
(SA01, H9)
22% of cells are Map2+ neurons. 
Among the Map2+ neurons, 36% 
are GABA+ and 53% are Darpp32+.
Cells are Ki67+
Quinolinic acid-lesioned rats. 
Integration, maturation, 
overgrowth, no functioal
assessment.
Generated teratoma-like
region
2. Ma et al. 
(Cell Stem Cell, 2012)
hESCs
(H9)
93% of cells are process-bearing
neurons. 90% of Gaba+ neurons are 
Darpp32+. No other markers
Quinolinic acid-lesioned mice. 
Integration, maturation, 
connection, no overgrowth,  
functional recovery on rotarod
3. Delli Carri et al. 
(Development, 2013)
hESCs (H9, 
HS401)
hiPSCs (DF3F)
51% of cells are Map2+ neurons. 
With respect to the Map2+ neurons, 
78% are GABA+, 60.3% Ctip2+,and 
20% Darpp32+
Quinolinic acid-lesioned rat. 
Integration, some maturation, 
some connection, no 
overgrowth
4. Nicoleau et al. 
(STEM CELLS, 2013)
hESCs (H9), 
hiPSCs
(190c17)
Quantification by qPCR analyses of 
these markers:Map2, Darpp32, 
Foxp1 and Foxp2
Quinolinic acid-lesioned rat.
No motor analysis
No ephys
5. Arber et al. 
(Development, 2015)
hESCs
(H1,H7,H9), 
hiPSCs (2F8, 
4FH)
80% of cells are Gaba, 45% 
Darpp32+, no Ctip2 on section after
transplantation
No rescue of apomorphine-
induced rotations 
 
Table 4: Summary of striatal protocols published  
 
Previously published protocols have used different morphogens or transcription factor 
expression patterns to generate striatal neurons from human pluripotent stem cells (Arber et al., 
2015; Aubry et al., 2008; Delli Carri et al., 2013; Ma et al., 2012; Nicoleau et al., 2013). These 
protocols encompass different stages that guide the differentiating cells towards a MSN fate. 
These steps include:  
1) a neural lineage commitment stage,  
2) a striatal precursor commitment phase,  
3) a maturation stage of the striatal neuronal population.  
For the first step, all the protocols used small molecules to block the TGF-β and BMP 
signalling, to promote the neural fate. For the second step, they administered morphogens that 
are able to promote the ventral telencephalic fate (for example SHH, that inhibits GLI3), and 
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also to inhibit the dorsal fate, for example Dickkopf-related protein 1 (DKK1) that inhibits the 
WNT pathway. For the maturation, they used neurotrophin factors, such as BDNF, the same that 
promotes the survival and the maturation of MSNs in vivo.  
 
4.1. Overview on published MSN differentiation protocols 
The first published attempt to derive human MSNs from pluripotent cells used a three-stage 
protocol on healthy human embryonic stem cells (hESCs) (Aubry et al., 2008). The hESCs were 
plated on a stromal feeder layer in neural induction media in order to induce rosette formation, 
which is an in vitro analogue of the neural tube (Wilson & Stice, 2006). Brain-derived 
neurotrophic factor (BDNF), sonic hedgehog (SHH) and DKK1 were added in order to induce 
the generation of striatal progenitors. Finally, BDNF, dibutyryl-cAMP (dbcAMP) and valproic 
acid were used in order to mature the cells into striatal neurons. The authors reported that this 
62-day long protocol was able to generate 20% of the cells expressing MAP2. Of these neural 
cells, 50% also expressed DARPP32, a marker of a MSN. Most cells were able to generate 
induced action potentials, demonstrating their neuronal functionality (Figure 20, row n°1). 
 
In 2012, Ma et al. published a 47-day long protocol using Embryoid Bodies (EBs) formation 
that used similar growth factors for neuronal maturation as Aubry et al., with the addition of 
glial cell line derived neurotrophic factor (GDNF) and interleukin growth factor (IGF). GDNF is 
implicated in the survival and maintenance of neurons (Lin & Tseng, 2015); IGF has a role in 
neuronal signalling, neurotrophic mechanisms, and neuroprotection (Hoshaw et al., 2005; 
Szczêsny et al., 2013). According to the paper, at day 27, 93% of the cells were positive for 
ßIII-TUBULIN, of which 90% were positive for GABA and this population was mostly 
DARPP32-positive. This is not sufficient to confirm that the neurons obtained in vitro are 
authentic MSNs. Indeed, no other molecular markers were analysed to better characterize the 
cells during in vitro differentiation, from the progenitors following neural induction until the 
mature neuronal populations at the end of differentiation, to confirm the striatal neuron identity 
(Ma et al., 2012)(Figure 20). 
 
In 2013, the lab in which I performed this thesis work published a paper on the differentiation of 
human pluripotent stem cells into striatal neurons (Delli Carri et al., 2013), where they used the 
dual SMAD inhibition method to induce the neuro-ectodermal fate, by using NOGGIN and 
SB431542, to inhibit TGF-β and BMP signalling (Chambers et al., 2009). This step is followed 
by a differentiation paradigm similar to those previously described. In this study, several 
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molecular markers associated with the developing human ganglionic eminence were analysed to 
gauge the differentiation and maturation of the cells. At day 80 cultures contained 25% GFAP-
positive cells and 51% MAP2-positive neurons, specifically 78% expressing GABA, 53% 
expressing CALBINDIN, 60% expressing CTIP2, and 20% expressing DARPP32. This is the 
only work that showed the co-expression of CTIP2 and DARPP32 in hES-derived neurons, that 
confirmed unequivocally the striatal identity of the obtained neurons (Delli Carri et al., 2013) 
(Figure 20, row n°3).  
 
An analogous differentiation protocol based on dual SMAD inhibition (Chambers et al., 2009) 
is published by Nicoleau et al., in 2013. In this protocol, the authors tested the role of WNT-
signalling in the generation of MSN in vitro (Nicoleau et al., 2013). The use of a WNT-
antagonist, DKK1, and SHH together produced human ventral-telencephalic neurons that were 
50-60% MAP2 positive, of which 25-30% were DARPP32-positive, indicating that sequentially 
organized WNT signals play an important role in striatal development (Figure 20, row n°4). 
However, also in this work the authors didn’t characterize the obtained neurons at the end of 
protocol.  
 
The dual SMAD inhibition (Chambers et al., 2009) was also used by Arber and colleagues in 
2015. In this protocol, the authors used ACTIVIN A, a member of the transforming growth 
factor beta (TGF-β) family of proteins, rather than traditionally used DKK1, to induce an LGE 
phenotype (Arber et al., 2015). Following ACTIVIN A treatment, ~50% cells expressed CTIP2 
and GSX2 at day 22, indicative of a correct LGE-fate acquisition. In addition, neurons were 
DARPP32+ (40%), CTIP2+ (80%) with GABAergic electrophysiological properties at day 43. 
However, after transplantation, the authors didn’t show any kind of characterization of the cells 
transplanted.  Also in this work was missing the specific identification of MSNs by the analysis 
of striatal neurons’ typical markers (Figure 20, row n°5).  
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1. Aubry et al. (PNAS, 2008) 
2. Ma et al. (Cell Stem Cell, 2012) 
3. Delli Carri et al (Development, 2013) 
4. Nicoleau et al. (Stem Cells, 2013) 
5. Arber et al. (Development, 2015) 
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Day  0 12 26 32 47 
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GABA 
progenitors 
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progenitors 
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Day  -3 1 20 45 
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on 
MEFs SHH Dkk-1 
LDN, 
SB  
10 
neuronal 
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telencephalic 
progenitors 
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progenitors 
BDNF, dbcAMP, VPA 
Day  0 9 20 43 
hES cells 
striatal 
neurons 
SB Activin A BDNF, GDNF 
LGE 
progenitors 
neuronal 
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LDN, D  
28 
Day  0 5 12 26 80 
hES cells 
LGE 
progenitors 
striatal 
neurons 
D/LDN, SB SHH, DKK-1 BDNF 
telencephalic 
progenitors 
neuroectodermal 
progenitors 
 
Figure 20: Details of striatal protocols published. 
 
During my PhD I have used the Delli Carri (Delli Carri et al., 2013) protocol for MSN 
generation. This protocol is actually the only one that unequivocally follows the phases of 
neural differentiation starting from hPSC cells to MSNs, and compares these populations in 
vitro with the developing human fetal brain (Onorati et al., 2014). Indeed, thanks to detailed 
gene-expression information obtained by the study of human fetal brain development performed 
by Onorati et al., in 2014, we are now able to identify and characterize every stage of human 
striatum development in vivo, and to understand if hPSC lines, differentiated towards a striatal 
fate, are able to recapitulate the principal stages of striatal development in vitro. 
 
4.2. Focus on Delli Carri et al. protocol, 2013 
As for the majority of the directed differentiation protocols, Delli Carri et al induced three 
phases encompassing neural induction, neural patterning and terminal differentiation of MSNs. 
These steps closely recapitulate what occurs in vivo in the developing striatum (Figure 21). 
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Figure 21: Diagram of Delli Carri protocol (2013). 
. 
(i) Neural induction 
Dual inhibition of SMAD signalling by NOGGIN (N) and SB431542 (SB) is used for neural 
induction from hPSC cells in order to achieve efficient neuroectodermal fate acquisition, as 
described in Chambers et al., published in 2009.  
For neural induction, 500nM of LDN-193189 (LDN), a NOGGIN analogue, was used to block 
the BMP pathway, which drives toward trophectoderm and ectoderm fate, in combination with 
10µM SB431542 (SB), to block TGB-β signalling, which promote mesendoderm fate. 
NOGGIN or LDN treatment in combination with SB (N+SB or LDN+SB) showed comparable 
neural conversion efficiency of hESCs. 
Neural induction of hPSC cells was achieved by exposure to LDN+SB for 12 days 
demonstrated by the formation of neural rosettes (Zhang et al., 2010) at day 15. At this stage 
neuroepithelial cells begin to express NESTIN, SOX2, OTX2 and PAX6, and show a down-
regulation of OCT4 and NANOG, which are typical markers of the pluripotent state (Figure 22). 
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Figure 22: Immunofluorescent analysis for markers for pluripotency OCT4, and for markers of neural 
induction PAX6, NESTIN, and OTX2. 
 
Interestingly, in the Onorati study at 2-3 weeks post-conception, we observed, in the human 
embryo the same immunoreactivity at day 5 of in vitro differentiation. In particular, OTX2 gene 
was expressed in N-CADHERIN+ neural folds and in the more posterior region of the closing 
neural tube (Onorati et al., 2014).  
From the day 15 of in vitro differentiation, the cells started to show also BF1 (FOXG1) 
expression, a gene that is highly expressed in the subpallium, as a result of the inhibition of the 
BMP pathway. 
 
(ii) Patterning and Specification 
To recapitulate in vitro ventralization of the telencephalon, two different pathways are 
modulated in vitro, SHH and WNT signalling. The former is important for the correct 
regionalization of the LGE and MGE, in a dose-dependent manner. The inhibition of the latter is 
essential to repress cortical fate. Experimentally, starting from day 5, regional patterning was 
achieved by treatment with DKK1 (100ng/ml) and a modified version of SHH (SHH C-25II) 
(200ng/ml) treatment. The SHH modification is necessary to make the morphogen more stable 
in the culture media. In particular, as outlined in Figure 23, DKK1 inhibits the WNT pathway, 
represented in red line, and SHH targets GLI3, which would otherwise activate WNT signalling, 
represented in green line (Figure 23). 
SHH 
GLI3 
WNT DKK-1 
 
Figure 23: Schematic representation of SHH, that inhibits GLI3, and DKK1, that inhibits WNT signalling. 
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WNT inhibition, by means of SHH and DKK1 administration, led to GXS2 and ASCL1 positive 
cells around day 25, which identify respectively neurons of VZ and SVZ proliferative 
progenitor zones. In vivo, GSX2 is detected mainly in the VZ while ASCL1 expression is 
restricted to the SVZ of the LGE (Onorati et al., 2014). Cells positive for PAX6 were also 
observed in our differentiated cells. The presence of PAX6 and GSX2 positive neurons in vitro 
at day 25 recapitulate the formation of the pallial-subpallial boundary in human embryo, 
occurring at about 3 weeks post-conception 
In the Delli Carri protocol few cells showed NKX2.1+-ISLET1+ co-expression, indicating 
possible presence of cholinergic interneuronal precursors (Onorati et al., 2014) This is in line 
with findings from Onorati et al., who identified neurons co-expressing NKX2.1+-ISLET1+ at 8 
weeks of human embryo development. As we already know from previous studies, ISLET1 is 
initially expressed in post-mitotic striatal precursors and is later restricted to cholinergic 
interneuron populations (Wang & Liu, 2001).  
 
(iii) Maturation 
The patterning stage was extended until day 26, followed by the terminal differentiation period 
(from day 26 to day 80) where the cells are exposed to 30ng/ml BDNF, a neurotrophin that 
promotes cell survival in vitro (Altar et al., 1997; Canals, 2004; Cattaneo et al., 2001; Crook & 
Housman, 2011; Fusco et al., 2003; Gauthier et al., 2004; Zuccato & Cattaneo, 2007). 
At day 45 of neural differentiation, βIII-TUBULIN+ neuronal cells with branched MAP2+ 
dendrites appeared in the culture (Figure 24, E and F). The majority of these neurons exhibited a 
GABAergic phenotype, as confirmed by immunocytodetection of glutamic acid dehydrogenase-
67 (GAD67) staining, the limiting enzyme for GABA synthesis (Behar et al., 1994)(Figure 24, F 
and G). 
 
Figure 24: Immunofluorescent analysis for neuronal markers at day 45. (Panel E) Expression of the pan-
neuronal markers MAP2 (red) and TAU (green) (scale bar=50 µm); (Panel F) Immunodetection of GAD65/67 
(green) and βIII-tubulin (red) (scale bar=50 µm); (Panel G) MAP2+(red) neurons express GABA (green) (scale 
bar=50 µm); (Panel H) Calbindin (CALB1) (green) with MAP2+(red) (scale bar=50 µm) (Delli Carri et al., 2013). 
 
At day 45 of the differentiation period, the cells matured and acquired expression of striatal 
markers, and in particular, of MSNs. The transcription factors FOXP2 and FOXP1 were 
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expressed in mature striatal neurons in combination with CALBINDIN (CALB), a calcium-
binding protein (Garcia-Calero et al., 2013; Hisaoka, Nakamura et al., 2010). 
There are indeed numerous DARPP32, CTIP2, FOXP2 and FOXP1 positive cells at these later 
stages (Figure 25). 
 
Figure 25: Immunofluorescent analysis for markers specific to identify authentic MSNs at day 45. (Panel I) 
The early post-mitotic striatal marker CTIP2 (green) and FOXP1 (red) is expressed in neuronal cells (scale bar=50 
µm); (Panel J) Immunodetection of FOXP2 (green) and βIII-tubulin (red) (scale bar=50 µm); (Panel K) CTIP2 
(red) in combination with Hoechst (blue) staining (scale bar=50 µm); (Panel L) Confocal image of MAP2+(red) 
neurons expressing DARPP32 (green) (scale bar=25 µm) (Delli Carri et al., 2013). 
 
MSN identity was also corroborated by analysis for DARPP32 and CTIP2 co-expression 
(Figure 26). 
 
Figure 26: Crop of DARPP32 and CTIP2 double staining at day 45. Confocal analysis confirming MSN 
identity by co-expression of CTIP2 (red) and DARPP32 (green) (scale bar=25 µm) (Delli Carri et al., 2013). 
Fifty-one percent of the cells at this stage were MAP2+ neurons (Figure 27), and 17% of the 
total were positive for NESTIN, suggesting the presence of cells with a neuronal precursor 
identity at this late stage in vitro.  
With respect to the MAP2+ neurons, 78% were GABA+, 60,3% CTIP2+ (86% of which co-
expressed GABA) and 53% CALB1+ neurons. 70,6% of the CALB1+ neurons co-expressed 
CTIP2, and 20% of the neurons were immunopositive for DARPP32, thus confirming the 
general acquisition of an MSN fate (Delli Carri et al., 2013).  
The protocol also showed a percentage of astrocytes, as GFAP+ cells, that appeared only around 
day 80 in culture (25% of cells) (Figure 27).  
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Figure 27: Quantification of different cells subtypes after 80 days of striatal protocols. Description of the 
different neuronal populations. MAP2+ 51±3%, n=1126 cells; GFAP+ 25±0.03%, n=712; nestin+/βIII-tubulin+ 
17.3±5.03%, n=208; nestin+ 7±4.9%, n=220; GABA+ 78.4±9.8%, n=1242; tyrosine hydroxylase (TH)+ 9.8±0.98%, 
n=826; VGLUT1+ 9.8±0.6%, n=1005; 5- hydroxytryptamine (5-HT)+ 0.2±0.02%, n=775; CTIP2+ 60.3±14.1%, 
n=320; CTIP2+/GABA+ 86±7.6%, n=320; CALB1+ 53±5%, n=1020; CALB1+/CTIP2+ 70.6±19.5%, n=770; 
DARPP-32+ 20±3.9%, n=987; CALB1+/CTIP2– 29.4±19.5%, n=770; calretinin (CAR)+ 9.8±3.9%, n=956; SST+ 
0.2±0.02%, n=810; PVALB+ 0%, n=790; NPY+ 0%, n=680; ChAT+ 0%, n=540) (mean ± SD) (Delli Carri et al., 
2013). 
 
All these human-specific gene expression transition patterns are essential tools to follow the 
progression of the differentiation and the maturation of the human neural progenitors in vitro. 
Due to the scarcity of human embryo developmental data these aspects had not been previously 
investigated. 
 
The aim of this thesis is to further analyze human embryonic striatal development in vitro using 
the Delli Carri et al. protocol, and to generate an improved protocol for MSNs production that 
reliably characterizes and describes all progenitor and neuronal populations generated and their 
maturation in vitro.  
  
After the thorough characterization of the various stages of neural differentiation, the aim is to 
identify the different subpopulations during striatal differentiation, and to increase the 
percentage of these populations in the culture in order to increase the efficiency of authentic 
MSNs generation in vitro. 
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Aim of the project 
 
Mimicking striatal development during in vitro differentiation of human Embryonic Stem cells 
(hESC) and pluripotent stem cells (hPSCs) is an invaluable method to investigate different 
aspects of striatal formation, model HD in a dish and generate cells for future cell replacement 
strategies. HD specifically affects medium spiny neurons (MSNs) that are located in the 
striatum of the adult brain. Our goal is to generate MSNs in vitro in a controlled and 
reproducible manner that mimics normal striatal development with a high degree of precision. 
To reach this goal I exploited the protocol published in 2013 to generate authentic MSNs (Delli 
Carri et al., 2013) and, during my PhD, I further characterized and improved the generation of 
these neurons by implementing three fundamental approaches:  
i) Characterize the stability and reproducibility of the directed differentiation protocol and 
study the differentiation potential into MSNs of a very diverse set of human pluripotent 
cell lines. This part was performed on human non-integrating iPS cell line (produced at 
Cedars Sinai, Los Angeles), hES Roslin Cells (generated by Roslin Cell Institute, 
Edinburgh), hESC H9 (produced by WiCell Research Institute in 2001) and hESC 
RUES2 (generated at Rockefeller Foundation in Ali Brivanlou lab, New York). 
ii) Outline specific cell transitions occurring in vitro to pinpoint potential pivoting moments 
during MSNs generation in vitro. This aim was reached by developing a highly 
automated pipeline for image acquisition that enabled us to characterize and quantify 
cell states present during differentiation with a high level of accuracy. 
iii) Identify transcription factors that are highly specific for MSNs generation and exploit their 
function to increase and optimize MSNs turnover. This part of the project involved 
developing a system to overexpress Gsx2 and Ebf1 during differentiation. 
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Main Results 
1. Reproducibility of the Delli Carri protocol: monitoring striatal differentiation phases in 
four hPSC lines 
In the first part of my thesis I applied the striatal differentiation protocol published from the lab 
in 2013 and defined as “Delli Carri protocol” to different human pluripotent stem cell (hPSC) 
lines. The aim was to test the robustness and the reproducibility of the published protocol, 
assessing cell-line dependent differences in the efficiency of in vitro differentiation. 
An important contribution to develop our striatal differentiation protocol was provided by recent 
data published in 2014 about human fetal brain development (Onorati et al., 2014). This study 
performed on human brain from 6 to 11 weeks of gestational age highlighted the progressive 
expression of a set of transcription factors (TFs) that distinguish the ventricular zone (VZ) of the 
LGE from the subventricular zone (SVZ) and the mantle zone (MZ), providing a complete map 
of markers to monitor striatum development in vitro and in vivo (Figure 28). 
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Figure 28: Most important markers specific for subpallium development toward striatal fate acquisition. 
The Delli Carri protocol was applied to four human pluripotent cell lines: 
• a human non-integrating iPS cell line (Mattis et al., 2015), from Svendsen’s Lab (Cedars 
Sinai, Los Angeles),  
• the Roslin hES Cells, a good manufacturing practice (GMP) human embryonic stem cells 
from Roslin Cell Institute in Edinburgh,  
• the H9 hES cells from the WiCell Research Institute, 
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• the RUES2 hES parental cell line from the Ali Brivanlou lab at the Rockefeller University. 
This last hES cell line is important in the context of the study of HD. In fact, Brivanlou’s lab 
has worked to create an isogenic allelic series of hESCs carrying different CAG expansions 
to study the effect of these mutations on neuronal differentiation.  
 
At first, the pluripotency state of the different cell lines was assessed by immunocytochemistry 
for OCT4 and SOX2. All the lines show positivity for these pluripotency markers with lower 
intensity in SOX2 staining, especially in RUES2 cell line (Figure 29). This could suggest a 
slightly different basal state of pluripotency between the lines that may have significant effect at 
the end of differentiation.  
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Figure 29: OCT4 and SOX2 immunocytochemistry, inset: Hoechst nuclear counterstaining in hPSCs (scale 
bar=100 µm). 
 
1.1. Neural induction  
For neural induction, cells were exposed to dual-smad inhibition (Chambers et al., 2009). To 
evaluate whether upon losing pluripotency the cells acquire a neuroectodermal identity, we 
analysed the expression of PAX6 and FOXG1 (see diagram in Figure 28). PAX6 is the earliest 
neuroectodermal marker expressed in the developing human CNS (Zhang et al., 2010), 
becoming at later stages a general pallial marker (Bayatti et al., 2008)(Onorati et al., 2014). 
Instead, FOXG1 is expressed in the prosencephalic primordium, and in the neuroepithelial 
progenitors (NEPs) of the VZ (Onorati et al., 2014). Here we monitored the expression of these 
two markers at day 15 of neural differentiation as a control for efficient neural induction (Figure 
30). We found that all the four hPSC lines at day 15 exhibit a correct neuroectodermal induction 
in terms of PAX6 and FOXG1 expression. 
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Figure 30: Immunodetection of FOXG1 and PAX6, inset: Hoechst nuclear counterstaining at day15 (scale 
bar=100µm). 
 
 
1.2. Patterning: LGE progenitor markers 
To follow the neural progression and to identify the neural progenitors, we monitored the 
patterning in vitro by assessing the expression of selected transcription factors. The first 
important step was to evaluate the presence of GSX2+ neural progenitors, localized in vivo in 
the VZ, and their maturation by monitoring ASCL1 expression. GSX2+/ASCL1+ cells represent 
those striatal precursors that move to SVZ during development (see diagram in Figure 28). We 
focused on cells at day 25 of neural differentiations following of the Delli Carri protocol (Figure 
21), since it corresponds to the end of the patterning phase (induced by SHH and DKK 
administration) and therefore we could evaluate their effect on the differentiation progression 
(Figure 31). Indeed, all the hPSC lines showed expression of GSX2 and ASCL1, suggesting that 
patterning had been completed successfully to obtain striatal progenitors. 
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Figure 31: Immunodetection of GSX2 and ASCL1, inset: Hoechst nuclear counterstaining at day25 (scale 
bar=100µm). 
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1.3. Specification: Striatal precursor  
To monitor the striatal specification phase of the four hPSC lines we performed 
immunocytochemistry for NKX2.1, ISLET1 and CTIP2, which are markers of the precursors of 
striatal neurons (see diagram in Figure 28). To identify these precursors during in vitro 
differentiation, we performed immunocytochemistry for these markers at day 30, selected 
because preliminary experiments have exhibited the expression of these markers at this time 
point. Figure 32 shows that hiPS, hES Roslin, hES H9 and hES RUES2 cells were all able to 
express NKX2.1, CTIP2 and ISLET1. Confirming the cells are maturating and acquiring a 
ventral MZ fate. 
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Figure 32: Immunodetection of NKX2.1, CTIP2, and ISLET1. Inset: Hoechst nuclear counterstaining at day 
30 (scale bar=100µm). 
 
Notably, we observed in our experiments some ISLET1+ cells that did not co-localize with 
CTIP2 at this stage, suggesting that they could differentiate into interneurons. This cell 
population was also observed in the developing rodent brain, where ISLET1 is initially 
expressed in all striatal precursors and later restricted to cholinergic interneurons (Wang & Liu, 
2001). 
Indeed, in in vivo studies, a subpopulation of striatal cells was found to be double positive for 
NKX2.1 and ISLET1, which would confirm the presence of cholinergic interneuronal 
precursors (Onorati et al., 2014). 
 
 
 
                                                                                                                                                         Main Results 
 
 48 
1.4. Maturation: Authentic MSNs 
MSNs represent more than 90% of striatal neurons in rodents and are identified by co-
expression of CTIP2 and DARPP32 (also known as PPP1R1B) (Arlotta et al., 2008). We 
therefore decided to identify the prospective MSN neurons by evaluating co-expression of 
GABA together with CTIP2 and DARPP32 (Figure 33). 
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Figure 33: Double labelling of cells for CTIP2 and DARPP32, and for CTIP2 and GABA, inset: Hoechst 
nuclear counterstaining at day 50 (scale bar=100µm). For each cell line, we performed at least four independent 
differentiation experiments, and the images showed are the most representative. 
 
All cell lines at day 50 showed expression of cells that were CTIP2+/GABA+. The more striking 
difference between the lines lies in the expression of DARPP32 which remains undetectable in 
differentiated RUES2, indicating that the striatal potential of this line (or its requirements to 
reveal such phenotype) is different from the other lines. 
We demonstrated that different types of hPSC, in particular hES and hiPS cell lines, are able to 
correctly respond to Delli Carri differentiation protocol. Only the hES RUES2 line showed 
problems in the acquisition of MSN fate, evaluated by the expression of DARPP32 and CTIP2 
markers at the end of differentiation. 
 
2. Quantification of neuronal subpopulation during differentiation  
To better characterize the different subpopulations during the later phase of differentiation and 
to quantify the expression of the markers that identify each neurodevelopmental stage in vitro, 
we worked to improve the acquisition and quantification methods. However, the quantification 
was hindered the formation of dense clusters of cells during the maturation phase of the 
differentiation protocol. Indeed, mature CTIP2+/DARPP32+ formed clusters that allowed the 
cells to interconnect, facilitating neuronal maturation. Unfortunately, standard wide-field 
microscopy is not sufficient to resolve individual cells within these structures, in order to count 
them and evaluate the expression of protein markers. To better quantify the cells in these 
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clusters, we first tried to dissociate them and re-plate the cells as a monolayer. Unfortunately, 
most of the cells died after dissociation and the few cells that survived were not able to express 
markers of mature neurons (data not shown). Since cell-to-cell contact is required for optimal 
neuronal maturation, we worked to set up an imaging pipeline to capture and quantify cells 
within the clusters (Figure 34). 
 
Figure 34: Pipeline for images acquisition and analysis. 
 
To solve this issue, we evaluated two different types of acquisition method based on confocal 
microscopy or a Nikon wide-field microscopy. The Nikon Eclipse Time Lapse is a platform for 
automated acquisition with a built-in software for analysis. For this reason, we have tried the 
Nikon wide-field instead our standard wide-field. With this Nikon platform, in fact, we are able 
to acquire a lot of images which are quantified at the same time. Images were acquired and then 
a deconvolution filter (image-based mathematical approach designed to reduce out-of-focus 
light) with 50 iterations was applied to obtain countable nuclei (Figure 35, panels in the center). 
In parallel we tested a Leica SP5 Confocal system and, to optimize image output, we applied 
noise reduction filter with two iterations after image acquisition (Figure 35, right panels). 
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Leica Widefield 6000 
Original Image 
40X 
Filter: Unsharp Mask 
Original Image 
Deconvolution (50 iterations) 
Nikon Eclipse 
40X 
Leica SP5 Confocal 
Filter: Noise Reduction (2 iterations) 
40X 
Original Image 
 
Figure 35: Original images and modification after Leica Widefield 6000, Nikon Eclipse and Leica SP5 
Confocal (scale bar= 25 µm). 
 
We found that the best system for our experimental purposes is represented by the Leica SP5 
Confocal coupled with a 40x objective. In fact, images acquired with this system appeared more 
defined and quantifiable than the ones provided by the Nikon Eclipse Time Lapse. To capture 
cells along the vertical extension of these clusters and to assure that each cell will be 
represented only in one layer, we acquired three z stack planes, one every 10 µm for each field. 
We color-coded nuclei in each z stack plane to avoid double counts and made the merge of 
images to identify the counted object (Figure 36).  
Focal plane
Top plane
Bottom plane
10 μm
10 μm
Hoechst Hoechst Hoechst
 
Figure 36: Merge of images obtained after the application of pseudo-colours to three z stacks counted (scale 
bar= 25 µm). 
 
With this type of acquisition in z stack, we were able to section the thickness of clusters and 
also to acquire a representative fraction of the cells that form the cluster itself.  
After acquisition, we applied noise reduction filter with two iterations to remove background 
and spots of secondary antibody. For a good representation of cells presented in each analyzed 
well, we decided to acquire nine fields (three in the top, three in the middle and three in the 
bottom side of the well) and for each field to acquire three z stack planes. 
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After improving the capturing procedure, then we worked to set up the pipeline for cells and 
protein markers quantification. To do that, we tested softwares for the quantification, and we 
compared the results to the manual counting method.  
For manual counting, we used ImageJ, a public domain Java image-processing program inspired 
by NIH Image for the Macintosh and PC. As a plugin to count the processed images we used 
Cell Counter. The plug-in is very simple and it basically assists the manual click-and-count by 
scoring the number of counts into different user-selected categories. With this plugin, we have 
manually analysed part of the pictures to be able to compare the number of positive cells 
obtained with the other methods.  
For automatic counting, we decided to use CellProfiler, the software that we found most 
suitable for our application. In fact, the same image analysed using the manual and the 
automatic method did not reveal any difference (see Figure 37). 
CellProfiler is a versatile, open-source software tool for quantifying data from biological 
images. It is designed for modular, flexible, high-throughput analysis of images, measuring size, 
shape, intensity, and texture of every cell (or other object) in every image. Using the point-and-
click GUI, users can construct an image analysis "pipeline", a sequential series of modules that 
each one performing an image processing function such as illumination correction, object 
identification (segmentation), and object measurement. We mixed and matched modules and 
adjusted the settings to measure the phenotype of interest. For our purpose, all the images 
carrying the different immunocytochemical staining were analysed starting from a 12 bits grey-
scale picture of the individual channels (blue, green, red and magenta– three colours staining). 
Images were filtered so that each channel was analysed for the appropriate marker. 
For the images processing we adopted the following modules: “Apply Threshold” to increase 
signal-to-noise ratio using three-classes “Adaptive” “Entropy” thresholding method; “Identify 
Primary Object” in the size range of 20 to 80 pixels using “Adaptive” thresholding strategy with 
three-classes “Entropy” and “Custom” smoothing method (Figure 37), because using these 
settings counted cells were more similar to the manual count. “Intensity” was used as method to 
distinguish clumped object and “Shape” as method to divide clumped objects (Figure 37). 
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Figure 37: Comparison between the counted cells with different types of CellProfiler threshold. 
 
This pipeline allowed us to obtain the percentage of cells positive for two or three given protein 
markers on the total number of DAPI positive cells (for the pipeline details see the Materials 
and Methods section). Moreover, expression level of each analysed protein marker can be 
accurately quantified. 
Using the new acquisition method and type of analysis for the quantification described above, 
we were able to follow in vitro the cells’ progression and maturation toward the acquisition of 
the striatal identity. In the following sections, we are going to focus our analysis on hES H9, 
because it showed higher consistency of marker expression between different biological 
replicates. 
 
2.1. VZ-SVZ transition 
The first important step was to evaluate if GSX2+/ASCL1+ cells represent those striatal 
precursors that move to the SVZ during development in vivo.  
To closely monitor the evolution of the cultures during the differentiation protocol, we analyzed 
them every 5 days from day 20 to day 50 with the aim to understand if they are able to 
recapitulate the VZ to SVZ transition in vitro. (Figure 38, Panel A). With the method described 
above, we quantified the percentage of positive cells for GSX2, ASCL1 and the co-expressing 
cells on the total number of DAPI counted cells. The obtained number was expressed with the 
mean with standard error (mean ± SEM).  
As we can observe in Figure 38 panel C, in parallel to a peak of GSX2+ cells at day 25 (15.49 ± 
1.24%) we detected an increase in the number of ASCL1+ cells which reaches the maximum 
peak at day 35 (30.21 ± 4.08%). In line with this, at day 35 we found the highest number of 
cells co-expressing GSX2+/ASCL1+ (3.70 ± 0.35%, represented in the graph with the orange 
line) (Figure 38, Panel C).  
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Quantification of the fluorescent signal of GSX2 and ASCL1 staining (object intensity) 
confirmed this data. Specifically, the diagram in Panel B of Figure 38 illustrates GSX2 (y-axis) 
versus ASCL1 (x-axis) signal. Each dot represents a cell with the relative expression of both 
markers. The intensity of the color in each panel is proportional to the number of cells 
expressing each intensity value (Figure 38, Panel B). 
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Figure 38: (Panel A) Immunofluorescence on hES H9 for GSX2 and ASCL1 (scale bar=25µm), (Panel B) 
Measurement of the intensity of the fluorescent signal (object intensity) of GSX2 and ASCL1 in each cell (x-
axis = mean intensity of ASCL1 signal; y-axis mean intensity of GSX2 signal in the log2 scale), (Panel C) 
Percentage of markers quantification on the number of the total counted cells (Dapi positive) (data are 
represented as means ± SEM). 
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Our experiments indicate that GSX2 intensity level reaches its peak at day 25 and then it 
gradually decreases until day 50. Instead, the level of ASCL1 signal reaches its maximum at day 
35 and then decreases from day 45 to 50.  
We concluded that in vitro the time-window between day 25 and 35 represents the temporal 
evolution of an “SVZ like” domain where we can clearly observe an increasing number of 
GSX2 and ASCL1 double positive cells.  
 
2.2. SVZ - MZ transition 
An additional critical step in the progression of neural progenitor maturation is the transition 
from SVZ toward the MZ.  
The study performed in mouse by Garel et al. published in 1999 had demonstrated that ebf1 
inactivation affects the differentiation of striatal cells while they migrate from the SVZ to the 
MZ, resulting in the expression of an abnormal combination of regulatory genes in the mantle 
zone. Based on this evidence, we decided to monitor in EBF1 in hES H9 cells at differentiation 
days 20, 25, 30 and 50. EBF1 was visualized in combination with PAX6 and CTIP2, 
specifically labeling neuronal population of MZ from early post mitotic stages in hES H9 cell 
line.  
We found that the number of PAX6+ cells increases from day 20 until day 50, probably due to 
the persistency of neural progenitors in our cultures. The presence of PAX6 at later time points 
(as day 50) could also indicate persistence of neurons with cortical identity as demonstrated by 
expression of cortical markers TBR1 and TBR2 (data not shown) (Figure 39, Panel A). 
 
The hES H9 cell line started to show EBF1 positive cells at day 20 (6.37 ± 0.60%). This number 
progressively increases (day 25: 14.15 ± 1.30% and day 30: 24.59 ± 2.15%) and it reaches a 
peak at the last time point analyzed (day 50) (33.70 ± 1.43%) (Figure 39, Panel C). 
 
In order to monitor the transition from SVZ to MZ we analysed CTIP2 expression. At day 20 
we observed very few CTIP2+ cells (0.95 ± 0.19%), which progressively increased from day 25 
(7.07 ± 1.29%), day 30 (8.38 ± 1.48%), until day 50 when it reached the highest numbers (34.63 
± 3.23%) (Figure 39, Panel C). The graphs reported in Figure 45 Panel B represents the strength 
of the intensity of each marker described. The graphs show the mean intensity of CTIP2 (x-
axis), PAX6 (y-axis) and EBF1 (z-axis), at each point representing the three values of each 
measured cell. The graphs show that as the differentiation progresses the intensity signal of 
CTIP2, EBF1 and PAX6 gradually increases. Accordingly, CTIP2 signal level reaches a 
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maximum towards terminal differentiation at day 50 as expected in mature post-mitotic neurons 
(Figure 39, Panel B). 
To confirm this transition, we also counted the number of cells that exhibited co-expression of 
EBF1 and CTIP2. At day 25 we observed very few cells co-expressing these markers (1.11 ± 
0.21% represented in the graph with the orange line). However, this percentage increased 
gradually until day 50 where we could observe 18.3% ± 1.21% of double positive cells (Figure 
39, Panel C). The data collected indicates that at day 50 of in vitro differentiation we identified 
a high percentage of EBF1+/CTIP2+ maturing neurons that are mimicking the in vivo migration 
from SVZ toward MZ. 
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Figure 39: (Panel A) Immunofluorescence in hES H9 for PAX6 (green), EBF1 (red) and CTIP2 (grey) (scale 
bar=25µm), (Panel B) Measurement of the intensity of the fluorescent signal (object intensity) of CTIP2, 
PAX6 and EBF1 in each cell (x-axis = mean intensity of CTIP2 signal; y-axis = mean intensity of PAX6 
signal; z-axis = mean intensity of EBF1 signal, in the log2 scale), (Panel C) Percentage of markers quantified 
on the number of the total counted cells (Dapi positive) (data are represented as means ± SEM). 
 
2.3. Striatal precursor in MZ  
 
The neurons identified in the previous analysis could mature and acquire a striatal precursor 
identity, characterized by the co-expression of NKX2.1, CTIP2 and ISLET1 markers. 
In fact, at 7–8 w in human embryos, ~74% of the total striatal cells was NKX2.1+ and most 
NKX2.1+ cells co-expressed ISLET1 and CTIP2 (80.7 ± 6% and 95.9 ± 0.9%, respectively).  
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At 20w NKX2.1 and ISLET1 were restricted to a few scattered cells (6.3 ± 2.7%) (Onorati et 
al., 2014). These observations suggested that the co-expression of these three TFs identifies the 
majority of striatal precursors, which later switch off the expression of NKX2.1 and ISLET1, 
and only CTIP2 expression is maintained. 
To detect this neuronal precursor population, we have monitored CTIP2, NKX2.1 and ISLET1 
every 5 days of differentiation in hES H9 cell line from day 20 to day 50 (Figure 40, Panel A).  
After quantification, we observed an increase in NKX2.1+ cells starting from day 25 (38.10 ± 
3.09%) detecting a peak at day 35 (45.17 ± 3.11%) that decreases at day 50 (9.01 ± 1.71%). At 
day 35, NKX2.1 expression is also correlated to a very high percentage of ISLET1+ cells (36.20 
± 5.53%), which decreased until day 50 (4.27 ± 0.74%). When we analyzed CTIP2 staining we 
found that at day 35, 53.11 ± 5.70% of the cells were positive for this TF, and this proportion 
remained unchanged until day 50 (48.20 ± 3.63%).  
The highest percentage of striatal neuronal precursors co-expressing NKX2.1, CTIP2 and 
ISLET1 was detected at day 35 (18.23 ± 3.10%, represented in the graph with the orange line) 
and this data was also confirmed by the signal intensity analysis. Specifically, the diagram in 
Panel B of Figure 45 illustrates the signals for ISLET1 (y-axis), CTIP2 (x-axis) and NKX2.1 (z-
axis) (Figure 45, Panel C), and indicates that highest level of intensity for the 3 markers was 
reached at day 35 (Figure 40, Panel B). 
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Figure 40: (Panel A) Immunofluorescence in hES H9 for CTIP2 (red), NKX2.1 (green) and ISLET1 (grey) 
(scale bar=25µm), (Panel B) Measurement of the intensity of the fluorescent signal (object intensity) of 
CTIP2, NKX2.1 and ISLET1 in each cell (x-axis = mean intensity of CTIP2 signal; y-axis = mean intensity of 
ISLET1 signal; z-axis = mean intensity of NKX2.1 signal, in the log2 scale), (Panel C) Percentage of markers 
quantification on the number of the total counted cells (Dapi positive) (data are represented as means ± 
SEM). 
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This data indicate day 35 as the time point in vitro with the highest percentage of striatal 
precursors i.e. cells NKX2.1+/CTIP2+/ISLET1+. The persistence of a NKX2.1-/CTIP2+/ISLET1- 
population at day 45 and day 50 suggests the appearance of mature striatal neurons (Onorati et 
al., 2014). To understand if this population corresponds to authentic MSNs we further analysed 
these cells. 
 
2.4. Identification of authentic MSNs 
Co-expression of CTIP2 and DARPP32 is not a sufficient criterion to determine the presence of 
authentic MSNs. In fact, DARPP32 is expressed also in neurons of layer VI of the adult cerebral 
cortex (Hisaoka et al., 2010), where also CTIP2 was detected, albeit at low levels (Alcamo et 
al., 2008). We therefore decided to analyse the expression of glutamic acid dehydrogenase-67 
(GAD67) staining, the limiting enzyme for GABA synthesis (Behar et al., 1994), which is also 
expressed in the embryonic striatum. 
Previous studies highlighted that hESC-derived DARPP32 neurons expressed GAD67, which is 
consistent with the medium-sized spiny neurons being GABAergic (Danjo et al., 2011). At day 
50, in three independent experiments we observed 12.4 ± 7.23% of DARPP32+ cells and 57.5% 
of them showed co-expression with CTIP2 (Figure 41, Panel A and B). 
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Figure 41: (Panel A) Immunofluorescence in hES H9 at day 50 for CTIP2 (red) and DARPP32 (green) (scale 
bar=50µm and 25µm), (Panel B) Measurement percentage of markers quantification on the number of the 
total counted cells (Dapi positive) (data are represented as means ± SEM, n= 3 independents experiments). 
 
The striatal identity of these neurons was confirmed by immunostaining with GAD67 (Figure 
42, Panel A) and with the measurement of the signal intensities of GAD67 (y-axis), CTIP2 (x-
axis) and DARPP32 (z-axis) (Figure 42, Panel B). In particular, the latter analysis portrayed 
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high intensity values for each marker, suggesting a population of mature striatal MSNs (Figure 
42, Panel B). 
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Figure 42: (Panel A) Immunofluorescence in hES H9 at day 50 for CTIP2 (red), GAD67 (grey) and 
DARPP32 (green) (scale bar=25µm), (Panel B) Measurement of the intensity of the fluorescent signal (object 
intensity) of CTIP2, DARPP32 and GAD67 in each cell (x-axis = mean intensity of CTIP2 signal; y-axis = 
mean intensity of GAD67 signal; z-axis = mean intensity of DARPP32 signal, in the log2 scale). 
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Figure 43: (Panel A) Immunofluorescence in hES H9 at day 50 for CTIP2 (red) and GABA (green) (scale 
bar=50 µm and 25µm), (Panel B) Measurement percentage of markers quantification on the number of the 
total counted cells (Dapi positive) (data are represented as means ± SEM, n= 3 independents experiments). 
At day 50 30.52 ± 15.50% of cells exhibited GABA positivity and 16.09 ± 10.88% were also 
CTIP2+, compared to a total of 28.95 ± 5.92% of CTIP2 positive cells (Figure 43, Panel A and 
B). To confirm the striatal identity of the cells, we checked the expression of GAD67 in parallel 
to the analysis of the signal intensity of these markers (Figure 44, Panel B): GAD67 (y-axis), 
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CTIP2 (x-axis) and GABA (z-axis) signal. We observed a high signal for these three markers, 
further confirming the striatal fate acquired by these cells. (Figure 44, Panel B).  
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Figure 44: (Panel A) Immunofluorescence in hES H9 at day 50 for CTIP2 (red), GAD67 (grey) and GABA 
(green) (scale bar=25µm), (Panel B) Measurement of the intensity of the fluorescent signal (object intensity) 
of CTIP2, GABA and GAD67 in each cell (x-axis = mean intensity of CTIP2 signal; y-axis = mean intensity 
of GAD67 signal; z-axis = mean intensity of GABA signal, in the log2 scale). 
 
2.5. Role of cell cycle state during differentiation  
One alternative way to monitor cell differentiation is represented by the analysis of markers of 
the cell cycle, as Ki67, a marker of active cell cycle and cell proliferation.  
Ki67 is preferentially expressed during late G1, S, G2 and M phases of the cell cycle, while 
non-cycling cells (G0 phase) lack Ki67 expression. Thus, Ki67 is commonly used as a 
proliferation marker.  
Analysis of Ki67+ cells had been performed also in the human fetal brain development (Onorati 
et al., 2014). The authors studied the co-expression of the proliferation marker Ki67 with 
MAP2, GABA, CTIP2, ISLET1, GSX2 and ASCL1 and they found that it delineates the VZ, 
SVZ and MZ compartments in the LGE at 7–8 w, confirming that Ki67 is a marker of the neural 
precursors only (Onorati et al., 2014). 
In parallel, to identify the mature post-mitotic neurons, we used p27 staining. Several reports 
demonstrated that p27 regulates many aspects of neurogenesis, including neural progenitor 
proliferation, migration and/or differentiation (Cunningham et al., 2002; Doetsch et al., 2002; 
Fero et al., 1996; Goto et al., 2004; Nguyen et al., 2006; Sakaue-Sawano et al., 2008; Zezula et 
al., 2001). All these studies indicate that p27 plays critical roles in the development of the 
central nervous system (Cunningham et al., 2002). The function of cell proliferation inhibitor of 
p27 is closely related with its subcellular localization (Reynisdóttir & Massagué, 1997; Tomoda 
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et al., 1999). Indeed, in the nucleus, p27 inhibits the activity of cyclin E/A-CDK2 and prevents 
the cell cycle progression (Sherr & Roberts, 1995). Conversely, p27 is exported to the 
cytoplasm after phosphorylation in Thr 187 or Ser 10 (Boehm et al., 2002). Cytoplasmic p27 
decreases the level of nuclear p27, a regulatory step that is required for a cell to re-enter the 
cycle, and promotes cell migration, as demonstrated in HepG2, fibroblasts, lung cancer cells, 
mesangial cells and neurons (Assoian, 2004; Besson et al., 2004, 2006; McAllister et al., 2003; 
Nguyen et al., 2006; Zezula et al., 2001). Several in vivo and in vitro studies have demonstrated 
that p27 has a key role during neuronal differentiation (Galderisi & Giordano, 2003). For 
instance, in rat embryos a strong p27 expression was observed also in the neurons located in the 
basal telencephalon and diencephalon (Lee et al., 1996) suggesting that high p27 expression is 
characteristic of post-mitotic neurons. Another study, from Casaccia-Bonnefil et al., 1997 
highlights the role of p27 in cell cycle exit showing that p27 deficiency compromises the 
differentiation process of oligodendrocyte precursors. 
Based on these data we investigated the cell cycle state of cells during differentiation by 
monitoring the expression Ki67 and p27, by immunofluorescent analysis, in two hES cell lines, 
H9 and RUES2, in three independent experiments for each line (Figure 45, Panel A and C).  
In both cell lines the levels of Ki67 started to decrease from day 30 until day 50, conversely, the 
number of p27+ cells increased and remained stable between day 30 and day (Figure 45, Panel B 
and D). In hES RUES2, in fact, at day 30 we detected 23.58 ± 18.19% of p27 positive cells, and 
at day 50, 35.15 ± 11.01% p27+ (Figure 45, Panel B). At day 30, the hES H9 cell line showed 
47.66 ± 4.81% and at day 50 45.79 ± 11.10% p27 positive cells (Figure 45, Panel D). This data 
suggested that only a portion of cells were able to maturate and become p27 positive. Between 
day 30 and day 50 this percentage did not increase suggesting that the number of post-mitotic 
cells had reached a plateau. 
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Figure 45: (Panel A) Immunofluorescence on hES RUES2 and (Panel C) H9 for p27 (red) and Ki67 (green) 
(scale bar=25µm), (Panel B) Measurement of percentage of markers quantification on the number of the 
total counted cells (Dapi positive) in hES RUES2 and (Panel D) in hES H9 (n=3 independent experiments for 
each cell line, with 27 images analysed for each time point; data are represented as means ± SEM; Anova 
One way, Tukey post-test *p<0.05, **p<0.01). 
 
 
To further analyze the cell cycle state during in vitro striatal differentiation we focused on hES 
H9 line and fixed the cells every 5 days from day 20 to day 50, to monitor p27 and Ki67 levels 
(Figure 46, Panel B). To correlate the portion of p27 positive cells to a marker of mature 
neurons, we also monitored in parallel the percentage of CTIP2+ cells (Figure 46, Panel A, B).  
In fact, when we calculated the percentage of CTIP2+/p27+ cells on the total number of 
CTIP2+cells, especially at day 45 and 50, we observed that almost all CTIP2+ cells were also 
p27+ (day 20: 54.56 ± 7.01%; day 25 82.67 ± 1.67%; day 30 83 ± 2.20%; day 35 82.74 ± 
1.93%; day 45 91.85 ± 1.09%; day 50 83.78 ± 1.99%) (Figure 46, Panel C). P27 is a good 
marker of post-mitotic neurons as it matches the increase in the percentage of CTIP2 positive 
cells. 
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Figure 46: (Panel A) Immunofluorescence in hES H9 for p27 (red) and CTIP2 (grey), (Panel B) Percentage 
of markers quantification on the number of the total counted cells (Dapi positive), analysed every 5 days, 
(Panel C) Percentage of double CTIP2/p27 co-expressing cells on the total CTIP2 positive cells (data are 
represented as means ± SEM). 
 
In summary, our in vitro analysis demonstrates that the striatal protocol published in 2013 is 
reproducible and is effective on different human pluripotent cell lines. Each cell line showed the 
appearance of the specific subpopulation of precursors and progenitors mimicking the in vivo 
striatum development. The new acquisition and quantification method allowed us to quantify 
more precisely the efficiency of the protocol highlighting new markers and also the possible 
problems in term of authentic MSN conversion. Therefore, we conclude that the efficiency to 
generate MSN neurons is partially cell line dependent because in hES RUES2 in particular we 
observed low efficiency in term of MSN conversion. This point will be under future 
investigation.  
Three independent experiments performed with hES H9 had shown that only 7.13 ± 4.52% of 
the cells are able to become authentic MSNs (i.e., DARPP32+/CTIP2+). For this reason, we 
decided to improve the Delli Carri by using an inducible expression approach; in particular, we 
wanted to express specific TFs involved in specification and maturation of neural precursors 
both in vivo (Garcia-Dominguez, 2003; Garel et al., 1999; Méndez-Gómez & Vicario-Abejón, 
2012) and in vitro, as we described.  
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3. Forced gene expression applied to the Delli Carri protocol 
Our previous data demonstrated that human ventral telencephalic progenitors could be 
generated from hES cells by using a SHH-treatment coupled with WNT-inhibition. These 
progenitors eventually differentiate into electrophysiologically active and mature neurons after 
80 days of differentiation, with 10-15% of them resembling authentic MSNs as demonstrated by 
the co-expression of the striatal markers DARPP32 and CTIP2 (Delli Carri et al., 2013). These 
data were confirmed in the experiments that I performed during my thesis on four independent 
hPSC. 
To further improve recovery and quality of human MSN from hES/hiPS cells, we have recently 
generated doxycycline-inducible hES lines that overexpress critical combinations of TFs known 
to be important for striatal specification and differentiation. 
In the first part of this thesis we described a set of transcription factors critical for establishing a 
dorsal-ventral and medial-lateral positional identity in striatal progenitor cells and for the 
specification of neuronal terminal differentiation. In particular, in the developing telencephalon, 
two TFs play a key role in contributing to the formation of the striatum: GSX2 and EBF1. 
GSX2 is first expressed in the ventricular zone (VZ) of the telencephalon, where it is involved 
in maintaining the identity of early striatal progenitors, while EBF1 controls cell differentiation 
in the murine embryonic striatum (Garel et al., 1999; Jain et al., 2001; Sussel et al., 1999). We 
therefore decided to establish a hES cell-based inducible gain-of-function (iGOF) system 
whereby TFs expressed in the developing striatum can be harnessed to improve MSN 
differentiation. 
 
3.1. Inducible overexpression of key transcription factors during neuronal differentiation 
We employed an inducible overexpression system commercially available (Clontech) that we 
adapted for transgene expression in hES cells. To this effect, the TetON cassette was moved 
into a chicken beta-actin promoter with a CMV enhancer-based plasmid (pCAG), which allows 
a persistent and stable expression of the gene of interest. This promoter was shown to be active 
after many passages in hES cells as confirmed by the continuous expression of the GFP protein 
after transfection of a pCAG-GFP vector (data not shown). pCAG-TetON was delivered by 
nucleofection in hES H9 cells along with a linear construct encoding for puromycin for 
selection of H9 cells stably expressing the pCAG-TetON. hES clones resistant to puromycin 
were picked, amplified, and tested for inducibility by transfecting a pTRE-Luciferase construct. 
We selected four clones: B5 and C6 showed no basal Luciferase activity while C4 and B6 
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exhibited a low-to-high luciferase activity after 48 hours of doxycycline treatment (for details 
see Materials and Methods) (Figure 47).  
 
Figure 47: Testing inducibility of four of hES Tet-ON clones with luciferase assay. 
 
Next, transient transfections were performed in these four clones using a pTRE responsive 
vector bearing cDNA for Gsx2 (pTRE-Gsx2). After 48 hours of doxycycline treatment 
transfected cells were fixed and analysed by immunofluorescence for GSX2 expression. C4 and 
B6 clones, but not B5, showed high GSX2 expression after transient transfection (Figure 48).  
 
Figure 48: GSX2 in C4, B6 and B5 clones after 48 hrs of doxycycline administration (scale bar=50 µm). 
 
C4 and B6 clones expressed OCT4 and SOX2 in pluripotency medium, and responded promptly 
to neural differentiation stimuli similarly to the original H9 cells (Figure 49 and data not 
shown).  
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Figure 49: OCT4 and SOX2 in C4 clone (scale bar=50 µm). 
 
3.2. Generation of inducible hES cell line for Gsx2 and Ebf1 
To generate hES cell line with inducible expression of Gsx2, Ebf1 and a combination of the two 
TFs, we transfected pTRE3G-IRES responsive vector (Clontech) bearing Gsx2 alone, Gsx2 an 
IRES sequence and Ebf1, and Ebf1 alone. Gsx2 cDNA was a gift from Kenneth Campbell, 
Cincinnati Children’s Hospital Medical Center, Cincinnati. Ebf1 cDNA was a gift from 
Giacomo Consalez, Division of Neuroscience, San Raffaele Scientific Institute, Milan. 
Transfected cells without doxycycline treatment represented our control lines. Briefly, after 
nucleofection and selection, several stable hES cell clones were picked, amplified, and tested 
for TFs expression and those with mild overexpression were selected (Figure 50, Panel A). 
Next, transgenes expression was examined by a time-course analysis and transcription was 
induced for 8, 24, and 48 hours in Gsx2, Gsx2-Ebf1, and Ebf1 inducible lines. We found 
transgene expression as soon as after 8 hours of doxycycline treatment, with a peak of 
expression at around 48-72 hours. We found that 55 ± 3% of the cells expressed Gxs2 in Gsx2 
iGOF (Figure 50, Panel D), 51 ± 19% and 48 ± 22% of the cells express Gsx2 and Ebf1, 
respectively, in Gsx2–Ebf1 iGOF (Figure 50, Panel G) while 60 ± 8% of the cells expressed 
Ebf1 in Ebf1 iGOF (Figure 50, Panel J). 
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Figure 50: (Panel A) Schematic representation of generation of the three hES iGOF cell lines; (Panel C, F, I) 
Immunofluorescence of GSX2 (red) and EBF1 (green) (scale bar=100 µm); (Panel D, G, J) quantification of 
TFs overexpression after doxycycline treatment. 
 
We then studied if the newly generated clonal lines were able to respond appropriately to the 
Delli Carri protocol and to generate authentic MSNs. We found that at day 40 of neural 
differentiation our cell lines expressed specific neuronal markers such as MAP2, CALBINDIN, 
FOXP2, CTIP2, and GABA (data not shown). Thus, the process of genetic modification and 
selection of the cells did not alter the capacity of these H9 sub-clones to differentiate toward a 
neuronal lineage. To determine the effects of Gsx2 and Ebf1 expression in human neural 
progenitors, we overexpressed Gsx2, Gsx2-Ebf1 and Ebf1 in different temporal windows during 
hES neural differentiation: day 10-15, day 15-20, and day 20-30. We observed that expression 
of the TFs between day 20-30, but not in the other temporal windows, reduced expression of 
cortical (PAX6) and MGE markers (NKX2.1) at day 30 (data not shown). This evidence 
suggested that, in this particular window of differentiation, overexpression of TFs could affect 
the differentiation rate. We therefore decided to expose cells to doxycycline from day 20 until 
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day 30. Cells were differentiated until day 80 in 5 different and independent experiments for 
each cell line. During differentiation, after 10 days of doxycycline treatment starting from day 
20, we confirmed, at day 30, correct overexpression of TFs by Western Blot analysis (Figure 51, 
Panel A) in the three generated iGOF lines (Figure 51, Panel B). 
A B 
 
Figure 51: Protein levels of Gsx2 and Ebf1 at day 30. (Panel A) Western Blot for Gsx2 and Ebf1 at day 30 in the 
three hES iGOF cell lines; (Panel B) quantification of GSX2 and EBF1 protein levels (Error bars show SD, n = 5 
independent experiments, *p< 0.05, **p< 0.005, ***p< 0.001). 
 
3.3. Gsx2 and Ebf1 Regulate Cell-Cycle Kinetics 
Cell proliferation in the developing telencephalon is a tightly regulated process, and it is 
essential to produce the correct number of post mitotic neurons. To examine the effects of Gsx2 
and Ebf1 overexpression on the cell cycle in human progenitor cells, we first performed a 
cumulative bromodeoxyuridine (BrdU) analysis in the proliferating hES cell lines inducible for 
Gsx2, Gsx2–Ebf1 and Ebf1. BrdU is a halogenated thymidine analogue that is incorporated into 
DNA synthesized during S-phase. With this approach, we were able to detect the cells in S 
phase, that have incorporated BrdU and, therefore, resulted positive for BrdU staining. 
After treating the cells with doxycycline for 5 days, we administered BrdU for either 30 min, 4, 
8, or 20 hours. We found that the Gsx2 iGOF line showed a reduced BrdU incorporation 
compared with the untreated cells (Figure 52, Panel A and quantification in Panel B). These 
data indicate that overexpression of Gsx2 alters the cell cycle by arresting its progression; in 
fact, Gsx2 overexpressing cells are not able to pass the phase S, where they would incorporate 
BrdU. 
In contrast, the Gsx2–Ebf1 inducible line showed a similar BrdU incorporation rate compared 
with the control line, suggesting that cell-cycle alteration by Gsx2 was rescued by Ebf1 
expression (Figure 52, Panel C and quantification in Panel D). Finally, cell cycle analyses were 
performed in the Ebf1 iGOF line. In contrast with the previous results, a significant increase in 
BrdU incorporation was recorded after 20 hours of induction in Ebf1 iGOF (Figure 52, Panel E 
and quantification in Panel F). Taken together these data suggest that expression of Gsx2 and 
Ebf1 alone affects the cell cycle by altering the entry in S phase. Particularly, in proliferating 
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cells, Gsx2 expression blocks the cell cycle progression, whereas Ebf1 promotes it (Garcia-
Dominguez, 2003; Garel et al., 1999; Méndez-Gómez & Vicario-Abejón, 2012). 
 
Figure 52: Cumulative BrdU assay. (Panel A, C, E) Immunofluorescence of BrdU incorporation (green) after 20 
hrs in the three hES iGOF cell lines in Dox and no Dox condition (scale bar=50 µm); (Panel B, D, F) quantification 
of BrdU incorporation (n=3 independent experiments, data are represented as means ± SD; two-tailed t test 
analysis. *p < 0.05, **p< 0.01).  
 
To test whether the overexpression of Gsx2 and Ebf1 regulated the cell cycle state also in hES-
derived neural progenitor cells, we administered doxycycline from day 20 to day 30 of the Delli 
Carri protocol and cell cycle kinetics were analysed by a BrdU/IddU double labelling paradigm. 
Both BrdU and iododeoxyuridineare (IddU) are halogenated thymidine analogues and are 
incorporated into DNA synthesized during S-phase. The sequential exposure of proliferating 
cells to IddU and subsequently BrdU allows us to differentiate between defined populations of 
cells, by using primary antibodies, that uniquely recognize the BrdU or IddU incorporation (for 
details see Material and Methods section). The relative sizes of these populations allow us to 
calculate the total cell cycle time (Tc) and the length of S-phase (Ts) of the proliferating pool. 
For the application of this assay we followed the Martynoga et al., protocol, published in 2005 
(diagram in Figure 53, Panel G). 
At day 0 of differentiation, without doxycycline induction, we found that the Tc of the different 
iGOF lines was of 19.4 ± 4.4 hours. Next at day 30 of differentiation, the Tc of the hES-derived 
neural progenitors was assessed (Figure 53, Panel A–F), and we found results in agreement with 
the BrdU cumulative analysis shown in Figure 52, Panel A-F: estimation of control cell (no 
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doxycycline) Tc was 12 ± 1 hours, whereas the Gsx2 overexpressing cells showed a Tc of 24 ± 
4 hours (Figure 53, Panel H). This indicates that the effect of Gsx2 overexpression on cell cycle 
is exerted by regulating its length. Next, we analysed the contribution of Ebf1 on the cell cycle 
by measuring Tc in Gsx2–Ebf1 iGOF cells, finding a value of 7 ± 1 hours, suggesting that Ebf1 
could override a Gsx2-mediated increase of cell-cycle length (Figure 53, Panel H). Ebf1 iGOF 
line showed a cell cycle duration similar to the double Gsx2–Ebf1 iGOF (Figure 53, Panel E–F-
H). All together these data indicate that in neuronal progenitors, only Gsx2 increases the cell 
cycle length. In fact, the cell line with only Ebf1 and the line with the combination of the two 
TFs has the same cell cycle length as the control cells.  
 
A
E
G
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C D
E F
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Figure 53: Calculation of cell cycle kinetics. (Panel A, B, C, D, E, F, G) Immunofluorescence of BrdU 
incorporation (red) and IddU incorporation (green) after 2 hours from the injection in the three hES iGOF cell lines 
in Dox and no Dox condition (scale bar=50 µm); (Panel H) quantification of cell cycle length (the whiskers of the 
graph show the largest and smallest values; ***p < 0.0005, *p < 0.05).  
 
To rule out the possibility that Gsx2 iGOF cells were undergoing differentiation (and thus 
incorporating less BrdU), we analysed MAP2 expression at day 30. This marker was chosen as 
it represents maturing neurons and is expressed in our differentiating cultures until day 80. Gsx2 
iGOF showed a marked reduction of MAP2+ cells (Figure 54), in agreement with the previous 
cell cycle analysis data and further suggesting that Gsx2 overexpressing cells do not exit the cell 
cycle.  
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Figure 54: GSX2 and MAP2 expression at day 30 in Gsx2 iGOF cell line (scale bar=100 µm). 
 
To confirm the effect of Gsx2 and Ebf1 on cell cycle kinetics, we analysed the expression of 
Ki67 and BrdU incorporation in differentiating iGOF lines. To do so, doxycycline was 
administered from day 20 until day 30 of differentiation, as reported diagram G in Figure 55, 
BrdU was administered for 2 hours at day 25 of neuronal maturation. The cells were then fixed 
at day 30 and analysed for BrdU incorporation and Ki67 expression. The cell cycle index was 
calculated by dividing the total number of BrdU+/Ki67- cells by the total number of BrdU+ cells. 
This number identifies the cells that became post-mitotic between after 25, which corresponds 
to the beginning of the maturation phase of the protocol. As showed in Figure 55 panel A-F, the 
three cell lines showed different phenotypes. Gsx2 overexpressing cells were more likely to 
remain in the cell cycle (50.2 ± 29.7% reduction of cell cycle exit over non-induced cells, 
Figure 55, Panel H); induced Gsx2-Ebf1 iGOF cells exited the cell cycle (150 ± 28% increase 
over non-induced cells, Figure 55, Panel H). Ebf1 iGOF overexpressing cells were 113 ± 7% 
more likely to exit the cell cycle (Figure 55, Panel H). 
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Figure 55: Immunofluorescence of Ki67 and BrdU at day 30 in the three iGOF cell lines. Gsx2 and Ebf1 
differentially regulate cell-cycle exit and promote striatal differentiation. (Panel A–F) Representative images of 
cell-cycle exit studies. Arrows point to BrdU+/Ki67− cells, that exited cell cycle; arrowheads point to BrdU+/Ki67+ 
cells, still proliferating (scale bar=75 µm); (Panel G) Schematic representation cell-cycle exit assay, by 
administering for 2 hours BrdU at day 25 of neuronal maturation in the temporal window of doxycycline treatment, 
from day 20 until day 30; (Panel H) Quantification of cell-cycle exit in Gsx2, Gsx2–Ebf1, and Ebf1 lines after 10 
days of doxycycline treatment compared with basal conditions (no doxycycline, dotted line). Box shows the 
median and the 25th and 75th percentiles. The whiskers of the graph show the largest and smallest values (data are 
represented as means ± SD, n=3, t-test **p < 0.005). 
 
Together, these results were in line with the hypothesis of Gsx2 retaining neural progenitor cells 
in an undifferentiated state, while Ebf1 induces cell-cycle exit and progenitor maturation. 
In conclusion, these data reflect the role of these two TFs in vivo, in fact in VZ Gsx2 maintains 
the neural progenitors in un-differentiated state, promoting their quiescent state (Méndez-
Gómez & Vicario-Abejón, 2012); whereas Ebf1 promotes the maturation of neural precursors in 
the MZ (Garcia-Dominguez, 2003; Garel et al., 1999)  
 
3.4. Evaluating the effects of TFs overexpression in MSN identity acquisition 
To determine the striatal differentiation potential of hES cells overexpressing Gsx2 and Gsx2-
Ebf1 between days 20 to 30, we conducted long-term differentiation experiments and analyzed 
the cells at day 80. We studied the expression of two key markers for mature striatal neurons, 
DARPP32 and CTIP2, along with MAP2 expression.  
We quantified the number of generated striatal MSNs by analysing the area occupied by 
CTIP2+/DARPP32+ cells per field. Interestingly, we found a significantly higher efficiency of 
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CTIP2+/DARPP32+ neuron generation in the doxycycline-induced iGOF Gsx2–Ebf1 line only, 
compared with non-induced cells (38.8 ± 13.7% and 3.8 ± 3.1% respectively, Figure 56, E). 
Overexpression of Gsx2 and Ebf1 increased by more than five-fold the numbers of 
differentiated MSNs compared to normal hES H9 cells (7.13 ± 4.52%).  
Finally, we studied if the Gsx2–Ebf1 combination could confer functional electrophysiological 
properties to the differentiated neurons. For this analysis, we took advantage of collaboration 
with Prof. Gerardo Biella at University of Pavia. Although passive membrane properties did not 
change significantly between doxycycline-treated and untreated cells (data not shown), we 
found interesting results studying sodium currents. In particular, Na+ current density was 
significantly higher Gsx2–Ebf1 overexpressing cells compared to doxycycline untreated cells 
(from 30.7 ± 6.6 pA/pF in control cells to 76.1 ± 10.1 pA/pF in Gsx2–Ebf1 overexpressing 
cells; Figure 56, F). This data suggested that the neurons obtained from the overexpression of 
Gsx2-Ebf1 were more able to initiate and propagate action potentials.  
As control, we verified the CTIP2 and DARPP32 expression in the other two iGOF lines, Gsx2 
and Ebf1 alone cell lines, and we confirmed that only with the combination of the two TFs we 
had an increase in MSNs efficiency (Figure 57, data not quantified). 
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Figure 56: Immunodetection in Gsx2-Ebf1 iGOF cell line at day 80. (Panel A, B, C, D) Staining for DARPP32 
and CTIP2 (scale bar=75 µm in A and B; and 250 µm in C and D); (Panel E) Quantification of DARPP32+/CTIP2+ 
cells on the Dapi positive area (data are represented as means ± SD, t test, **p < 0.005); (Panel F) Measurements of 
the Na+ current density (data are represented as means ± SD, t test, ***p < 0.001). 
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Figure 57: Immunodetection in Gsx2 and Ebf1 iGOF cell lines at day 80. (Panel A) Staining for DARPP32 and 
CTIP2 at day 80 without Doxycycline and (Panel B) after Doxycycline treatment in Gsx2 iGOF cell line; (Panel C) 
Immunofluorescence of DARPP32 and CTIP2 at day 80 without Doxycycline and (Panel D) after Doxycycline 
treatment in Ebf1 iGOF cell line (scale bar=100 µm) 
 
In summary, these experiments showed that only the Gsx2-Ebf1 overexpression facilitate 
striatal maturation in hES cells in vitro. 
To confirm the data obtained in the Gsx2-Ebf1 iGOF cell line, we decided to test a non-
integrating system for the ectopic expression of these TFs. 
 
3.5. Modified mRNA as non-integrating strategy for TF expression: preliminary results 
The described iGOF system is based on a random integration approach, which bears risks of 
mutagenesis in the treated cells. In order to progress towards a possible therapeutic translation 
of this approach, we have considered using a non-integrating virus-free system for the 
overexpression of Gsx2–Ebf1 based on Modified mRNAs (mmRNAs) (Elango et al., 2005; Uzri 
& Gehrke, 2009), which are a new non-integrating strategy for reprogramming cell fate based 
on administration of synthetic mRNAs modified to overcome innate antiviral responses. 
The cDNA of a gene of interest, optimized with regard to human codon usage, is cloned into a 
basic vector system containing the T7 promotor and a 5’ and 3’ UTR. RNA is generated in an 
animal component–free production process by T7-based transcription and subsequent 5’ 
capping and 3’ polyadenylation. Optionally, Ψ-UTP- and 5-mCTP-modified nucleotides are 
introduced to reduce innate immune responses against RNA in downstream applications. RNA 
is DNase treated, sterile filtered, and lyophilized (Figure 58). 
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Figure 58: Design of the vector contained gene of interest under control of T7 promoter. 
 
To promote efficient translation and boost RNA half-life in the cytoplasm, a 5’ guanine cap is 
incorporated by inclusion of a synthetic cap analogue during the transcription in vitro. The open 
reading frame (ORF) of the gene of interest is flanked by a 5’ untranslated region (UTR) 
containing a Kozak translational initiation signal and an alpha-globin 3’ UTR terminating with 
an oligo(dT) sequence for template addition of a polyA tail. Cytosolic delivery of mmRNA into 
mammalian cells can be achieved via electroporation or by complexing the RNA with a cationic 
vehicle to facilitate uptake by endocytosis. Published results indicate that a repetitive 
transfection regimen would be required to sustain high levels of ectopic expression for short-
lived proteins over an extended period of time (Warren et al., 2010) (Figure 59).  
 
 
Figure 59: Pharmacokinetic properties of synthetic mRNA are improved by nucleotide analogue 
incorporation during in vitro RNA synthesis. 
 
Modified mRNAs encoding for GFP were transfected in neural progenitors of hES H9 at day 20 
(as described in Figure 60), and we tested two different reagents and protocols for the 
transfection, the StemMACS™ mRNA (Miltenyi Biotec) and TransIT®-mRNA (Mirus 
Company). For the measurement of the transfection efficiency, we fixed the cells treated with 
100ng and 200ng after 24 and 48 hours. The 200ng of GFP mmRNA transfected with Miltenyi 
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protocol at 48 hours post transfection showed the highest expression of GFP (31 ± 6.05%) 
(Figure 61). 
1 5 15 20 22 25 30 35 40 45
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Figure 60: Experimental design for setting and using of mmRNA. 
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Figure 61: (bottom) Testing different protocols and concentration of mmRNA transfection (scale bar=50 
µm) on hES H9 and (top) quantification (data are represented as means ± SEM). 
 
After this set up, we applied the same mmRNA concentration and transfection protocol to 
transfect MSN progenitors from day 20 until day 25 hES H9 with mmRNA for Gsx2 followed 
by mmRNA transfection for Ebf1, from day 25 until day 30 (experimental details in Figure 60).  
As we could observe in Figure 62, we obtained 32.73 ± 6.15% Gsx2+ cells and 32.73 ± 6.15% 
Ebf1+ cells. 
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Figure 62: Transfection efficiency for Gsx2 and Ebf1 mmRNA during differentiation of hES H9 (scale 
bar=100 µm and 50 µm) and quantification (data are represented as means ± SEM). 
 
In a preliminary experiment, we also observed a down regulation in PAX6 expression after 
Gsx2 mmRNA transfection at day 25. The transfected cells showed 15.73 ± 2.18% PAX6+ 
compared to 49.57 ± 5.19% in the un-transfected cells (Figure 63). This data confirms the effect 
of Gsx2 expression on the down-regulation of PAX6, the same observed in the iGOF cell line. 
This first observation corroborates the idea that this non-integrating system is a viable 
alternative to the overexpression system.  
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Figure 63: Gsx2 mmRNA transfection effect on Pax6 expression (scale bar=50 µm) and quantification (n=1 
experiment, with 25 images analyzed; data are represented as means ± SEM, t-test ****p<0.0001). 
 
These preliminary data showed that mmRNAs are well expressed in hES cells and hES cells-
derived neural progenitors (Figure 63).  
The application of mmRNA solves the problem of the integration used in the iGOF system, 
which modified the genome of the cells. In this system, in fact, we didn’t know the number of 
copy of nucleofected plasmids that carried the TFs integrated in the cell genome.  
Aiming at the development of an ectopic expression system compatible with the GMP 
procedures necessary for the cell replacement approach, the mmRNA approach represents a 
promising method to increase the number of authentic MSNs without genome alteration. 
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3.6. Evaluation of survival and maturation of iGOF (Gsx and Ebf1 overexpressors)-
derived MSNs after transplantation  
To evaluate the potential for cell replacement therapies of the striatal progenitors and neurons 
obtained in vitro we focused on the evaluation of the ability of these cells to survive and mature 
in the resident tissue in vivo. First of all, we worked on setting up cell transplantation condition 
with the aim to observe a good survival and maturation of the transplanted cells. Preliminary 
experiments performed in my lab had shown a good survival of neural progenitors transplanted 
at day 20 of the Delli Carri protocol. According to these evidences, colleagues in the lab have 
performed several transplantations following the same paradigm and we evaluated the capacity 
of these neurons to mature in the resident tissue. Then, they applied the new-improved 
transplantation approach on the Gsx2-Ebf1 iGOF cell line, to evaluate their capacity to mature 
in the striatum of the host.  
Intrastriatal injection of Quinolinic Acid (QA) in rats produces an axon-sparing lesions similar 
to those observed in HD. QA was a potent excitant of neurons in the brain, by acting as an 
agonist at the N-methyl-D-aspartate (NMDA) sensitive population glutamate receptors, 
therefore causes selective neuronal lesions. Injection of QA in the striatum generally spares 
GABAergic interneurons and affected only MSNs, which are able to up take and metabolize the 
QA. For this reason, this is a good reproduction of neuropathology of HD than other 
excitotoxins (Beal et al., 1991; Schwarcz et al., 1986). Transplantation of human cells into 
experimental animals may elicit an immune rejection. Athymic nude rats, immunodeficient due 
to the lack of a normal thymus, in combination of QA lesions provide a useful model for our 
cell transplantation studies.  
This model allows us to verify if it is possible to repopulate a lesioned striatum with in vitro-
differentiated MSNs. My goal has been to characterise the hES-derived MSN progenitors after 
in vivo transplantation in this animal model of HD. These experiments were performed in 
collaboration with Prof. Alessandro Vercelli at the Neuroscience Institute Cavalieri Ottolenghi 
(NICO) in Turin and Prof. Rosa Maria Moresco at San Raffaele University in Milan. 
We decided to transplant cells after 20 days of in vitro differentiation. This time point was 
selected based on previous experiments showing that cells differentiated until day 20 showed 
optimal survival 2 weeks after transplantation (Figure 64). Moreover, a small percentage of 
Ki67+ cells was found demonstrating that the day 20 grafted neural progenitors promptly exited 
cell cycle, without forming overgrowths. With respect to Delli Carri et al., where the cells were 
transplanted at day 38 of differentiation we expect that grafting younger cells could increase 
their survival and integration in the striatum of the host. 
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Figure 64: Section of rat striatum showing hNuclei+ cells two weeks after transplantation. Cells have been 
grafted at day 20 of in vitro differentiation. 
 
To characterize the hES H9-derived MSN progenitors after transplantation in QA-lesioned 
athymic rats, we followed the experimental protocol reported in Figure 65.  
3
 
Figure 65: Experimental design of in vitro culture and transplantation procedure. 
 
The lesion was produced by my colleagues through an unilateral striatal injection of 210 nmol 
of freshly made QA using the following stereotaxic coordinates: AP= +0.5, L= +/-2.8, V= 5.0. 
Seven days later we grafted 3x105 cells in both lesioned and non-lesioned striata. 
20 animals were sorted into two groups of 10 animal each and sacrificed 2 weeks and 2 months 
after surgery. Good survival of the cells was evident at both time points as highlighted by 
hNuclei staining, which specifically recognizes human cells, in the post mortem striatal tissue.  
To analyse the identity of the surviving cells at 2 weeks and 2 months after surgery we 
performed immunohistochemistry for NESTIN by using a human specific antibody and for the 
neuronal marker MAP2. We found that cells delivered to the lesioned hemisphere were able to 
integrate in the host tissue already 2 weeks from grafting (Figure 66). 
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Non-lesioned side Lesioned side 
 
Figure 66: hNESTIN and MAP2 immunostaining on specimens of lesioned and non-lesioned striatum 2 
weeks after surgery. A better integration of cells in the lesioned side is indicated by the higher MAP2 
staining. 
 
No expression of synaptic marker SYNAPSIN was found 2 weeks after surgery (Figure 67). 
This is not surprising at this early time point, after only two weeks after grafting, where 
transplanted cells are not expected to have already established direct cell-to-cell connections. 
Non-lesioned side Lesioned side 
 
Figure 67: Immunohistochemistry of hNESTIN and SYNAPSIN in rat striatal tissue 2 weeks after grafting. 
 
We then analysed whether the transplanted cells could generate mature MSNs by assessing 
CTIP2/DARPP32 co-expression in 3 sections spanning the rostro-caudal axis of the graft in 
both lesioned and non-lesioned sides 2 months after transplant in 10 animals (Figure 68). The 
frequency of CTIP2 and DARPP32 positive cells over hNuclei was determined by stereological 
approach. Figure 69 shows that 50% CTIP2+ cells, 3% of which were also DARPP32+, were 
present 2 months after surgery. 
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Non-lesioned side Lesioned side 
 
Figure 68: Immunohistochemistry for hNuclei, CTIP2, DARPP32 in rat striatal tissue 2 months after 
transplant. 
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Figure 69: Stereological quantification in lesioned and non-lesioned side in the grafts 2 months after 
transplant of CTIP2, DARPP32, and DARPP32-CTIP2 co-expressing positive cells. 
 
Figure 70 shows the widespread presence of surviving cells 2 months after transplant in the 
entire section of the brain of one representative animal. We therefore decided to look into more 
detail at the ability of these cells to extend processes throughout the brain by evaluating co-
expression of hNCAM/hNESTIN in sections distal from the grafts. Figure 71 shows sporadic 
hNCAM positive fibres running through the corpus callosum 2 months after transplant. 
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Non-lesioned side Lesioned side 
 
Figure 70: hNestin mosaic of the entire rat brain section, 2 months after surgery. 
 
 
Figure 71: Immunohistochemistry of hNCAM positive fibers running through the corpus callosum and 
showing the ability of the graft to extend processes along long distances. 
 
These preliminary observations suggest that hES-derived MSN progenitors derived according to 
the Delli Carri protocol can survive, mature and extend processes outside of the striatal nuclei. 
Day 20 immature neural progenitors were also able to differentiate and express mature striatal 
markers such as CTIP2 and DARPP32 without showing signs of overgrowth. We decided to 
adopt this experimental design to evaluate the survival and maturation capacity of differentiated 
Gsx2-Ebf1 iGOF cells in vivo. 
 
To investigate long-term survival and differentiation of Gsx2-Ebf1 iGOF cells after 
transplantation in the striatum of QA-lesioned, athymic adult rats, the transplanted animals were 
followed up for two months and then sacrificed for immunohistochemical analysis to determine 
the striatal differentiation potential of hES cells overexpressing Gsx2–Ebf1 in vivo in term of 
hNuclei+ MSNs detected in the striatum of the host. 
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Since cells at day 20 of the differentiation protocol are more suitable for transplantation, we 
decided to anticipate the induction of Gsx2 and Ebf1 to the temporal window day 15-20 of 
neuronal differentiation and cells at day 20 were used for transplantation in the QA lesioned rats 
(Figure 72, Panel A). 
Two months after transplantation, we found hNuclei+ cells in the transplantation site (Figure 72, 
Panel B and C, the red cells), suggesting survival of the grafted cells (average of 53 ± 16% 
hNuclei+ cells on the total DAPI cells). To further investigate the co-expression of CTIP2 and 
DARPP32 in hNuclei+ cells, we performed a triple staining shown in Figure 72, Panel E and F. 
We quantified the cells that were hNuclei/CTIP2 double positive, and we found 23 ± 6% of 
cells expressing both markers (Figure 72, Panel D).  
A
B C
D
E F
 
Figure 72: Immunohistochemistry of Gsx2-Ebf1 iGOF cell line 2 months after transplantation. (Panel A) 
Experimental design for hES cell-derived neural progenitor transplantation in QA-lesioned athymic rats. (Panel B, C, E, 
F) Immunohistochemistry for hNuclei+, CTIP2, and DARPP32 or GABA cells two months after transplantation. 
Arrows point to grafted human cells expressing either CTIP2 or DARPP32 (scale bar=35 µm and scale bar=15 µm for 
insets); (Panel D) Quantification of human cells in the grafted site, hNuclei+ cells, and of CTIP2+ cells in the hNuclei+ 
population. Box shows the median and the 25th and 75th percentiles. The whiskers of the graph show the largest and 
smallest values.  
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Surprisingly, when we quantified the percentage of hNuclei+ MSNs obtained from the 
transplantation of cells that did not receive doxycycline, we found the similar percentage of CTIP2 
and DARPP32 positive cells in the graft (Figure 73, Panel A-B).  
A B 
 
Figure 73: Quantification of percentage of hNuclei+ MSNs cells obtained from the transplantation. (Panel A) 
Quantification of DARPP32 cells of human origin in the grafts, (Panel B) CTIP2 cells of human origin in the grafts 
in un-treated cells (indicated WT) and doxycycline treated (indicated iGOF) cells (data are represented as means ± 
SD). 
 
All the data collected with the iGOF cell lines, published in Faedo et al., 2017 (Faedo et al., 
2017), had shown the role of Gsx2 in restraining cell-cycle progression in neural progenitors, 
while the differentiation defect was rescue by Ebf1 expression. The co-recruitment of Gsx2 and 
Ebf1 caused a more efficient neuronal differentiation. Even if these two TFs are not expressed 
in the same region and time during human fetal brain development (Onorati et al., 2014), their 
combined expression in hES derived neural progenitors allowed to increase the neuronal 
differentiation, in term of authentic MSNs. However, the overexpressing cells after in vivo 
transplantation in QA athymic rat, did not show an increase in number of CTIP2+/DARPP32+ 
compared to un-treated cells. These results suggest that Gsx2–Ebf1 overexpression improves 
striatal differentiation in vitro, but it does not have an effect on the maturation of striatal 
progenitors in vivo.  
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Conclusions and Future Prospects 
 
This PhD thesis mainly aimed at two goals. First, to study the steps of in vitro differentiation 
from hPSC into MSN with the differentiation protocol published by Delli Carri et al., 2013 and 
validates its reproducibility across multiple cell lines. Second, to improve this protocol in order 
to obtain authentic MSNs that could be potentially used as disease modelling platform in pre-
clinical studies for Huntington’s Disease (HD).  
 
All the four tested lines (H9 hES, Roslin hES, RUES2 hES and hiPS) showed canonical neural 
induction in terms of PAX6 and FOXG1 expression, and at day 25 we identified equal 
frequencies of ventral neural progenitor positive for GSX2 and ASCL1 markers. At day 35, the 
cells acquired a striatal precursor identity as indicated by co-labelling of NKX2.1, CTIP2 and 
ISLET1 markers. At the end of the differentiation (day 50), all the cell lines showed positivity 
for the MSN markers CTIP2, GABA and DARPP32 albeit with some variability. In conclusion, 
with these experiments we have demonstrated that the protocol previously established in the lab 
can be applied with good reproducibility to diverse hPSC lines. 
 
The newly elaborated pipeline for image analysis allowed us to quantify several nuclear and 
cytoplasmic markers. This approach enabled us to quantify DARPP32 and CTIP2, and study the 
cell cycle dynamics during the differentiation protocol. For example, this analysis has 
highlighted that the expression of p27, both in H9 and RUES2 lines, remains static and showed 
no increase in expression from day 30 until the end of differentiation. This result correlates with 
the persistency of a Ki67+ fraction in the same culture conditions. Conversely, our analysis 
showed that only a fraction of cells became p27 positive at day 30, with no increase until the 
end of the protocol (day 50: 7.13 ± 4.52%), suggesting that in these conditions only a part of the 
cells was instructed to transit to a post-mitotic phase. Despite general consistency, our data 
highlighted a different intrinsic ability of the hESC lines to mature in MSNs and exit from cell 
cycle. Specifically, RUES2 cells failed in generating DARPP32 positive neurons at the end of 
differentiation. 
In this context and with the aim of improving the striatal differentiation protocol, we used H9 
hES cells to study the effects of the forced expression of Gsx2 and Ebf1, transcription factors 
important for striatal neural progenitor specification and their maturation, respectively. We also 
implemented a non-integrating system based on modified mRNA for ectopic expression of the 
same TFs as a potential future strategy for cell replacement applications. Our data provide the 
proof of principle that TF expression in vitro can improve the efficiency of our differentiation 
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protocol. Notably, time-controlled expression of Gsx2 and Ebf1 during in vitro differentiation 
has allowed to significantly increase the overall efficiency of the procedure from 7.12 % to 
38.8% of MSNs generated after 50 days of differentiation. This was also reflected in the cell 
cycle state of the cells. In particular after Gsx2 induction, we observed changes in neural 
progenitor’s cell cycle. In fact, Gsx2 may keep ventral neural progenitor cells in an un-
differentiated state, by promoting cell cycle to “pause”, thus inducing a G0-like state inhibiting 
neural maturation. This effect was rescued by Ebf1 expression and cells were able to mature and 
exit from the cell cycle. These findings suggest that monitoring the cell cycle state during 
differentiation combined with forcing it’s exit by using compounds in specific time windows 
could be a good strategy to improve the percentage of post-mitotic neurons at the end of 
differentiation. 
Other studies highlighted that the cell cycle state can influence the acquisition of a specific fate 
after application of different differentiation protocols (Dalton, 2013; Pauklin & Vallier, 2014). 
Pauklin and Vallier have demonstrated that hESCs in early G1 phase are more permissive to 
endoderm differentiation, while cells in late G1 are prone to switch from endodermal to 
neuroectodermal fate acquisition (Pauklin & Vallier, 2014). In light of these observations, we 
can speculate that the changes in cell cycle state in different cell lines could have a significant 
downstream effect during differentiation. This might explain the variability observed in 
DARPP32 expression in our four cell lines. In this case, the use of compounds able to modulate 
cell cycle progression and synchronisation may represent a promising approach to improve 
neural induction, cell fate acquisition and maturation. 
 
As previously reported in Delli Carri et al., 2013, the data obtained after in vivo transplantation 
of hESCs differentiated in vitro confirmed a relatively poor efficiency of conversion of hESC 
into MSNs. We thought that transplanting cells at day 20 of the differentiation protocol instead 
that at day 38 as in Delli Carri, could help to promote their survival and integration in the 
striatum of the host. At day 20, in fact, the cells are in a neural progenitor state and are therefore 
more permissive and tolerant to transplant. Nonetheless, we obtained a small number of human 
MSNs in the striatum of QA lesioned rats, showing also in this case that the cells were not able 
to mature with high efficiency in the host brain. Low efficiency of conversion may be the result 
of different exposure to morphogens that cells face in vivo. As described, in vitro differentiation 
relies on 25 days of continuous exposure to SHH and WNT signalling inhibition that is 
prematurely terminated during the in vivo paradigm at the time of transplantation, shortening the 
window of exposure of the cells to SHH and WNT signalling inhibition by 5 days. This may 
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compromise in vivo the efficiency of conversion leading to the observed reduced frequency of 
MSNs.  
Generation of authentic MSNs was not improved also when we tested grafting efficiency of 
hESC expressing Gsx2 and Ebf1. Transplantation of iGOF cells in QA-lesioned animals did not 
achieve an increase of bona fide MSNs in the graft 2 months after transplantation as expected 
according to the in vitro data showing a significant increase in the overall efficiency MSNs 
generation compared to un-transfected cells. Also in this case, discrepancies between the in 
vitro and in vivo paradigms could explain the obtained data. In order to perform the transplant at 
day 20 of differentiation, the cells received doxycycline from day 15 to day 20 while for the in 
vitro experiments we overexpressed Gsx2 and Ebf1 from day 20 until day 30. We therefore 
believe that low efficiency in the generation of MSNs in vivo may be due to the different 
doxycycline exposure window used to force expression of the TFs. In the next future, we will 
transplant iGOF cells at day 20 and sustain the transgenes expression by in vivo administration 
of doxycycline through drinkable water, based on the fact that this antibiotic is able to pass the 
blood-brain barrier, as shown in Torper et al., 2013 (Torper et al., 2013).  
 
In summary, this thesis work highlights that the generation of precisely patterned neural cells 
from human Embryonic Stem cells (hESC) and pluripotent stem cells (hPSCs) is a crucial step 
to develop optimal cellular models to study neurodevelopment and to model neurodegenerative 
disease. This work provides a detailed characterization of authentic striatal medium spiny 
neurons (MSNs) by implementing a highly elaborate microscope image acquisition pipeline that 
enabled us to identify and quantify specific cell states and transitions occurring during our in 
vitro differentiation protocol (Delli Carri et al., 2013). In addition, we pinpointed Gsx2 and 
Ebf1 as two essential transcription factors during these shifts in identities and designed an 
overexpressing system to deliver these factors in a time controlled manner. This strategy has 
improved conversion into mature MSNs in vitro from 7% to 38%. However, further studies will 
be required to test whether in vivo transplantation of Gsx2-Ebf1 overexpressing cells in adult 
athymic QA-lesioned rats is a good strategy to increase generation efficiency of authentic 
MSNs. In this respect, the implementation of the mmRNA strategy will be useful as an 
alternative approach for the non-integrating ectopic expression of these TFs. Therefore, we are 
planning to optimize this system in GMP cell lines, in the prospective of cell replacement 
therapies. 
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Materials and Methods 
 
ES cell culture. hES H9 cell line was cultured on Cultrex™ (12-18 mg/ml, Trevigen) with 
mTeSR (StemCell Technology) and medium was changed daily. Cells were splitted once a 
week with PBS plus EDTA 0.5 mM, without centrifugation and re-plated without the Rock 
inhibitor (Y-2763221, Cell Guidance System).  
hES RUES2 parental cell line was cultured on Geltrex™ (120-180 ug/ml, Thermo Fisher 
Scientific) with mTeSR (StemCell Technology) and medium was changed daily. Cells were 
passaged enzymatically with twice a week by ReLESR (StemCell Technology). 
hES Roslin cell lines (RC9 and RC17) was cultured on Cultrex™ (12-18 mg/ml, Trevigen) with 
StemPro™ hESC SFM (Thermo Fisher Scientific) and medium was changed daily. Cells were 
splitted once a week with PBS plus EDTA 0.5 mM and, after centrifugation, re-plated with 
Rock inhibitor (Y-2763221, Cell Guidance System). 
hiPS cells were cultured on Cultrex™ (12-18 mg/ml, Trevigen) with mTeSR (StemCell 
Technology) and medium was changed daily. Cells were splitted twice a week with ReLESR 
(StemCell Technology) and, after centrifugation, re-plated with the Rock inhibitor (Y-2763221, 
Cell Guidance System).  
 
Neuronal differentiation. hES and hiPS cells were plated for neuronal induction. Briefly, cells 
were plated at a density of 0.7 × 105 cells cm2 on Cultrex™ (12-18 mg/ml, Trevigen) coated 
dishes in grow medium supplemented with 10 µM ROCK inhibitor (Y-2763221, Cell Guidance 
System). Cell cultures were expanded for three days until they were 70% confluent. The starting 
differentiation medium includes DMEM/F12 (Life Technologies) with N2 and B27 (Life 
Technologies), supplemented with 500 nM LDN193189 (Sigma) and 10 µM SB431542 
(Tocris), which was used until re-plating. The medium was changed daily. Starting on day 5, 
200 ng ml-1 SHHC-25II (R&D) and 100ng ml-1 DKK-1 (Peprotech) were added to the culture 
and maintained until day 25. After the appearance of rosettes (between day 10 and day 15), the 
entire cell population was detached using Accutase (Millipore) and re-plated at a cell density of 
2.5 × 104 cells cm2 on dishes coated with Cultrex™ (12-18 mg/ml, Trevigen) without grow 
factors. The cells were maintained in terminal differentiation medium, which was composed of 
N2 medium supplemented with B27 and 30ng ml-1 BDNF, until the end of differentiation.  
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Immunofluorescence. Cells were fixed in 4% (wt/vol) paraformaldehyde (PFA) for 15 minutes 
at room temperature (RT) and washed 3 times with phosphate-buffered saline (PBS). Cells were 
then permeabilized with PBS containing 0.5% Triton X-100 (Sigma) and blocked with 10% 
(vol/vol) normal goat serum (NGS; Vector) for 1 hour at room temperature (RT). Next, cells 
were incubated overnight at 4°C with different primary antibodies. In the Table 6 details for 
each antibody were reported. 
Ki67 Abcam AB15580 1:1000
Oct3/4 Santa Cruz SC-5279 1:100
p27 Cell Signaling BK3698S 1:1000
Sox2 Millipore AB5603 1:200
Foxg1 Diatech M227 1:1000 for human cells: EDTA 60°C 10min
Ki67 Abcam AB15580 1:1000
p27 Cell Signaling BK3698S 1:1000
Pax6 Covance (BioLegend) 901301 1:2500
βIII-Tubulin Promega T8660 1:2500
Ascl1 BD 556604 1:1000
Ctip2 Abcam AB18465 1:1000
Ebf1 Santa Cruz SC-137065 1:1000
Gsx2 Millipore ABN162 1:250 for human cells: EDTA 60°C 10min
Islet1 DHSB 39.4D5-S 1:1000
Ki67 Abcam AB15580 1:1000
Map2 BD 556320 1:1000
Nkx2.1 Abcam AB76013 1:1000
p27 Cell Signaling BK3698S 1:1000
Pax6 Covance (BioLegend) 901301 1:2500
Tbr1 Abcam AB23345 1:1000
Tbr2 Abcam AB31940 1:1000
βIII-Tubulin Promega T8660 1:2500
Ctip2 Abcam AB18465 1:1000
Darpp-32 Abcam AB40801 1:250
Ebf1 Santa Cruz SC-137065 1:1000
GABA Sigma A2052 1:500
GAD67 Millipore MAB5406 1:2500
Islet1 DHSB 39.4D5-S 1:1000
Ki67 Abcam AB15580 1:1000
Map2 BD 556320 1:1000
Nkx2.1 Abcam AB76013 1:1000
p27 Cell Signaling BK3698S 1:1000
Pax6 Covance (BioLegend) 901301 1:2500
Tbr1 Abcam AB23345 1:1000
Tbr2 Abcam AB31940 1:1000
Antibodies_Day0 Company Code Working dilution Unmasking
Antibodies_Day50 Company Code Working dilution Unmasking
Antibodies_Day25 Company Code Working dilution Unmasking
Antibodies_Day15 Company Code Working dilution Unmasking
 
Table 5: Antibodies used to better characterize striatal differentiation protocol at different time points. 
After 3 washes in PBS 0.1% Triton X-100 (Sigma), appropriate secondary antibodies 
conjugated to Alexa fluorophores 488, 568, 546 and 647 (Molecular Probes, Invitrogen) were 
diluted 1:500 in blocking solution and mixed with Hoechst 33258 (5 µg ml-1; Molecular Probes, 
Invitrogen) to counterstain the nuclei. Images were acquired with a Leica DMI 6000B 
microscope (5x, 10x and 20x objectives), analyzed with LAS-AF imaging software, and then 
processed using Adobe Photoshop, only to adjust contrast for optimal RGB rendering.  
For the quantification, the images were acquired by Leica TCS SP5 confocal microscope (40x 
objective, zoom 1.7). Confocal images were acquired at a resolution of 1024 X 1024 dpi and 
200 Hz speed in 12 bits, and each focal plane was 10 µm thick. We acquired three z stacks for 
each focal plane and 9 different fields for each analyzed well.  
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Laser intensity, gain, and offset were maintained constant in each analysis and each time point.  
After acquisition, for the quantification analysis on the images were applied the Median Filter, a 
nonlinear filter, with Kernel size of a 3 x 3 pixel matrix to remove noise and background. 
Histological specimens of transplantations were examined using a Leica TCS SP5 confocal 
microscope. Confocal images were taken at a resolution of 1024 X 1024 dpi and 150 Hz speed, 
and each focal plane was 1 µm thick. Laser intensity, gain, and offset were maintained constant 
in each analysis. In collaboration with NICO institute in Turin, there were analyzed three 
animals for each condition.  
 
Quantification with CellProfiler software. CellProfiler is a versatile, open-source software 
tool to quantify data from biological images. It is designed for modular, flexible, high-
throughput analysis of images, measuring size, shape, intensity, and texture of every cell (or 
other object) in every image. For our purpose, all the images carrying the different 
immunocytochemical staining were analysed starting from a grayscale picture of the individual 
channels (blue, green and red – two colours staining). Images were filtered so that each channel 
was analysed for the appropriate marker Images of nuclear markers (DAPI, GSX2, CTIP2, 
ASCL1, PAX6, FOXG1) were processed with the following modules: 
• “ApplyThreshold” to remove background using two-classes “Global” “Otsu” thresholding 
method 
• “IdentifyPrimaryObject” in the size range of 5 to 15 pixels using “Global” or “Adaptive” 
thresholding strategy with 2-classes “Otsu” and “Automatic” smoothing method. “Laplacian of 
Gaussian” was used as method to distinguish clumped object and “Propagate” as method to 
divide clumped objects. 
Images carrying staining for cytoplasmic markers such as Darpp32 were processed first using 
the EnhanceOrSuppressFeatures module using the operation “Enhance”, feature “Tubeness” 
and a smoothing scale of 2.0. 
Objects were then identified using the “IdentifyPrimaryObject” module with a typical object 
diameter of 5-20 pixels, “Global” thresholding strategy and MCT thresholding method using 
“Intensity” as method to distinguish clumped object and again “Intensity” as method to divide 
clumped objects. 
To establish whether a cell is double positive for the two markers performed in the same 
staining or anyway to relate every object identified to a DAPI-positive object, we used the 
“RelateObjects” module. This module allows associating child objects with parent objects so 
                                                                                                                                          Materials and Methods 
 
 92 
relating objects identified by one staining with the DAPI or with a second staining (double 
positive cells). 
The frequency of cells positive for each marker was calculated using the “CalculateMath” 
module by dividing the number of parent object by the number of DAPI-identified objects. 
The data were finally exported into spreadsheets using the “ExportToSpreadsheet” module. 
An example of Pipeline for the triple nuclear staining DAPI, ASCL1 and GSX2 with all the 
module variable details is the following: 
Pipeline "CellProfiler Pipeline: http://www.cellprofiler.org 
Version:3 
DateRevision:20140723173957 
GitHash:6c2d896 
ModuleCount:13 
HasImagePlaneDetails:False 
Images:[module_num:1|svn_version:\'Unknown\'|variable_revision_number:2|show_window:False|notes:\
x5B\'To begin creating your project, use the Images module to compile a list of files and/or folders that you 
want to analyze. You can also specify a set of rules to include only the desired files in your selected 
folders.\'\x5D|batch_state:array(\x5B\x5D, dtype=uint8)|enabled:True|wants_pause:False :Filter 
images?:Images only Select the rule criteria:and (file doesnot contain ""foxp2"") 
 
Metadata:[module_num:2|svn_version:\'Unknown\'|variable_revision_number:4|show_window:False|notes
:\x5B\'The Metadata module optionally allows you to extract information describing your images (i.e, 
metadata) which will be stored along with your measurements. This information can be contained in the file 
name and/or location, or in an external file.\'\x5D|batch_state:array(\x5B\x5D, 
dtype=uint8)|enabled:True|wants_pause:False] 
    Extract metadata?:No 
    Metadata data type:Text 
    Metadata types:{} 
    Extraction method count:1 
    Metadata extraction method:Extract from image file headers 
    Metadata source:File name 
    Regular expression:^(?P<Plate>.*)_(?P<Well>\x5BA-P\x5D\x5B0-9\x5D{2})_s(?P<Site>\x5B0-
9\x5D)_w(?P<ChannelNumber>\x5B0-9\x5D) 
    Regular expression:(?P<Date>\x5B0-9\x5D{4}_\x5B0-9\x5D{2}_\x5B0-9\x5D{2})$ 
    Extract metadata from:All images 
    Select the filtering criteria:and (file does contain """") 
    Metadata file location: 
    Match file and image metadata:\x5B\x5D 
    Use case insensitive matching?:No 
 
NamesAndTypes:[module_num:3|svn_version:\'Unknown\'|variable_revision_number:5|show_window:Fal
se|notes:\x5B\'The NamesAndTypes module allows you to assign a meaningful name to each image by which 
other modules will refer to it.\', \'---\', \'Load the images by matching files in the folder against the unique 
text pattern for each stain\x3A d0.tif for nuclei, d1.tif for the PH3 image. The two images together comprise an 
image set.\'\x5D|batch_state:array(\x5B\x5D, dtype=uint8)|enabled:True|wants_pause:False] 
    Assign a name to:Images matching rules 
    Select the image type:Grayscale image 
    Name to assign these images:DNA 
    Match metadata:\x5B\x5D 
    Image set matching method:Order 
    Set intensity range from:Image metadata 
    Assignments count:3 
    Single images count:0 
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    Select the rule criteria:and (file does contain ""ch00"") 
    Name to assign these images:OrigRed 
    Name to assign these objects:Cell 
    Select the image type:Grayscale image 
    Set intensity range from:Image metadata 
    Retain outlines of loaded objects?:No 
    Name the outline image:LoadedObjects 
    Select the rule criteria:and (file does contain ""ch01"") 
    Name to assign these images:OrigGreen 
    Name to assign these objects:Nucleus 
    Select the image type:Grayscale image 
    Set intensity range from:Image metadata 
    Retain outlines of loaded objects?:No 
    Name the outline image:LoadedObjects 
    Select the rule criteria:and (file does contain ""ch02"") 
    Name to assign these images:OrigBlue 
    Name to assign these objects:Cytoplasm 
    Select the image type:Grayscale image 
    Set intensity range from:Image metadata 
    Retain outlines of loaded objects?:No 
    Name the outline image:LoadedOutlines 
 
Groups:[module_num:4|svn_version:\'Unknown\'|variable_revision_number:2|show_window:False|notes:\
x5B\'The Groups module optionally allows you to split your list of images into image subsets (groups) which 
will be processed independently of each other. Examples of groupings include screening batches, microtiter 
plates, time-lapse movies, etc.\'\x5D|batch_state:array(\x5B\x5D, 
dtype=uint8)|enabled:True|wants_pause:False] 
    Do you want to group your images?:No 
    grouping metadata count:1 
    Metadata category:None 
 
ApplyThreshold:[module_num:5|svn_version:\'Unknown\'|variable_revision_number:7|show_window:Tru
e|notes:\x5B\x5D|batch_state:array(\x5B\x5D, dtype=uint8)|enabled:True|wants_pause:False] 
    Select the input image:OrigBlue 
    Name the output image:ThreshBlue 
    Select the output image type:Grayscale 
    Set pixels below or above the threshold to zero?:Below threshold 
    Subtract the threshold value from the remaining pixel intensities?:No 
    Number of pixels by which to expand the thresholding around those excluded bright pixels:0.0 
    Threshold setting version:1 
    Threshold strategy:Global 
    Thresholding method:Otsu 
    Select the smoothing method for thresholding:Manual 
    Threshold smoothing scale:1.0 
    Threshold correction factor:1.0 
    Lower and upper bounds on threshold:0.0,1.0 
    Approximate fraction of image covered by objects?:0.01 
    Manual threshold:0.0 
    Select the measurement to threshold with:None 
    Select binary image:None 
    Masking objects:None 
    Two-class or three-class thresholding?:Two classes 
    Minimize the weighted variance or the entropy?:Weighted variance 
    Assign pixels in the middle intensity class to the foreground or the background?:Foreground 
    Method to calculate adaptive window size:Image size Size of adaptive window:10 
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ApplyThreshold:[module_num:6|svn_version:\'Unknown\'|variable_revision_number:7|show_window:Tru
e|notes:\x5B\x5D|batch_state:array(\x5B\x5D, dtype=uint8)|enabled:True|wants_pause:False] 
    Select the input image:OrigGreen 
    Name the output image:ThreshGreen 
    Select the output image type:Grayscale 
    Set pixels below or above the threshold to zero?:Below threshold 
    Subtract the threshold value from the remaining pixel intensities?:No 
    Number of pixels by which to expand the thresholding around those excluded bright pixels:0.0 
    Threshold setting version:1 
    Threshold strategy:Global 
    Thresholding method:Otsu 
    Select the smoothing method for thresholding:Manual 
    Threshold smoothing scale:1.0 
    Threshold correction factor:1.0 
    Lower and upper bounds on threshold:0.0,1.0 
    Approximate fraction of image covered by objects?:0.01 
    Manual threshold:0.0 
    Select the measurement to threshold with:None 
    Select binary image:None 
    Masking objects:None 
    Two-class or three-class thresholding?:Two classes 
    Minimize the weighted variance or the entropy?:Weighted variance 
    Assign pixels in the middle intensity class to the foreground or the background?:Foreground 
    Method to calculate adaptive window size:Image size 
    Size of adaptive window:10 
 
ApplyThreshold:[module_num:7|svn_version:\'Unknown\'|variable_revision_number:7|show_window:Tru
e|notes:\x5B\x5D|batch_state:array(\x5B\x5D, dtype=uint8)|enabled:True|wants_pause:False] 
    Select the input image:OrigRed 
    Name the output image:ThreshRed 
    Select the output image type:Grayscale 
    Set pixels below or above the threshold to zero?:Below threshold 
    Subtract the threshold value from the remaining pixel intensities?:No 
    Number of pixels by which to expand the thresholding around those excluded bright pixels:0.0 
    Threshold setting version:1 
    Threshold strategy:Global 
    Thresholding method:Otsu 
    Select the smoothing method for thresholding:Manual 
    Threshold smoothing scale:1.0 
    Threshold correction factor:1.0 
    Lower and upper bounds on threshold:0.0,1.0 
    Approximate fraction of image covered by objects?:0.01 
    Manual threshold:0.0 
    Select the measurement to threshold with:None 
    Select binary image:None 
    Masking objects:None 
    Two-class or three-class thresholding?:Two classes 
    Minimize the weighted variance or the entropy?:Weighted variance 
    Assign pixels in the middle intensity class to the foreground or the background?:Foreground 
    Method to calculate adaptive window size:Image size 
    Size of adaptive window:10 
 
IdentifyPrimaryObjects:[module_num:8|svn_version:\'Unknown\'|variable_revision_number:10|show_wi
ndow:True|notes:\x5B\x5D|batch_state:array(\x5B\x5D, dtype=uint8)|enabled:True|wants_pause:False] 
    Select the input image:ThreshBlue 
    Name the primary objects to be identified:Nuclei 
    Typical diameter of objects, in pixel units (Min,Max):5,15 
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    Discard objects outside the diameter range?:Yes 
    Try to merge too small objects with nearby larger objects?:No 
    Discard objects touching the border of the image?:Yes 
    Method to distinguish clumped objects:Laplacian of Gaussian 
    Method to draw dividing lines between clumped objects:Propagate 
    Size of smoothing filter:10 
    Suppress local maxima that are closer than this minimum allowed distance:7.0 
    Speed up by using lower-resolution image to find local maxima?:Yes 
    Name the outline image:PrimaryDAPI 
    Fill holes in identified objects?:After both thresholding and declumping 
    Automatically calculate size of smoothing filter for declumping?:Yes 
    Automatically calculate minimum allowed distance between local maxima?:Yes 
    Retain outlines of the identified objects?:Yes 
    Automatically calculate the threshold using the Otsu method?:Yes 
    Enter Laplacian of Gaussian threshold:0.7 
    Automatically calculate the size of objects for the Laplacian of Gaussian filter?:Yes 
    Enter LoG filter diameter:5.0 
    Handling of objects if excessive number of objects identified:Continue 
    Maximum number of objects:500 
    Threshold setting version:1 
    Threshold strategy:Global 
    Thresholding method:Otsu 
    Select the smoothing method for thresholding:Automatic 
    Threshold smoothing scale:1.0 
    Threshold correction factor:1 
    Lower and upper bounds on threshold:0.0,1.0 
    Approximate fraction of image covered by objects?:0.05 
    Manual threshold:0.0 
    Select the measurement to threshold with:None 
    Select binary image:None 
    Masking objects:None 
    Two-class or three-class thresholding?:Two classes 
    Minimize the weighted variance or the entropy?:Weighted variance 
    Assign pixels in the middle intensity class to the foreground or the background?:Foreground 
    Method to calculate adaptive window size:Image size 
    Size of adaptive window:10 
 
IdentifyPrimaryObjects:[module_num:9|svn_version:\'Unknown\'|variable_revision_number:10|show_wi
ndow:True|notes:\x5B\x5D|batch_state:array(\x5B\x5D, dtype=uint8)|enabled:True|wants_pause:False] 
    Select the input image:ThreshRed 
    Name the primary objects to be identified:Ascl1 
    Typical diameter of objects, in pixel units (Min,Max):8,20 
    Discard objects outside the diameter range?:Yes 
    Try to merge too small objects with nearby larger objects?:No 
    Discard objects touching the border of the image?:Yes 
    Method to distinguish clumped objects:Laplacian of Gaussian 
    Method to draw dividing lines between clumped objects:Propagate 
    Size of smoothing filter:10 
    Suppress local maxima that are closer than this minimum allowed distance:7.0 
    Speed up by using lower-resolution image to find local maxima?:Yes 
    Name the outline image:PrimaryAscl1 
    Fill holes in identified objects?:After both thresholding and declumping 
    Automatically calculate size of smoothing filter for declumping?:Yes 
    Automatically calculate minimum allowed distance between local maxima?:Yes 
    Retain outlines of the identified objects?:Yes 
    Automatically calculate the threshold using the Otsu method?:No 
    Enter Laplacian of Gaussian threshold:0.1 
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    Automatically calculate the size of objects for the Laplacian of Gaussian filter?:Yes 
    Enter LoG filter diameter:5.0 
    Handling of objects if excessive number of objects identified:Continue 
    Maximum number of objects:500 
    Threshold setting version:1 
    Threshold strategy:Adaptive 
    Thresholding method:Otsu 
    Select the smoothing method for thresholding:Automatic 
    Threshold smoothing scale:1.0 
    Threshold correction factor:1 
    Lower and upper bounds on threshold:0.0,1.0 
    Approximate fraction of image covered by objects?:0.05 
    Manual threshold:0.0 
    Select the measurement to threshold with:None 
    Select binary image:None 
    Masking objects:None 
    Two-class or three-class thresholding?:Two classes 
    Minimize the weighted variance or the entropy?:Weighted variance 
    Assign pixels in the middle intensity class to the foreground or the background?:Foreground 
    Method to calculate adaptive window size:Image size 
    Size of adaptive window:10 
 
IdentifyPrimaryObjects:[module_num:10|svn_version:\'Unknown\'|variable_revision_number:10|show_
window:True|notes:\x5B\x5D|batch_state:array(\x5B\x5D, dtype=uint8)|enabled:True|wants_pause:False] 
    Select the input image:ThreshGreen 
    Name the primary objects to be identified:Gsx2 
    Typical diameter of objects, in pixel units (Min,Max):8,20 
    Discard objects outside the diameter range?:Yes 
    Try to merge too small objects with nearby larger objects?:No 
    Discard objects touching the border of the image?:Yes 
    Method to distinguish clumped objects:Laplacian of Gaussian 
    Method to draw dividing lines between clumped objects:Propagate 
    Size of smoothing filter:10 
    Suppress local maxima that are closer than this minimum allowed distance:7.0 
    Speed up by using lower-resolution image to find local maxima?:Yes 
    Name the outline image:PrimaryGsx2 
    Fill holes in identified objects?:After both thresholding and declumping 
    Automatically calculate size of smoothing filter for declumping?:Yes 
    Automatically calculate minimum allowed distance between local maxima?:Yes 
    Retain outlines of the identified objects?:Yes 
    Automatically calculate the threshold using the Otsu method?:No 
    Enter Laplacian of Gaussian threshold:0.1 
    Automatically calculate the size of objects for the Laplacian of Gaussian filter?:Yes 
    Enter LoG filter diameter:5.0 
    Handling of objects if excessive number of objects identified:Continue 
    Maximum number of objects:500 
    Threshold setting version:1 
    Threshold strategy:Adaptive 
    Thresholding method:Otsu 
    Select the smoothing method for thresholding:Automatic 
    Threshold smoothing scale:1.0 
    Threshold correction factor:1 
    Lower and upper bounds on threshold:0.0,1.0 
    Approximate fraction of image covered by objects?:0.05 
    Manual threshold:0.0 
    Select the measurement to threshold with:None 
    Select binary image:None 
                                                                                                                                          Materials and Methods 
 
 97 
    Masking objects:None 
    Two-class or three-class thresholding?:Two classes 
    Minimize the weighted variance or the entropy?:Weighted variance 
    Assign pixels in the middle intensity class to the foreground or the background?:Foreground 
    Method to calculate adaptive window size:Image size 
    Size of adaptive window:10 
 
CalculateMath:[module_num:11|svn_version:\'Unknown\'|variable_revision_number:2|show_window:True
|notes:\x5B\x5D|batch_state:array(\x5B\x5D, dtype=uint8)|enabled:True|wants_pause:False] 
    Name the output measurement:Ascl1vsDAPI 
    Operation:Divide 
    Select the numerator measurement type:Image 
    Select the numerator objects:Ascl1 
    Select the numerator measurement:Count_Ascl1 
    Multiply the above operand by:1.0 
    Raise the power of above operand by:1.0 
    Select the denominator measurement type:Image 
    Select the denominator objects:Nuclei 
    Select the denominator measurement:Count_Nuclei 
    Multiply the above operand by:1.0 
    Raise the power of above operand by:1.0 
    Take log10 of result?:No 
    Multiply the result by:100 
    Raise the power of result by:1.0 
    Add to the result:0.0 
    Constrain the result to a lower bound?:No 
    Enter the lower bound:0.0 
    Constrain the result to an upper bound?:No 
    Enter the upper bound:1.0 
 
CalculateMath:[module_num:12|svn_version:\'Unknown\'|variable_revision_number:2|show_window:True
|notes:\x5B\'CalculateMath can also be used to obtain a per-image percentage of PH3-positive nuclei if 
ClassifyObjects is not practical to use for your assay\x3A Divide the PH3 nuclei count by the total nuclei count 
and multiply by 100. \'\x5D|batch_state:array(\x5B\x5D, dtype=uint8)|enabled:True|wants_pause:False] 
    Name the output measurement:Gsx2vsDAPI 
    Operation:Divide 
    Select the numerator measurement type:Image 
    Select the numerator objects:Gsx2 
    Select the numerator measurement:Count_Gsx2 
    Multiply the above operand by:1 
    Raise the power of above operand by:1 
    Select the denominator measurement type:Image 
    Select the denominator objects:Nuclei 
    Select the denominator measurement:Count_Nuclei 
    Multiply the above operand by:1 
    Raise the power of above operand by:1 
    Take log10 of result?:No 
    Multiply the result by:100 
    Raise the power of result by:1 
    Add to the result:0 
    Constrain the result to a lower bound?:No 
    Enter the lower bound:0 
    Constrain the result to an upper bound?:No 
    Enter the upper bound:1 
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ExportToSpreadsheet:[module_num:13|svn_version:\'Unknown\'|variable_revision_number:11|show_win
dow:True|notes:\x5B\'Export the per-image measurements to a comma-delimited file 
(.csv).\'\x5D|batch_state:array(\x5B\x5D, dtype=uint8)|enabled:True|wants_pause:False] 
    Select the column delimiter:Tab 
    Add image metadata columns to your object data file?:No 
    Limit output to a size that is allowed in Excel?:No 
    Select the measurements to export:Yes 
    Calculate the per-image mean values for object measurements?:No 
    Calculate the per-image median values for object measurements?:No 
    Calculate the per-image standard deviation values for object measurements?:No 
    Output file location:Default Input Folder sub-folder\x7CDocuments/CellProfiler Counts 
    Create a GenePattern GCT file?:No 
    Select source of sample row name:Metadata 
    Select the image to use as the identifier:None 
    Select the metadata to use as the identifier:None 
    Export all measurement types?:Yes 
    Press button to select measurements to 
export:Experiment\x7CModification_Timestamp,Experiment\x7CPipeline_Pipeline,Experimen
t\x7CRun_Timestamp,Experiment\x7CCellProfiler_Version 
    Representation of Nan/Inf:Null 
    Add a prefix to file names?:Yes 
    Filename prefix\x3A:Paola 
    Overwrite without warning?:Yes 
    Data to export:Image 
    Combine these object measurements with those of the previous object?:No 
    File name:Image.csv 
    Use the object name for the file name?:Yes 
 
Generation of hES H9 inducible lines. For the generation of inducible hES cell lines, we first 
modified the commercially available pCMV-TetON-3G (Clontech) plasmid by removing the 
TetOn-3G cassette by digestion with EcoRI and HindIII (Biolabs). To create the inducible 
plasmid, we replaced the CRE cassette in a pCAG-CRE vector (Addgene) and inserted the gel-
purified TetON-3G cassette, to generate a pCAG-TetON-3G vector. Then, we inserted in the 
pTRE3G-IRES responsive vector (Clontech) Gsx2 (in the first MCS) to create the pTRE3G-
Gsx2 plasmid, Gsx2 (in the first MCS) together with Ebf1 (in the second MCS) to create the 
pTRE3G-Gsx2-IRES-Ebf1 plasmid, and Ebf1 alone (in the second MCS) to create the 
pTRE3G-IRES-Ebf1. Gsx2 cDNA was a gift from Kenneth Campbell (Cincinnati), Ebf1 cDNA 
was a gift from Giacomo Consalez (Milano). 
hES (H9) cell line was cultured as described. 7 x106 cells were used for introducing the 
constructs by Nucleofection (Lonza) using a mouse ES cell nucleofection kit and 
electroporation protocol B16. 7µg of pCAG-TetON-3G in the first round and 7µg of pTRE-
Gsx2 or pTRE-Gsx2-Ebf1 or pTRE-Ebf1 were used, together with 700ng of linear resistant 
marker (Puromycin). Cells were then plated in two Cultrex-coated 6 cm dishes with mTeSR 
(StemCell Technology) medium supplemented with Rock inhibitor (Y-2763221). After 72 hours 
antibiotics (Puromycin) were added to the medium for positive selection. Following 
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approximately 2 weeks in selection medium, hES cell colonies were carefully selected and 
expanded in Cultrex-coated 48-well plates. Clones were then expanded and tested for transgene 
expression after 48 hours of doxycycline treatment. During the first round, the clones were 
screened by transient transfections with a pTRE-Luciferase vector (Clontech), during the second 
round; the clones were screened by 48 hours doxycycline treatment and immunofluorescence 
analysis for Gsx2, Gsx2-Ebf1, and Ebf1. 
 
Cell-Cycle Analysis with IdU and BrdU. For the assay based on IdU and BrdU 
administration, it was added IddU (Sigma) in the culture medium for 1 hours and 30 minutes 
followed by BrdU (Sigma) for 30 minutes. At the end of treatment with BrdU, the cells were 
fixed. For the double immunostaining for IdU and BrdU, a primary antibody mouse anti-
BrdU/IdU was used, which recognizes both BrdU and IdU (clone B44, BD), and rat anti-BrdU 
(clone BU1/75, Abcam) which recognized only BrdU. To unmask BrdU and IdU staining after 
4% PFA fixation, cells was treated with 0.2N HCl for 5 minutes at room temperature and then 
with 2N HCl for 20 minutes at 37°C. After 3 washes in PBS 0.1% Triton X-100 (Sigma), 
appropriate secondary antibodies conjugated to Alexa fluorophores 488, and 568 (Molecular 
Probes, Invitrogen) were diluted 1:500 in blocking solution and mixed with Hoechst 33258 (5 
µg ml-1; Molecular Probes, Invitrogen). For the estimation of cell cycle length, it was followed 
the paradigm described in Martynoga et al., 2005. 
 
Cumulative BrdU Labelling. For the cumulative BrdU labelling, BrdU was added to the cell 
culture medium for different time windows in different wells. BrdU immunofluorescence is 
performed as described above for the cell-cycle analysis. 
 
Study of Cell-Cycle Exit. As described above, hES iGOF cell lines were treated with 
doxycycline from day 20 to day 30 of neuronal differentiation. At day 25 cells were exposed to 
BrdU for 2 hours to label cells in the S-phase of the cell cycle. Neuronal differentiation was 
carried on until day 30, when cells were fixed and processed as described above for BrdU 
immunofluorescence. Cells were also stained for Ki67 to label all proliferating cells at day 30. 
Cell-cycle exit index was calculated by dividing the total number of BrdU+/Ki67− cells by the 
total number of BrdU+ cells. 
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Transplantations. For transplantation experiment we collaborated with professor Vercelli and 
his group at the Neuroscience Institute Cavalieri Ottolenghi (NICO) in Turin, and professor 
Moresco and her group at San Raffaele University in Milan.  
Athymic NIH-FOXN1 nude rats (Charles River) of 200–250 g were lesioned with quinolinic 
acid (QA). For the transplantation of hES H9-derived cells, the QA lesion was induced by 
intrastriatal injection of 120 to 210 nmol of freshly prepared QA 7 days before cell 
transplantation following stereotaxic coordinates: AP= +0.5, L= +/-2.8, V= 5.0.  
For the Gsx2–Ebf1 iGOF transplantation experiments the nude rats were lesioned 8 days before 
transplantation and the QA lesion was induced by intrastriatal injection of 210 nmol of freshly 
made QA in the right striatum using the following stereotaxic coordinates: AP, +0.6; L, ±2.8; V, 
5.0. We injected 1 M PBS in the left striatum.  
hESCs H9 and Gsx2-Ebf1 iGOF were differentiated following the protocol of Delli Carri et al., 
2013, described above. The Gsx2-Ebf1 iGOF cells were treated with doxycycline from day 15 
to day 20 of differentiation to induce Gsx2 and Ebf1 expression.  
At day 20, both hES H9 and Gsx2-Ebf1 iGOF, the cells were detached with Accutase 
supplemented with N2 1:100 for 20–30 min at 37 °C. Cells were then resuspended to obtain a 
single cell suspension at a concentration of 50 x 103 cells per µL and then transplanted in 
complete medium by bilateral stereotaxic transplantation in lesioned adult athymic rats using 
the following coordinates: AP, +0.9; L, +3.1/–3.1; DV, 5.0. A total of 3 x 105 cells (6 µL) per 
injection site were delivered by a single injection. Two months after transplantation, the animals 
were killed, transcardially perfused, and the brains cryosectioned for immunohistochemical 
analyses. Animal experiments were carried out according to the National regulatory 
requirements and the Institutional Animal Care and Use Committee (IACUC).  
 
mmRNA Transfections. For the preparation of mmRNA transfection mix we followed the 
manual of the StemMACS mRNA Reprogramming Kit (Miltenyi Biotec) using the StemMACS 
mRNA Transfection Reagent and StemMACS mRNA Transfection Buffer. We used 200 ng 
mmRNA of GSX2 and EBF1 (gently provided by Miltenyi Biotec) daily for 5 consecutive days. 
As a transfection control, 100ng and 200 ng of nuclear GFP (Miltenyi Biotec) were used for the 
preliminary experiments for the setting up of transfection condition and protocols. For the set up 
we also tested the TransIT®-mRNA Reprogramming Kit (Mirus Company) using the 
TransIT®-mRNA Transfection Reagent and TransIT®-mRNA Transfection Buffer.  
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Statistical Analysis. Data represented in this thesis were analysed by PRISM software 
(GraphPad, version 6), for the statistical tests. Statistical significance was tested with the 
unpaired (nonparametric) t test as reported in each figure and legend. All results were expressed 
as means ± SEM for the images quantification and means ± SD for TF effect analysis.  
The sample size was chosen based on our preliminary studies and on the variability across 
differentiations. Given that the long-term differentiation experiments (50 - 80 days) are 
susceptible to variability, we decided to perform five different biological experiments to address 
this issue. No data points were excluded from the reported analyses. Differentiation experiments 
were excluded when a poor neural induction was obtained (low Otx2, N-cadherin, and Pax6 
expression). For the TFs analysis, the cell counting experiments were performed using specific 
software (CellProfiler or ITCN in ImageJ, partially automatic); therefore, they were performed 
blindly. The remaining cell counts were performed manually; no blinding was performed. 
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Medium spiny neurons (MSNs) are a key population in the basal
ganglia network, and their degeneration causes a severe neurode-
generative disorder, Huntington’s disease. Understanding how ven-
tral neuroepithelial progenitors differentiate into MSNs is critical for
regenerative medicine to develop specific differentiation protocols
using human pluripotent stem cells. Studies performed in murine
models have identified some transcriptional determinants, including
GS Homeobox 2 (Gsx2) and Early B-cell factor 1 (Ebf1). Here, we
have generated human embryonic stem (hES) cell lines inducible
for these transcription factors, with the aims of (i) studying their
biological role in human neural progenitors and (ii) incorporating TF
conditional expression in a developmental-based protocol for gen-
erating MSNs from hES cells. Using this approach, we found that
Gsx2 delays cell-cycle exit and reduces Pax6 expression, whereas
Ebf1 promotes neuronal differentiation. Moreover, we found that
Gsx2 and Ebf1 combined overexpression in hES cells achieves high
yields of MSNs, expressing Darpp32 and Ctip2, in vitro as well in
vivo after transplantation. We show that hES-derived striatal pro-
genitors can be transplanted in animal models and can differentiate
and integrate into the host, extending fibers over a long distance.
MSNs | Gsx2 | Ebf1 | hES cells | HD
The striatum is the largest component of the basal ganglia, it isthe hub of converging excitatory connections from the cortex
and thalamus, and it originates the direct and indirect pathways,
which are distinct basal ganglia circuits involved in motor control
(1). In humans, the degeneration of the principal striatal neuronal
population, the medium spiny neurons (MSNs), causes a severe
neurodegenerative condition, Huntington’s disease (HD). A main
goal in the field is the study of the mechanisms underlying neuronal
specification and degeneration. A large number of studies per-
formed in model organisms, such as the mouse model organism,
have provided fundamental insights into brain development, shed-
ding light on genes, signaling pathways, and general rules of brain
formation. It is not incidental to point out that obvious species-
specific differences exist in many aspects between mice and humans
(gestation, morphology, and gene expression regulation in time and
space). Thus, additional model systems are needed to uncover
specific functions of a gene in human development (2, 3). This task
is also driven by the need to investigate neurological diseases, such
as HD, in a model that more closely resembles human biology.
Here, we decided to take advantage of human embryonic stem
(hES) cells to develop a model to study the roles of selected tran-
scription factors (TFs) in human striatal development and as a
strategy to increase recovery of authentic MSNs for transplantation
purposes. During brain development, a set of TFs are expressed in
different regions and times and cooperate to establish a dorsal–
ventral and medial–lateral positional identity in progenitor cells and
to specify neuronal terminal differentiation. In particular, in the
developing telencephalon, two TFs play a key role in contributing to
the formation of the striatum: the GS Homeobox 2 (Gsx2) and
Early B-cell factor 1 (Ebf1).
Gsx2 is expressed in the ventral ventricular zone (VZ) of the
telencephalon, where it is involved in maintaining the identity of
early striatal progenitors, and it is required for promoting a striatal
fate (4–8). Recently, two studies have reported about the role of
Gsx2 in mouse neural stem cells, showing that Gsx2 regulates
progenitor proliferation and differentiation (9, 10). Nonetheless,
these studies focused on Gsx2 function in mouse neurospheres and
in adult neural stem cells models that could bear different signa-
tures with respect to human embryonic ventral progenitors. Ebf1 is
a helix–loop–helix TF that has been shown to control cell differ-
entiation in the murine embryonic striatum (11–13), but it has never
been studied in a human model system of striatal development.
We have previously demonstrated that human ventral telence-
phalic progenitors can be generated from hES cells by using a Shh
treatment coupled with Wnt inhibition (14, 15). These progenitors
eventually differentiate into mature, electrophysiologically ac-
tive neurons. However, the protocol yielded cultures containing
Darpp32+–Ctip2+ cells never exceeding 10–15%. We therefore
wished to establish a hES cell-based inducible gain-of-function
(iGOF) system whereby TFs expressed in the developing striatum
can be harnessed to improve MSN differentiation and to study
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human striatal development. We uncovered roles for Gsx2 and Ebf1
during human striatal specification and differentiation, in particular
in cell-cycle regulation. Moreover, we report that a specific tem-
poral window of Gsx2 and Ebf1 overexpression in hES cells
achieves high yields of MSNs in vitro, expressing Darpp32 and
Ctip2, and that these cells can be found in vivo after transplantation.
We show that these hES-derived striatal progenitors can be trans-
planted in animal models and can differentiate and integrate into
the host, extending fibers over a long distance.
Results
Generation of Inducible hES Cell Lines. To shed light on the tran-
scriptional program that drives human striatal differentiation, we
decided to develop an inducible overexpression system in hES H9
cells. To this goal, we modified a commercially available TetON
construct (Clontech) by moving the TetON cassette into a chicken
beta-actin promoter with CMV enhancer-based plasmid (pCAG)
(Methods) to avoid silencing effects (16). This construct was in-
troduced by nucleofection (Fig. S1A) in hES H9 cells (p40–p50)
along with a linear construct carrying a gene encoding for puromycin
resistance. After selection, several stable hES cell clones were picked,
amplified, and tested for inducibility by using a pTRE-Luciferase
construct. We selected four clones that showed no basal Luciferase
activity and high induction after 48 h of doxycycline treatment. We
amplified and characterized the clones C4 and B6 that showed the
highest Luciferase expression after transient transfection (Fig. S1A,
chart). They responded promptly to differentiation stimuli similarly
to the original H9 cells (Fig. S1 K–N). Next, we constructed three
conditional vectors with the pTRE promoter, regulating Gsx2
(pTRE-Gsx2), Gsx2 alongside with Ebf1 by means of an IRES2
sequence (pTRE-Gsx2-Ebf1), and Ebf1 alone (pTRE-Ebf1). Us-
ing these three constructs, we carried out nucleofections in the
hES-inducible clones (Fig. S1A′). After selection, several stable
hES cell clones were picked, amplified, and tested for Gsx2, Gsx2–
Ebf1, and Ebf1 expression. Four Gsx2, one Gsx2–Ebf1, and two
Ebf1 overexpressing clones were chosen for the next experiments.
We quantified Gsx2, Gsx2–Ebf1, and Ebf1 overexpression in the
inducible hES cell clones after 72 h of doxycycline treatment (Fig.
S1 B–J). Quantification of Gsx2+ cells after 72 h of doxycycline
induction in Gsx2 iGOF showed 55 ± 3% expression (Fig. S1D).
Quantification of Gsx2+ and Ebf1+ cells in Gsx2–Ebf1 iGOF
showed 51 ± 19% and 48 ± 22% expression, respectively (Fig.
S1G), with virtually all of the cells coexpressing Gsx2 and Ebf1
(Fig. S1 F′ and F′′). Finally, quantification of Ebf1+ cells in Ebf1
iGOF showed 60 ± 8% expression (Fig. S1J). We next used
Western Blot analysis to perform a second quantification experi-
ment during neuronal differentiation, at day30, after 10 d of
doxycycline treatment (Fig. S1O) in the three iGOF lines. Western
Blot quantification (Fig. S1P) showed up-regulation of Gsx2
(12-fold in Gsx2–Ebf1 and 124-fold in Gsx2 iGOF) and Ebf1 (243-
fold in Gsx2–Ebf1 and 267-fold in Ebf1 iGOF) in the three lines
compared with basal culture conditions (no doxycycline).
Gsx2 and Ebf1 Regulation of Patterning Genes. The patterning ac-
tivity of Gsx2 during ventral telencephalic development has been
extensively studied in mouse models (4–7, 17). However, no
Fig. 1. Gsx2 and Ebf1 roles during patterning of telencephalic progenitors. (A–D) Gsx2–Ebf1 iGOF line down-regulates Pax6 and Nkx2.1 expression during the day 20–30
developmental window. Instead, Gsx2 and Ebf1 single lines down-regulated only Pax6 (E–L). Representative immunofluorescence images for Pax6 (green) and Nkx2.1 (red)
expression. (Scale bar, 100 μm.) (M) Schema illustrating the experimental design. (N) Quantification analysis for Pax6 and Nkx2.1 expressing cells; n = 3 biological replicates.
For Pax6 analysis, n = 8 (no dox) and n = 10 (dox). *P < 0.05, **P < 0.01, ***P < 0.003 two-tailed t test analysis. Data are presented as means ± SD.
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information is available about its roles during human development.
To determine the effects of Gsx2 and Ebf1 overexpression in hu-
man neural progenitors, we used a specific protocol that we pre-
viously showed to have the potential to generate, first, ventral
telencephalic progenitors and, then, mature MSNs after 80 d in
vitro (14, 15). However, the protocol yields cultures containing
Darpp32+/Ctip2+ cells never exceeding 10–15%. We therefore
wished to implement this protocol by establishing a hES cell-based
iGOF system whereby TFs expressed in the developing striatum can
be used to increase MSN yield. Thus, we decided to overexpress
Gsx2, Gsx2–Ebf1, and Ebf1 in different temporal windows during
hES neural differentiation: day 10–15, day 15–20, and day 20–30. To
test this TF-mediated specification, we first analyzed regional pat-
terning in the hES-derived neural progenitors. We found that Gsx2,
Gsx2–Ebf1, and Ebf1 iGOF down-regulated Pax6, a dorsal cortical
marker, at day 30 (Fig. 1 A, B, E, F, I, and J, and quantification in
Fig. 1N) and at day15 (Fig. S2 A–D), corresponding to the end of
the doxycycline treatments. Because Pax6 is also an important early
neuroectodermal marker in humans (3), we sought to determine if
Gsx2 overexpression could compromise the process of neural in-
duction in hES cells. To test this possibility, Gsx2 expression was
induced during the day 10–15 time window, the earliest period used
in this study. Importantly, Gsx2 activation did not down-regulate
Otx2 andN-Cadherin (two early neural plate markers) expression at
day15, the end of the doxycycline treatment (Fig. S2 E–H), sug-
gesting that the cells correctly went through neural induction.
Next, we performed immunostaining for Nkx2.1, a marker
expressed in proliferative cells of the MGE, in striatal inter-
neurons and in Ctip2+ cells of the mature striatum (and in the
hypothalamus). Because at this time point (day 30) most cells are
still proliferating and we do not usually detect Ctip2 expression,
the down-regulation of Nkx2.1 that we found in the double
Gsx2–Ebf1 iGOF line (Fig. 1 C, D, G, H, K, and L, and quan-
tification in Fig. 1N) suggests a suppression of an MGE fate.
Next, to move forward a transient and nonintegrating system, we
generated a modified mRNA (mmRNA) for Gsx2. We transfected
this mmRNA into H9 hES-derived neural progenitor cells from day
20 to day 25 of differentiation using the same protocol used for the
iGOF lines. As shown in Fig. S2 I–K, Gsx2 overexpressing cells
reduced Pax6 expression similarly to that found in the Gsx2 iGOF
line (threefold decrease in both overexpressing systems).
Together, the data indicate that in hES cells that are undergoing
neuronal conversion, Gsx2 and Ebf1 overexpression suppresses the
dorsal marker Pax6 and the MGEmarker Nkx2.1 while maintaining
typical neuroepithelial markers (Otx2, N-Cadherin).
Given the in vivo expression of Gsx2 in progenitor cells and
Ebf1 in early postmitotic neurons, we next investigated if and
how Gsx2 and Ebf1 overexpression modified cell proliferation.
Gsx2 and Ebf1 Regulate Cell-Cycle Kinetics. Regulation of cell pro-
liferation in the developing telencephalon is a tightly regulated
process, and it is essential to produce the correct number of post-
mitotic neurons. To examine the effects of Gsx2 and Ebf1 over-
expression in human progenitor cells, we first performed a
cumulative BrdU analysis in the hES cell lines inducible for Gsx2
and Gsx2–Ebf1. After treating the cells with doxycycline for 5 d, we
administered BrdU for 30 min and 4, 8, and 20 h. We found that the
Gsx2 iGOF line showed a reduced BrdU incorporation compared
with the untreated cells (Fig. 2A and quantification in Fig. 2B). In
contrast, the Gsx2–Ebf1 double inducible line showed a similar
BrdU incorporation propensity compared with the control line,
suggesting that cell-cycle alteration by Gsx2 was rescued by Ebf1
(Fig. 2 C andD). Finally, we performed the same analysis also in the
Ebf1 iGOF line, finding that at 20 h there was a significant increase
in BrdU incorporation compared with the control line, the opposite
phenotype found in Gsx2 iGOF cells (Fig. 2 E and F). These data
suggested an involvement of Gsx2 and Ebf1 in cell-cycle regulation.
To test this hypothesis also in hES-derived neural progenitor cells
(the biological context that more closely resembles the developing
embryonic human brain), we administered doxycycline from day 20
to day 30 of the neuronal differentiation protocol and analyzed cell-
cycle kinetics by a BrdU/IddU double labeling paradigm (18, 19)
(see Methods for details and Fig. 2K for experimental design). We
first tested this method in our hES cell lines, in basal conditions (no
doxycycline), with culture conditions permitting pluripotency, find-
ing a cell-cycle time (Tc) of 19.4 ± 4.4 h, comparable to previous
published data (20). Next, we analyzed the Tc of day 30 hES-
derived neural progenitor cells (Fig. 2 G–L), and we found results
in agreement with the BrdU cumulative analysis performed in Fig.
2 A–E. Estimation of control cell (no doxycycline) Tc was 12 ± 1 h,
whereas the Gsx2 overexpressing cells showed a Tc of 24 ± 4 h.
Next, we analyzed the contribution of Ebf1 by measuring Tc in
Gsx2–Ebf1 iGOF cells, finding a value of 7 ± 1 h, suggesting that
Ebf1 could override a Gsx2-mediated increase of cell-cycle length.
In agreement with these findings, when we examined the single
Ebf1 iGOF line, we found that this line showed a cell cycle similar
to the double Gsx2–Ebf1 iGOF (Fig. S3 A–C).
To rule out the possibility that Gsx2 iGOF cells were un-
dergoing differentiation (and thus incorporating less BrdU), we
analyzed Map2 expression at day30, the same time point used for
the previous analysis. Gsx2 iGOF showed a marked reduction of
Map2+ cells (Fig. S3 D–G), in agreement with the previous cell-
cycle analysis data and further suggesting that Gsx2+ cells could
not exit the cell cycle. Moreover, we investigated this Gsx2-
mediated cell-cycle regulation also in another two hES inducible
clones (G18 and G17; Fig. S3 H–M), finding similar results.
Together, these results suggest that Gsx2 regulates cell-cycle
progression in human neural progenitor cells.
Gsx2 Constitutive OverexpressionModifies Proliferative Characteristics and
Differentiation Potential of hES-Derived Neuroepithelial Stem Cells. To
test if this Gsx2-driven cell-cycle regulation is telencephalic-
dependent or represents a general role, we decided to test its over-
expression in long-term self-renewing neuroepithelial stem (LT-NES)
cells. LT-NES cells represent an excellent model for studying human
neuroepithelial cell biology (21). They are hES cell-derived neural
progenitors with an anterior hindbrain identity. Here, we decided to
take advantage of this cell population and its regional identity to gain
insights into the cell-cycle regulation by Gsx2.
We generated an LT-NES cell line overexpressing Gsx2 by
nucleofection of a pCAG-Gsx2-IRES-Puromicyn vector and iso-
lation of stable, positive clones. We characterized different clones,
finding identical phenotypes across the different lines. A control
cell line was also generated by using a pCAG-EGFP-IRES-
Puromycin vector, and we found identical self-renewal capacity and
differentiation potential compared with the unmodified cell line.
First, we decided to analyze the effects of Gsx2 overexpression
during proliferation of LT-NES cells by means of BrdU studies.
We first performed a BrdU pulse of 2 h, and we found a decrease
in BrdU incorporation in LT-NES cells overexpressing Gsx2 (LT-
NES-Gsx2), compared with the control cell line (form 36.3 ± 5.1%
to 26.8 ± 5.9%, P < 0.005; Fig. S4 A–C). A similar proliferative
defect was found after BrdU pulses of 4 and 24 h (Fig. S4C). We
reasoned that this decrease in BrdU incorporation could be linked
to an increase in cell differentiation or to an increase in cell-cycle
length, which leads to a reduction in the number of times the cells
pass through the S phase, thus reducing BrdU incorporation.
Thus, we performed differentiation experiments and cell-cycle
length studies to distinguish between these two possibilities.
First, we differentiated the cells for 10 d, and we analyzed the
expression of the early neuronal marker βIII-Tubulin. We found
that the number of newly formed neurons was decreased in LT-
NES-Gsx2 compared with the control cell line (form 28.9 ± 7.8% to
15.1 ± 1.8%, P < 0.05; Fig. S4 D–F), in agreement with the results
previously found in the Gsx2 iGOF hES line (Fig. S3 D–G). A
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similar result was found when studying the expression of a more
mature neuronal marker such as Map2 (Fig. S4 J and K). Moreover,
even when it was possible to detect βIII-Tubulin expression in
LT-NES-Gsx2 cells (at early passages), more mature and lineage-
specific markers, such as GABA, were absent (Fig. S4 L and M),
further suggesting that Gsx2 overexpression impairs neuronal
differentiation and maturation. Next, we asked if the decrease in
BrdU incorporation was caused by a cell-cycle disregulation. To
this goal, we performed an analysis of cell-cycle characteristics
using the BrdU/IddU double labeling paradigm to estimate the
cell-cycle length in the two cell populations, the LT-NES-Gsx2 and
LT-NES-EGFP cells. We found that Gsx2 overexpression caused
a significant increase in total cell-cycle length (Tc) compared with
the control cell line (Fig. S4 G–I). This increase was even more
pronounced after a few passages (Fig. S4I, see increment between
p5 and p10, from 26.88 ± 1.84 h to 135.30 ± 33.79 h, P < 0.005),
suggesting that Gsx2 overexpression has a cumulative effect during
time. The control cell line, during the same time period, did not show
a statistically significant increase in Tc (from 6.9 ± 0.1 to 9.5 ± 3, P >
0.1; Fig. S4I).
In conclusion, these data demonstrated that a constitutive Gsx2
overexpression was detrimental for proper neuronal differentia-
tion and maturation, even in a nontelencephalic compartment,
corroborating the results obtained in the hES inducible lines.
Thus, to summarize the results shown in Fig. 2 and Fig. S4, Gsx2
has a major role in regulating proliferation, by lengthening the cell
cycle in a context-independent manner.
Ebf1 Promotes Neuronal Differentiation and Maturation. The fore-
going data demonstrate that Gsx2 has important roles in regu-
lating cell-cycle progression, whereas Ebf1 expression probably
enhances differentiation. To investigate the specific role of Ebf1
in human neural progenitor cells, we first studied the Ebf1 iGOF
line. After overexpressing Ebf1 (by doxycycline treatment) in the
day 20–30 temporal window of hES neuronal differentiation, we
compared βIII-Tubulin expression with control (no doxycycline)
Fig. 2. Gsx2 and Ebf1 modulate cell-cycle kinetics. (A, C, and E) Representative images of a BrdU cumulative labeling experiment in Gsx2 (A), Gsx2–Ebf1 (C), and Ebf1
(E) iGOF lines in culture condition allowing pluripotency. BrdU was added to the culture media at 0.5, 4, 8, and 20 h. (B, D, and F) Quantification of BrdU+ cells at the
different time points. Data are represented as means ± SD; two-tailed t test analysis. *P < 0.05, **P < 0.01. (Scale bar, 75 μm.) (G–J) Representative images of neuronal
progenitor cell-cycle length analysis using BrdU/IdU colabeling. Day 30 hES cell-derived neural progenitors, treated for 10 d with doxycycline, were exposed to IdU at T
0 h and with BrdU at T 1.5 h (see experimental design in K). Arrowheads point to cells that left the S-phase at T 1.5 h (Lcells, green only cells), whereas yellow cells are
still in the S-phase at T 2 h. (Scale bar, 75 μm.) (L) Quantification of Tc estimation from BrdU/IdU analysis of Gsx2 and Gsx2–Ebf1 iGOF. Box shows the median and the
25th and 75th percentiles. The whiskers of the graph show the largest and smallest values. ***P < 0.0005, ****P < 0.0001.
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cells. Ebf1 overexpression resulted in a significant increase in the
number of βIII-Tubulin+ cells (Fig. S5 A–D, quantification in
Fig. S5C). Next, to further test the Ebf1 role in increasing neu-
ronal differentiation, we transfected an mmRNA for Ebf1
(Miltenyi Biotec) in unmodified H9 hES-derived neural pro-
genitor cells (exposed to the same protocol used for the iGOF
lines). First, we tested transfection efficiency by staining for Ebf1
after 2 consecutive days of mmRNA delivery, finding a trans-
fection efficiency of 32 ± 5% (Fig. S5 E and F). Next, we in-
vestigated βIII-Tubulin expression after 5 consecutive days of
transfections (day 30). We found 17 ± 3% of cells expressing
βIII-Tubulin compared with 11 ± 1% of untreated cells (Fig. S5
G and H, and quantification in Fig. S5I, P < 0.01, n = 3, unpaired
t test). We then investigated if Ebf1 overexpression had an effect on
neurite length or complexity. Interestingly, by using NeurphologyJ
analysis (22), we found an increase of attachment points (Fig. S5 J–L)
on neuronal soma (from 3.5 ± 0.1% to 4.7 ± 0.7% in transfected
cells, normalized over total soma number, P < 0.05, n = 3, unpaired t
test). These data strongly suggest that Ebf1 has a role as a neuronal
differentiation player during hES differentiation.
Fig. 3. Gsx2 and Ebf1 differentially regulate cell-cycle exit and promote striatal differentiation. (A–F) Representative images of cell-cycle exit studies following the
experimental design depicted in Top Right. Arrows point to BrdU+Ki67− cells (that exited cell cycle); arrowheads point to BrdU+Ki67+ cells (still proliferating). (Scale bar,
75 μm.) (G) Quantification of cell-cycle exit in Gsx2, Gsx2–Ebf1, and Ebf1 lines after 10 d of doxycycline treatments compared with basal conditions (no doxycycline,
dotted line). Box shows the median and the 25th and 75th percentiles. The whiskers of the graph show the largest and smallest values. **P < 0.005. (H–K) Repre-
sentative images of neuronal monolayers generated from the Gsx2–Ebf1 iGOF line: immunofluorescence for Ctip2 (red) and Darpp32 (green) at day 80 of striatal
differentiation, in day 20–30 doxycycline-treated (I and K) and nontreated cells (H and J). H and I, 5×magnification; J and K, 20×magnification. (L) Quantification of
Darpp32+ cells by automated cell counts of 10× fields normalized to the area occupied by nuclear counterstaining. The images in the figure represent reproducible
results from four out of five differentiation experiments reaching day 80. [Scale bar, 250 μm (J and K) and 75 μm (H and I).] ****P < 0.0001. (M) Sodium current density
of neuronal monolayer cultures at day 100 of differentiation in control and doxycycline-treated conditions. Data are represented as means ± SD. Individual round and
squared dots represent individual recorded cells. Sodium current density was significantly higher (***P < 0.001) in Gsx2–Ebf1 overexpressing cells.
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Gsx2 and Ebf1 Overexpression Differentially Regulates Early Neuronal
Differentiation. Taking into account the different proliferative re-
sponses of hES-derived neural progenitors to Gsx2 and Ebf1 over-
expression and the increased neurogenesis after Ebf1 overexpression,
we decided to investigate the tendency of Ebf1 and Gsx2–Ebf1 iGOF
lines toward differentiation. First, we monitored neuronal differenti-
ation during the differentiation process, finding better neuronal
morphology in the two lines after doxycycline treatment. To quantify
this differentiation propensity, we performed cell-cycle exit studies, by
administering for 2 h BrdU at day 25 of neuronal maturation in a day
20–30 temporal window of doxycycline treatment. The cells were then
fixed at day 30 and analyzed for BrdU and Ki67 expression (see
schema in Fig. 3). Cell-cycle exit index was calculated by dividing the
total number of BrdU+ Ki67− cells by the total number of BrdU+
cells. As shown in Fig. 3 A–F and quantified in Fig. 3G, the three cell
lines showed different phenotypes. Gsx2 overexpressing cells were
more likely to remain in the cell cycle (50.2 ± 29.7% reduction of cell-
cycle exit over no-doxycycline cells; no doxycycline levels were arbi-
trarily set to 100; P < 0.005, n = 3; Fig. 3 A and B, quantification in
Fig. 3G), in agreement with the data presented in Fig. S3 D–G. Ebf1
incorporation caused increased differentiation output in Gsx2–Ebf1
iGOF line (150 ± 28% increase in cell-cycle exit over no-doxycycline
cells; no doxycycline levels were arbitrarily set to 100; P < 0.05, n = 3;
Fig. 3 C and D, quantification in Fig. 3G). Finally, Ebf1 single iGOF
overexpressing cells were 113 ± 7% more likely to exit the cell cycle
(no doxycycline levels were arbitrarily set to 100%; P < 0.05, n = 3;
Fig. 3 E and F, chart in Fig. 3G).
Again, these results were in line with the hypothesis of Gsx2
retaining neural progenitor cells in an undifferentiated state and
Ebf1 controlling cell-cycle exit and progenitor maturation.
Gsx2–Ebf1 Overexpression Induces MSN Differentiation from hES Cells.
To determine the striatal differentiation potential of hES cells
overexpressing Gsx2–Ebf1 in the day 20–30 developmental win-
dow, we conducted long-term differentiation experiments and
analyzed the cells at day 60 and day 80.
First, we evaluated the number of cells expressing the striatal
neuronal markers Isl1 and Ctip2 at day 60 of differentiation. Isl1+
cells increased from 4.4 ± 0.9% in control cells (no doxycycline) to
25 ± 5% in Gsx2–Ebf1 overexpressing cells (P < 0.00005, n = 3; Fig.
S6 C and D). Ctip2+ cells increased from 8.5 ± 2.3% in control cells
(no doxycycline) to 20 ± 3.9% in Gsx2–Ebf1 overexpressing cells
(P < 0.0005, n = 3; Fig. S6 E and F). To further validate these
findings using a different system and to move toward a non-
integrating system, we also performed transfection experiments in
the RC17 hES cell line using mmRNAs for Gsx2 and Ebf1. Fol-
lowing the experimental strategy shown in Fig. S6B, Isl1+ cells in-
creased from 6.2 ± 2.2% in nontransfected cells to 17.2 ± 3.2% in
cells transfected sequentially with Gsx2 and Ebf1 (Fig. S6G andH).
At day 60 of differentiation, Ctip2+ cells increased from 20.10 ±
7.4% in nontransfected cells to 42.9 ± 7.5% in cells transfected
sequentially with Gsx2 and Ebf1 (Fig. S6 I and J).
Next, we analyzed the neuronal population at day 80 of differenti-
ation by studying Darpp32 and Ctip2 expression. Initially, we quanti-
fied the generated striatal neurons by expressing the density of
Ctip2+/Darpp32+ area per arbitrary surface area (Fig. 3 H and I),
finding a higher efficiency of Darpp32+/Ctip2+ neuron generation in the
iGOF line compared with the control line (from 3.8 ± 3.1% to 38.8 ±
13.7%). Then we focused on the number of Darpp32+ cells by per-
forming automating soma cell counting (by using the NeurphologyJ
ImageJ plugin; see Methods for quantification details), and we found a
higher number of Darpp32+ cells per unit area in the iGOF line than in
control cells (from 79.5 ± 26.3 in basal condition to 693 ± 76 in iGOF;
number of cells per area; see Methods for quantification details, n = 3;
Fig. 3 J and K, quantification in Fig. 3L; n = 3).
Finally, we studied if the Gsx2–Ebf1 combination could confer
functional electrophysiological properties to the differentiated
neurons. Although passive properties did not change significantly
between doxycycline-treated and nontreated cells, we found in-
teresting results studying sodium currents. In particular, Na+
current density was significantly higher in doxycycline-treated cells
(from 30.7 ± 6.6 pA/pF in control cells to 76.1 ± 10.1 pA/pF in
Gsx2–Ebf1 overexpressing cells, P < 0.001; Fig. 3M).
Gsx2–Ebf1 iGOF Cells Survive and Differentiate in Vivo After
Transplantation. Next, we wanted to assess long-term survival and
differentiation of Gsx2–Ebf1 iGOF cells after transplantation in the
striatum of QA-lesioned, athymic adult rats. The transplanted ani-
mals were followed up to 2 mo and then killed for immunohisto-
chemical analysis. To this goal, we decided to induce Gsx2 and Ebf1
expression from day 15–20 of neuronal differentiation and perform
the transplant at day 20 (Fig. 4A). This time point was chosen
according to previous studies performed in our laboratory, showing
an increase in cell survival when cells were transplanted at day 20
compared with day 30. Two months after transplantation, we found
many human nuclei+ cells in the transplanted site (Fig. 4 B and C,
red cells), suggesting optimal survival (average of 53 ± 16% human
nuclei+ cells; Fig. 4D). We then analyzed the expression of markers
of mature striatal neurons: Ctip2, GABA, and Darpp32. In-
terestingly, Ctip2 and GABA were largely present in the lesioned
transplanted site (human nuclei+ cells) (Fig. 4B, arrowheads point
to examples of Ctip2+/hNuclei+ cells). In addition, immunostain-
ing for Darpp32 and Ctip2 showed similar results (Fig. 4C), with
these two striatal markers expressed in the site of transplantation.
To further investigate the coexpression of Ctip2 and Darpp32 in
human nuclei+ cells, we analyzed the immunostaining for Ctip2/
human nuclei (Fig. 4C’) and Darpp32/human nuclei (Fig. 4C’’) on
the same section shown in Fig. 4C. Insets in Fig. 4 C’ and C’’ show
representative human nuclei+ cells expressing both Ctip2 and
Darpp32 markers. We quantified the cells that were human nuclei/
Ctip2 double-positive, and we found 23 ± 6% of cells expressing
both markers. When we quantified control (No Dox) cells, we
found similar results (Fig. S7 C and D for Darpp32 and Ctip2
quantifications, respectively). Future studies will need to address
the role of the in vivo environment in differentiating hES cells.
These results suggest that Gsx2–Ebf1 iGOF cells were able to
differentiate into striatal neurons in vivo as in vitro.
Long-Distance Axonal Outgrowth and Local Circuitry Integration of
hES-Derived Striatal Neurons After Transplantation. We next per-
formed a histological analysis of long-distance, target-specific out-
growth by using a human-specific antibody for NCAM (hNCAM).
When grafted to the lesioned striatum, both WT and iGOF cells
showed hNCAM-rich grafts (Fig. 4 E and E’ as well as F and F’ and
Fig. S7 A and B for low-magnification pictures showing graft size).
These grafts were able to extend axons to the substantia nigra (Fig. 4
G and G’ as well as H and H’), a specific striatal target. We also
quantified fiber length (Methods) in iGOF and control cells (Fig.
S7E), finding similar results. Moreover, we could also observe the
presence of human cells expressing the neurotransmitter GABA (Fig.
4 I and J). Lastly, these hES-derived progenitors were also able to
differentiate into local circuitry interneurons, as shown by the pres-
ence of human cells expressing Calbindin (Fig. 4K), Calretinin (Fig.
4L), and Nkx2.1 (Fig. S7 F and G).
In summary, we provide evidence of an efficient integration in
the host neuronal circuitry with human axonal extension to
striatal-specific targets as the substantia Nigra.
Discussion
This study aimed to achieve two goals: (i) to study Gsx2 and Ebf1
function during human ventral telencephalic development, and
(ii) to improve MSN differentiation from hES cells by transcrip-
tional specification. In both efforts, we have succeeded in applying
an iGOF system for forcing TF expression in defined temporal
windows and in combining this approach with a morphogens-
driven ventral telencephalic specification.
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In making progress toward the first aim, we have demonstrated a
dual role for Gsx2 in embryonic human neural progenitors. First, it
imparts a regional identity by directly or indirectly down-regulating
Pax6 expression. We found this effect during different time windows
of Gsx2 induction, suggesting a time-independent primary function
for this TF. It is also important to note that Gsx2 iGOF cells
responded properly to neural induction extrinsic signals as evi-
denced by the correct expression of early neural plate markers
such as Otx2 and N-Cadherin. Second, Gsx2 has a major role in
regulating proliferation, by lengthening the cell cycle in a context-
independent manner: We found similar results in cells as different
as LT-NES, self-renewing hES cells, and hES-derived neural
progenitors. To begin with, we show that in LT-NES cells, a model
of human neuroepithelial cells, constitutive Gsx2 overexpression
caused a progressive increase in cell-cycle length during passages,
leading to a proliferation block and to differentiation impairment.
Interestingly, Gsx2 time-restricted overexpression showed the
same consequences on cell-cycle regulation, suggesting that this is a
key Gsx2 role in neuronal progenitors. Moreover, because LT-NES
cells have a ventral anterior hindbrain identity and hES-derived
neural progenitors express more anterior markers, such as Otx2, this
Gsx2 activity on cell-cycle regulation is context-independent and
likely reflects a primary role. Interestingly, it is well accepted that
during mouse development cell-cycle lengthening is correlated with
enhanced neurogenesis (23). Our data about Gsx2-regulated cell-
cycle lengthening are somehow in contrast, as we found a reduction
in differentiation. It is probable that Gsx2 retains human neural
progenitor cells in a condition that prevents excessive proliferation
Fig. 4. Gsx2–Ebf1 overexpressing cells maturate in vivo into MSNs and extend axonal projections into distant targets. (A) Experimental design for hES cell-
derived neural progenitor transplantation in QA-lesioned athymic rats, after 5 d of doxycycline treatment. (B–C’’) Representative images of grafted cells 2 mo
after transplantation, assayed for human nuclei marker and specific MSNs markers. Insets in C’ and C’’ are magnifications of regions depicted in C’ and C’’.
Arrowheads point to human cells expressing both Ctip2 and Darpp32. Arrows point to grafted human cells expressing either Ctip2 or Darpp32. [Scale bar,
35 μm (B–C’’) and 15 μm (Insets).] (D) Quantification of human cells in the grafted site (hNuclei+ cells) and of Ctip2+ cells in the hNuclei+ population. Box shows
the median and the 25th and 75th percentiles. The whiskers of the graph show the largest and smallest values. [Scale bar, 75 μm (B, C, C’, and C’’) and 30 μm
(Insets in C’ and C’’).] (E–H’) DAB-developed sections stained for human NCAM antibody showing the neuronal outgrowth of intrastriatal transplants of hES-
derived striatal progenitor cells. E–H and G’ and H’ were counterstained with Cresyl-Violet to show the surrounding tissue. (I–J) Examples of hNuclei+GABA+
cells found both in WT (I) and iGOF cells (J). [Scale bar, 250 μm (E, F, G, and H) and 25 μm (E’, F’, G’, and H’).] (K and L) Examples of hNuclei cells expressing the
local interneurons markers Calbindin (K) and Calretinin (L). Calbindin+ cells displayed a morphology reminiscent of the typical fusiform shape of human
interneurons. Calretinin+ cells exhibited ovoid somata, as expected for human striatal interneurons. [Scale bar, 25 μm (I and J) and 5 μm (K and L).]
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and differentiation, with implications for the generation of the cor-
rect number of differentiated progeny during human development.
A recent paper has evidenced that in adult neural stem cells Gsx2
overexpression promotes the transition from quiescent to activated
neural stem cells (9). Nonetheless, they also pointed out how a high
level of Gsx2 blocks the lineage progression toward transit ampli-
fying progenitors, a more differentiated cell population. Our find-
ings obtained in human neural progenitors are in line with the
suggestion that fine-tuned Gsx2 levels must be reached to promote
neuronal differentiation. The ventral mouse and human telen-
cephalon express at high-level Gsx2 in the VZ (4), including the
LGE proliferative region, and these expression data likely reflect
the roles played by this TF. Later during development, the Gsx2
expression is reduced in both the number of Gsx2+ cells and the
intensity levels (5), suggesting that its expression must be down-
regulated over time to allow neuronal maturation.
Thus, our data point to a role for Gsx2 in restraining cell-cycle
progression in neural progenitors while instructing a regional ventral
phenotype. Of note, the differentiation defect observed in Gsx2
iGOF cells was rescue by Ebf1: the corecruitment of Gsx2 and Ebf1
caused a more efficient neuronal differentiation, while preserving the
regional patterning activity of Gsx2, as shown by the Pax6 down-
regulation. Interestingly, even if these two TFs are not expressed in
the same region and time during development, their combination in
hES cell-derived neural progenitors allowed a proper cell-cycle pro-
gression and neuronal differentiation, while maintaining a patterning
activity (Pax6 down-regulation). We show here that Ebf1, by using
iGOF lines or mmRNA transfections, can enhance neuronal differ-
entiation in hES-derived neuronal populations, in terms of neuronal
numbers and morphological characteristics.
In this work, we also identified a temporal window for an efficient
iGOF transcriptional activation or mmRNAs transfections leading
to improved human neural progenitor patterning and differentiation
toward MSNs. In the last few years, the use of specific extrinsic
signals in combination with the dual SMAD inhibition strategy
resulted in the development of protocols for the derivation of many
central and peripheral nervous system lineages from hES and iPS
cells (24). Here we show that TFs with a different expression pattern
and timing can be combined to efficiently differentiate hES H9 cells
toward a striatal phenotype. This study has then provided a working
system for combining extrinsic (morphogens) and intrinsic (TFs)
players to manipulate hES or iPS cell fates. In particular, by com-
bining a ventral-inducer like Gsx2 and a neuronal differentiation-
effector as Ebf1 we could shift the differentiation outcome toward
MSNs. Of interest for future studies in stem-cell therapies for HD,
we show that, upon transplantation in HD rat models, Gsx2–Ebf1
iGOF cells can survive, differentiate, and express key striatal
markers such as Ctip2 and Darpp32. Moreover, we show that
striatal-patterned hES cells can project axons over long distances in
the adult brain (of clinical importance), providing appropriate in-
nervation of striatal GABA targets as the substantia nigra.
These findings in combination with the ability to use mmRNAs for
nonintegrating transient gene expression might further pave the way
for a rational modulation of cell fates, especially in clinical settings.
We also show that hES cells can be harnessed to model human
embryonic development and neuronal differentiation by inducible
expression of key developmental TFs. This technique allows
mimicking and testing the temporal widows of TF activation
during human embryonic development.
Methods
ES and LT-NES Cell Culture. The hES H9 cell line (Wicell) was cultured onMatrigel
(BD, Becton Dickinson) or Matrix (Cell Guidance System). Pluripro (Cell Guidance
System) medium was changed daily. Cells were passaged enzymatically with
Accutase (Invitrogen) every 3 d. LT-NES cells were derived as described in ref. 21
and maintained in DMEM/F12 (Life Technologies) supplemented with N2 1:100
(Life Technologies), B27 1:1,000 (Life Technologies), and 10 ng/mL Fgf2 and Egf
(Peprotech). LT-NES neuronal differentiation was triggered by removing Fgf2
and Egf from the medium.Mycoplasma contamination was checked every 3 mo.
Neuronal Differentiation. hES cells were plated for neuronal induction as de-
scribed in ref. 25. Briefly, cells were plated at a density of 0.7 × 105 cells per cm−2
on Matrigel-coated dishes in Pluripro medium supplemented with 10 μM
ROCK inhibitor (Y-2763226, Sigma). Cell cultures were expanded for 3 d until
they were nearly confluent. The starting differentiation medium included
DMEM/F12 (Life Technologies) with N2 and B27 (Life Technologies), supple-
mented with 5 μM Dorsomorphin (Sigma) or 500 nM LDN 193189 (Sigma) and
10 μM SB431542 (Tocris), which were used until day 12. Every 2 d, the medium
was replaced with new medium. Starting on day 5, 200 ng·mL−1 SHHC-25II
(R&D) and 100 ng·mL−1 DKK-1 (Peprotech) were added to the culture and
maintained for 3 wk. After the appearance of rosettes (around day 15), the
entire cell population was detached using Accutase (Millipore) and replated at
a cell density of 2.5 × 104 cells per cm−2 on dishes coated with Matrigel (BD,
Becton Dickinson). The cells were maintained in terminal differentiation me-
dium, which was composed of N2 medium supplemented with B27 and
30 ng·mL−1 BDNF, until the end of differentiation.
Generation of hES H9 Inducible Lines. To generate an inducible hES cell line, we
first modified a pCMV-TetON-3G (Clontech) by removing the TetOn-3G
cassette by digestion with EcoRI and HindIII (Biolabs). Then, we removed the
CRE cassette of a pCAG-CRE vector (Addgene) and inserted the gel-purified
TetON-3G cassette to generate a pCAG-TetON-3G vector. Next, we inserted in
the pTRE3G-IRES responsive vector (Clontech) Gsx2 alone (in the first MCS),
Gsx2 (in the first MCS) together with Ebf1 (in the secondMCS), and Ebf1 alone
(in the first MCS). Gsx2 cDNA was a gift from Kenneth Campbell, Cincinnati
Children’s Hospital Medical Center, Cincinnati, Ebf1 cDNAwas a gift from Giacomo
Consalez, Division of Neuroscience, San Raffaele Scientific Institute, Milan.
ThehESH9 cell linewas culturedasdescribed.Weused8×106 cells for introducing
the constructs by Nucleofection (Lonza) using a mouse ES cell nucleofection kit
and electroporation protocol B16. We used 7 μg of pCAG-TetON-3G in the first
round and 7 μg of pTRE-Gsx2 or pTRE-Gsx2-Ebf1 in the second round, together with
700 ng of linear resistant marker (Clontech, Puromycin during the first round and
Hygromycin during the second round). Cells were then plated in two Matrigel-
coated 6-cm dishes with Pluripro medium supplemented with Rock inhibitor
(Y-2763226). After 72 h, antibiotics (Puromycin during the first round andHygromycin
during the second round) were added to the medium for positive selection. Fol-
lowing ∼2 wk in selection medium, hES cell colonies were carefully selected and
expanded in Matrigel-coated 48-well plates. Clones were then expanded and tested
for transgene expression after 48 h of doxycycline treatment. During the first round,
the clones were screened by transient transfections with a pTRE-Luciferase
vector (Clontech). During the second round, the clones were screened by 48 h
of doxycycline treatment, and immunofluorescence analysis was performed
for Gsx2 and Gsx2–Ebf1.
Immunofluorescence. Cells were fixed in 4% (vol/vol) paraformaldehyde (PFA)
for 15 min at room temperature (RT) and washed 3×with PBS. Cells were then
permeabilized with 0.5% Triton (Sigma) and blocked with 10% normal goat
serum (Vector) for 1 h at RT. Next, cells were incubated overnight at 4 °C with
the following primary antibodies and dilutions: anti-OCT4, 1:100 (Santa Cruz);
anti-OTX2, 1:500 (Chemicon); anti-PAX6, 1:2,000 (Hybridoma Bank); anti-NESTIN,
1:200 (R&D); anti–βIII-Tubulin, 1:1,000 (Promega); anti-MAP2, 1:500 (BD Bio-
science); anti-CALBINDIN, 1:200 (Swant); anti-GABA, 1:500 (Sigma); anti-CTIP2,
1:500 (Abcam); anti-DARPP32, 1:200 (Epitomics); anti-GSX2 (Millipore);
hNuclei (Chemicon); and Calbindin, Calretinin, and Parvalbumin (Swant). After
three washes in PBS 0.1% Triton, appropriate secondary antibodies conju-
gated to Alexa fluorophores 488 or 568 (Molecular Probes, Invitrogen) were
diluted 1:500 in blocking solution and mixed with Hoechst 33258 (5 μg·mL−1;
Molecular Probes, Invitrogen) to counterstain the nuclei. Images were acquired
with a Leica DMI 6000B microscope (5×, 10×, and 20× objectives) and analyzed
with LAS-AF imaging software and then processed using Adobe Photoshop,
only to adjust contrast for optimal RGB rendering with the same procedure in
doxycycline-treated and untreated cells.
Histological specimens from transplantations were examined using a Leica
TCS SP5 confocal microscope. Confocal images were taken at a resolution of
1024 × 1024 dpi and 150 Hz speed, and each focal plane was 1 μm thick.
Laser intensity, gain, and offset were maintained constant in each analysis.
Three animals for each transplant type were analyzed. hNCAM fiber quan-
tification was performed using Spaceballs (MBFbiosciences).
Cell-Cycle Analysis with IdU and BrdU. IddU (Sigma) was first added in the
culturemedium for 1.5 h followed by BrdU (Sigma) for 30min. Cells were then
fixed at the end of the BrdU treatment. For IdU/BrdU double labeling, primary
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antibodies used were mouse anti-BrdU/IdU (which recognizes both BrdU and
IdU, clone B44, 1:100; BD), and rat anti-BrdU (clone BU1/75, 1:100; Abcam).
After 4% PFA fixation, cells are first treated with 0.2N HCl for 5 min at RT and
then with 2N HCl for 20 min at 37° for BrdU/IdU immunofluorescence. Cell-
cycle lengths (estimation) were calculated as previously described (18): Cells
labeled initially with IdU and leaving S-phase during the interval between
IdU and BrdU were labeled with IdU but not BrdU (leaving fraction).
Cumulative BrdU Labeling. BrdU is added to the cell culture medium for
different time windows in different wells. BrdU immunofluorescence is
performed as described above for the cell-cycle analysis.
Cell-Cycle Exit Study. iGOF cell lines were treatedwith doxycycline from day 20
to day 30 of neuronal differentiation. At day 25 cells were exposed to BrdU
for 2 h to label cells in the S-phase of the cell cycle. Neuronal differentiation
was carried on until day30, when cells were fixed and processed as described
above for BrdU immunofluorescence. Cells were also stained for Ki67 to label
all proliferating cells at day 30. Cell-cycle exit index was calculated by dividing
the total number of BrdU+ Ki67− cells by the total number of BrdU+ cells.
mmRNA Transfections. The transfectionmixwaspreparedaccording to themanual
of the StemMACSmRNAReprogrammingKit (Miltenyi Biotec) using the StemMACS
mRNA Transfection Reagent and StemMACS mRNA Transfection Buffer. We used
200 ng mmRNA of GSX2 and EBF1 (gently provided by Miltenyi Biotec) daily for 5
consecutive days. As a transfection control, 100 ng of nuclear GFP (Miltenyi Biotec)
was used the first day of transfection to monitor the transfection efficiency.
Transplantations. Athymic NIH-FOXN1 Nude rats (Charles River) of 200–250 g
were lesioned 8 d before transplantation with quinolinic acid (QA). The lesion
was generated by monolateral injection of 210 nmol of freshly made QA in the
right striatum using the following stereotaxic coordinates: AP, +0.6; L, ±2.8; V,
5.0. We injected 1 M PBS in the left striatum. Gsx2–Ebf1 iGOF cells were differ-
entiated as described above. Cells were treated with doxycycline from day 20 to
day 30 of differentiation to induce Gsx2 and Ebf1 expression. At day 30, cells
were detached with Accutase supplemented with N2 1:100 for 20–30 min at
37 °C. Cells were then resuspended to obtain a single cell suspension at a con-
centration of 50 × 103 cells per μL and then transplanted in complete medium by
bilateral stereotaxic transplantation in lesioned adult athymic rats using the
following coordinates: AP, +0.9; L, +3.1/–3.1; DV, 5.0. A total of 2 × 105 cells (4 μL)
per injection site were delivered by a single injection. Two months after trans-
plantation, the animals were killed, transcardially perfused, and the brains
cryosectioned for immunohistochemical analyses. Animal experiments
were carried out according to the National regulatory requirements and
the Institutional Animal Care and Use Committee (IACUC). The experimental
protocol has been approved by the Ethics Committee of the San Raffaele
Scientific Institute and by the Italian Ministry of Health (Protocol no. 722
approved on January 12th, 2016).
Patch-Clamp Recordings and Data Analysis.Whole-cell patch-clamp recordings
were performed at RT in voltage and current-clamp configuration. During
recordings cells were visualized using an inverted microscope (Nikon Eclipse
TE200) and maintained in a solution containing (in mM) NaCl (140), KCl (3),
glucose (10), Hepes (10), MgCl2 (1), and CaCl2 (2) at pH 7.4 with NaOH. Pi-
pettes were produced from borosilicate glass capillary tubes (Hilgenberg
GmbH) by means of a horizontal puller (P-97, Sutter instruments), and their
resistance was 2–4 MΩ, when filled with (in mM) CsCl (135), NaCl (3), Hepes
(10), EGTA (10), CaCl2 (0.5), and MgCl2 (1) at pH 7.3 with CsOH. To isolate the
sodium current, cells were recorded using an extracellular solution con-
taining (in mM) NaCl (140), KCl (3), TEA-Cl (10), Hepes (10), 4-AP (5), MgCl2
(1), and CaCl2 (1) at pH 7.4 with NaOH, and pipettes were filled with a so-
lution containing (in mM) CsCl (120), NaCl (10), TEA-Cl (20), Hepes (10), EGTA
(10), and MgCl2 (2) at pH 7.3 with CsOH. Recordings were performed with
an AXOPATCH 200B amplifier (Molecular Devices) and digitized with a
DigiData1322A (Molecular Devices). Data were acquired using the software
Clampex (Molecular Devices), sampled at 50 kHz and filtered at 10 kHz. The
series resistance was minimized and monitored throughout the experiment.
Analysis was performed with Clampfit (Molecular Devices) and Origin 6.0
(Microcal Software Inc.). Statistics reported are mean ± SEM, unless otherwise
specified. Statistical tests were performed using Instat (GraphPad Software).
Two-tailed P values were used throughout.
Statistical Analysis. Statistical tests were performed with PRISM software
(GraphPad, version 6). Statistical significance was tested with the unpaired
(nonparametric) t test as reported in each figure and legend. All results were
expressed as means ± SD. The sample size was chosen based on our pre-
liminary studies and on the variability across differentiations. Given that the
long-term differentiation experiments (80 d) are susceptible to variability, we
decided to perform five different biological experiments (Fig. 3) to address this
issue. No data points were excluded from the reported analyses. Differentia-
tion experiments were excluded when a poor neural induction was obtained
(low Otx2, N-cadherin, and Pax6 expression).
Themajority of the cell counting experiments (Figs. 1–4)were performed using
specific softwares (CellProfiler, fully automatic, or ITCN in ImageJ, partially
automatic); therefore, they were performed blindly. The remaining cell counts
were performed manually; no blinding was performed.
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